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SUMMARY
The cytoplasmic ribonuclease inhibitor/ribonuclease 
system has been detected in a wide variety of tissues and 
species. In most of the tissues studied, cytoplasmic 
ribonuclease is undetectable due to the presence of excess 
inhibitor. The observation that tissues with high levels 
of RNA/protein synthesis have high levels of free inhibitor 
has been taken to imply some essential role for the inhibitor 
in the control of protein synthesis. The precise nature of 
this regulatory function is however unknown. Studies on 
the enzyme associated with the inhibitor in vivo indicated 
that it was similar, but not identical to secretory pancreatic 
RNase A.
Previous studies on the inhibitor/ribonuclease system of 
rat uterus revealed that free inhibitor was detectable in 
the uteri of immature rats, but disappeared after administration 
of oestrogen or during normal sexual maturation of the rat.
The following studies were undertaken in order to determine 
the mechanism whereby oestrogen decreased inhibitor activity, 
and to gain a better understanding of the precise function of 
the inhibitor/ribonuclease system. The main points to emerge 
from these studies were as fallows
(i) Antiserum raised to purified rat liver inhibitor was used 
to quantitate total inhibitor levels in control, oestrogen- 
treated, and mature rat uteri. These studies revealed that 
inhibitor levels increased by up to 50?^ after hormone-treatment 
and normal development. It was therefore apparent that the
loss of inhibitor activity was not due to reduced synthesis 
of the protein.
(ii) Total and free ribonuclease activity was assayed, and 
revealed that the total activity increased by up to eight fold 
after oestrogen-treatment and during normal development.
Free enzyme activity became detectable in uterine cytoplasm. 
Taken together, these results indicated that the loss of 
inhibitor activity arose through saturation by endogenous 
ribonuclease.
(iii) Activity stain analysis of the uterine cytoplasmic 
ribonucleases revealed the presence of at least two distinct 
species with approximate molecular weights of 14,000 and 
18,000. The activity of both of these species appeared to 
increase after oestrogen-treatment and during normal develop­
ment. An attempt to detect and quantitate these enzymes 
using antiserum raised to bovine RNase A was not successful.
(iv) A cDNA clone encoding rat pancreatic RNase A mRNA 
was obtained, and used in an attempt to detect the mRNA 
encoding the endogenous uterine enzymes. It was not possible 
to detect a clear cut example of an RNase A like mRNA in 
control or oestrogen-treated uterine RNA. These results did 
not however rule out the possibility that the uterine enzymes 
were induced at.the transcriptional level by oestrogen.
(v) A technique was developed whereby free inhibitor and 
inhibitor/ribonuclease complexes could be resolved on non-
- denaturing polyacrylamide gels, and subsequently detected by 
immunoblotting. These studies confirmed that the loss of
inhibitor activity was due to saturation by endogenous 
enzyme. Furthermore, it was found that 3-6 distinct enzyme 
species or enzyme variants were present in the cytoplasm 
of oestrogen-treated uteri. The relative levels of these 
enzymes were found to differ in a variety of tissues analysed. 
Ferguson plot analysis revealed that they differed on the 
basis of charge, and to a lesser extent, molecular weight.
(vi) The cytoplasmic ribonucleases of rat liver and mature 
rat uteri were purified using a relatively rapid procedure 
giving high yields. The different species were resolved 
to some extent using chromatography on heparin-sepharose.
Thus, in rat liver one major and one minor species were 
resolved, (RLC I and RLC II), whilst in mature rat uteri 
three species were resolved, (RUC T, RUC II and RUC III).
RLC I was shown to be homogeneous as determined by SDS-PAGE. 
Insufficient quantities of the other enzymes were available 
for similar analyses. The relative molecular weight of 
each activity was determined by activity staining. These 
studies revealed that each activity consisted of more than 
one distinct species or variant. It was assumed that 
heparin-sepharose chromatography did not completely resolve 
all of the species present. Tentative analysis indicated 
that the species RUC II and RUC III corresponded to the 
oestrogen-induced species.
(vii) Some of the properties of the purified enzymes were 
compared. The enzymes were shown to differ on the basis of 
pH optima, kinetic parameters, and their relative activity
towards the homopolymers Poly (u) and Poly (c) relative 
to yeast RNA.
 ^ The aforementioned results are discussed in relation
to the possible function of the inhibitor/ribonuclease 
system.
1. INTRODUCTION
This thesis describes* an analysis of the effects of 
oestrogen on the ribonuclease and ribonuclease inhibitor 
activity of the immature rat uterus. The study is introduced 
by brief reviews of both the mechanism of action of oestrogen, 
and of mammalian ribonuclease, its cytoplasmic inhibitor, 
and their possible roles in the modulation of RNA stability.
1.1 The mechanism of action of steroid hormones
The classical two step model of steroid hormone action, 
proposed by Jenson and de Sombre (l972), is illustrated in 
Figure 1. The following sections are intended to highlight 
recent advances in our understanding of the various steps 
involved in this model.
Figure 1 . The Oenson-de Sombre two-step model of steroid hormone 
action.
Key: - Plasma steroid binding protein.
S - Steroid hormone.
- Cytoplasmic steroid receptor.
R^T - Transformed cytoplasmic steroid receptor.
R|^  - Nuclear receptor.
According to the lenson-de Sombre two-step model, the steroid 
hormone, bound to plasma steroid binding protein, (e.g. sex hormone 
binding-globulin), enters the target cell by passive diffusion across 
the plasma membrane (a). Binding of free steroid by the cytoplasmic 
receptor (b) results in a change in the nature of the receptor, termed 
transformation (c). The transformed receptor has increased affinity 
for DNA/chromatin. Subsequent translocation of the transformed 
receptor/hormone complex (d) and binding to specific regions of DNA/ 
chromatin, results in increased transcription from specific genes 
(e) and consequential translation of the induced RNA, (f,g).
Blood
(a)
Plasma membrane
Target cell
(c)
Rc<<l
EU 6?
(d)
(e)
(f)
RNA
V  NUCLEUS y
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1.1»! Entry of steroid hormones into target cells
It is generally held that steroid hormones, due to 
their lipophillic nature, enter cells by passiye diffusion 
across the plasma membrane, and are concentrated in target 
cells due to the presence of a cytoplasmic receptor protein 
specific for a given steroid hormone. The evidence for this 
model is not unequivocal; Milgrom ejk ad. (1973) > presented 
evidence for facilitated transport of oestrogen into target 
cells, whilst others have also postulated a protein mediated 
step in the entry of oestrogen into uterine cells (Baulieu,
1973; Uriel et al., 1976). Whilst these studies are of 
interest, further work is required to confirm their significance.
1.1.2 Binding of steroid hormones to cytoplasmic receptor proteins
The cytoplasmic receptor proteins for a number of steroid 
hormones have been extensively studied. Briefly, it is 
apparent that binding of steroid to receptor results in 
changes in the nature of the receptor, termed transformation, 
that result in translocation of the hormone/receptor complex 
from the cytoplasm to the nucleus.
The nature of the transformation process is poorly 
understood, and there is evidence that different mechanisms 
are operating for different steroid/receptor systems. For 
example, the oestrogen receptor of rat uterus, prior to 
hormone binding, sediments in sucrose gradients at a value 
of h s. Binding of oestrogen shifts the sedimentation 
coefficient to 5 s and increases the affinity of the receptor 
for DNA/chromatin (Jenson and de Sombre, 1973)* It has been
suggested that the transition from the 4 s to 3 s form 
results from dimerization of receptor monomers or the addition 
of a non-steroid binding subunit,(Notides and Nielson, 1974; 
Yamamoto and Alberts, 1974). In contrast, transformation of 
the glucocorticoid receptor is not accompanied by any change 
in its sedimentation coefficient (Xalimi ^t ad., 197^).
Recent evidence suggests that a common non-hormone 
binding protein is associated with the non-transformed receptors 
of progesterone, oestrogen, androgens and glucocorticoids 
(Joab e^ ad., 1984). This discovery may be of importance to 
our understanding of the mechanism of steroid hormone .receptor 
transformation. Studies on steroid hormone receptors have 
been extensively reviewed by Grody e_t ad. (1982).
The mechanism whereby transformed steroid receptors are 
translocated to target cell nuclei is also poorly understood. 
Some of the mechanisms proposed have been reviewed by Knowler 
and Beaumont (1983). More recently, evidence has arisen 
that brings into question the existence of cytoplasmic receptor 
proteins; Velshons et ad. (1984) used cytochalasin B induced 
enucleation to obtain cytoplast and nucleoplast fractions 
from oestrogen receptor rich GH^ cells, derived from rat 
pituitary tumours. The cytoplasts were found to contain little 
oestrogen binding activity, with most of the unfilled receptor 
residing within the nucleoplasts. More convincingly. King and 
Greene (1984), carried out immunohistochemical analysis on a 
wide range of oestrogen receptor positive tissues and cell 
lines using a monoclonal antibody specific for oestrogen 
receptor. The presence of receptor protein was confined to
the nucleus in all of the tissues and cell lines analysed.
Clearly, further studies are required to confirm these findings 
and to determine whether a similar situation is pertaining in 
other steroid/receptor systems. If this is found to be the 
case, the classical Jenson and de Sombre model will have to 
be modified.
1.1.3» Binding of steroid/receptor complexes to target cell nuclei 
Many steroid hormone effects are directly attributable to 
increased transcription from specific genes. The mechanism 
whereby hormone/receptor complexes enhance transcription has 
been extensively studied. One of the methods employed to 
analyse transcriptional activation has been to use cloned 
fragments of specific genes to detect changes in the DNase 1 
sensitivity of the genes after hormone administration.
Increased DNase 1 sensitivity has been associated with the 
activation of a number of eukaryotic genes, and reflects local 
changes in the chromatin structure around the gene, (for 
review see Mathis ejk al. , I980). Thus, in the liver of male 
Xenopus laevis frogs, oestrogen induces DNase 1 sensitivity 
in the vitellogenin gene family (Gerber-Huber ejk ad., I98I). 
Similarly, in the chick oviduct the ovalbumin gene, as well 
as the related pseudogenes X and Y are rendered sensitive 
to DNase 1 after oestrogen—stimulation (Lawson et al.. I980).
Recently, evidence has accumulated that indicates that 
steroid/receptor complexes interact specifically with DNA 
in the region of hormone induced genes. Studies on the 
insect steroid hormone ecdysone revealed that fluorescently
labelled ecdysone/receptor complexes bind to regions of the 
giant polytene chromosomes of Drosophila melanogaster 
salivary glands at which ecdysone induced chromosomal 'puffs' 
are seen (Ashburner, 1974; Gronemeyer and Pongs, I98O;
Bonner, I982).
When cloned mouse mammary tumour virus (MMTV) DNA is 
transfected into cultured hepatic cells, glucocorticoids 
induce MMTV specific mRNA 8 fold over control values (Hynes 
et al., 1981). Utilizing purified glucocorticoid receptor, 
Payvar ejb al (198I) demonstrated that four widely separated 
regions of MMTV proviral DNA were efficient competitors for 
glucocorticoid receptor binding. One of these regions was 
located 400 b.p. upstream of the proviral promotor. Further 
studies, utilizing techniques such as transfection of chiameric 
genes into receptor positive cell lines and DNA footprinting 
studies have helped to delineate a DNA sequence that is 
involved in receptor binding, (Hynes _et aT. , 1983; Scheidereit 
et al., 1983).
A consensus hexanucleotide TGTTCT has been found in all 
glucocorticoid receptor binding sites analyzed so far, 
including two sites upstream of the chicken lysozyme gene 
(Renkawitz et al., 1984), two sites in the human metallothionein 
IIA gene (Karin ^t al. , 1984)_j and three sites in the rabbit 
uteroglobin gene (Cato ejfc al., I985). Similarly, DNA sequences 
that bind progesterone receptor have been detected in the 
ovalbumin gene (Compton ejt ad., I983; Mulvihill e_t al. , I982), 
and sequences that bind the oestrogen receptor have been 
found in the xenopus vitellogenin genes (Jost e_t al. , I983)
and also in the chicken vitellogenin and apo VLDL II genes 
(Burch, 1984).
One of the more interesting observations concerning 
these receptor binding elements is the sequence homology 
they share with viral enhancer elements (Parker, I983). In 
addition, like viral enhancers, the glucocorticoid receptor 
binding element has been shown to increase transcription from 
a heterologous promotor independently of its orientation or 
distance from the gene. (Hynes e_t al. , I983; Chandler ejfc al. , 
1983). Another interesting observation has been that in genes 
which can be regulated by more than one steroid hormone, for 
example the chicken lysozyme gene and MMTV proviral DNA, the 
binding sites for the different receptors map to the same 
region of DNA (Renkawitz ejfc al., 1984). Presumably different 
steroid receptors recognize distinct DNA sequences in these 
regions.
The mechanism whereby binding of receptor to these 
elements induces transcription from nearby genes is still 
largely unknown, and it is possible that interaction of the 
receptors with other components of the nucleus is also important. 
Schrader ejb al. (1977) have proposed that the two subunits of 
the progesterone receptor A and B bind to DNA and group of 
non-histone proteins, the AP^ proteins, respectively. More 
recently however, the binding of the B subunit to AP^ proteins 
has been disputed (Loosfelt ejk al. , 1984; Gronemeyer ejfc al.
1985).
Whilst recent progress in this area has been fruitful, 
further studies are clearly required to elucidate the mechanism
of action of steroid hormones on the transcription of specific 
genes. Recently, the nucleotide sequence of mRNA coding for 
the glucocorticoid receptor has been published (Miesfield 
et al.. 1984). This information should facilitate studies 
on the structure of st'croid receptors and hence provide an 
approach to studying in more detail the interaction of receptors 
with receptor binding elements.
1.1.4 Post-transcriptional effects of steroid hormones
In addition to the well characterised effect of steroid 
hormones on the transcription of specific genes, there have 
also been a number of reports of regulation of gene expression 
at the post-transcriptional level.
Cox (1977)> has reported that oestrogen selectively 
stabilizes ovalbumin mRNA in the chick oviduct. The half 
life of ovalbumin RNA in oestrogen stimulated chick oviduct 
was approximately 24 h. Withdrawal of the hormone reduced 
the half life to between 4 and 5 h. In the liver of Xenopus 
laevis, the stability of vitellogenin mRNA increased in the 
presence of oestrogen. This effect was shown to be independent 
of de_ novo protein synthesis (Brock and Shapiro, I983) . 
Interestingly, the stability of albumin mRNA in Xenopus liver 
decreases in the presence of oestrogen. (Wolffe ejt al. , 1985)»
As distinct from steroid effects on mRNA stability, a 
number of groups have reported steroid effects on the 
efficiency of translation. Robins and Schimke (1978) 
demonstrated that progesterone increases the efficiency of 
initiation of ovalbumin RNA in the chick oviduct, whilst 
Pennequin ejk aT. (1978) found that oestrogen increased the
efficiency of initiation of all classes of oviduct mRNA.
In the rat uterus, WhelTy &  0 982.) demonstrated that
oestrogen increased the rate of nascent polypeptide elongation 
during the first hour of stimulation. Actinomycin did not 
block this effect, suggesting its independence from nuclear 
events.
Generally, the mechanisms whereby post-transcriptional 
regulation of gene expression occurs are poorly understood, 
and considerably more work is required to determine how 
steroid hormones can effect these mechanisms.
1.1.5 Classical steroid hormone systems
Table 1 illustrates some of the characteristics of the 
most extensively studied steroid hormone systems. The effect 
of a given hormone on a given target tissue can be conveniently 
divided into two types; Firstly, the steroid can result in 
increased synthesis of major secretory proteins, such as 
vitellogenin in xenopus liver, and secondly, the steroid 
can result in a hypertrophic response where overall protein 
synthesis is increased, often leading to subsequent cell 
growth and division e.g. oestrogen effects in the mammalian 
uterus. Some target tissues undergo both of these responses 
to a given steroid hormone, e.g. oestrogen effects in the 
chick oviduct.
Table 1 . Classical steroid hormone systems.
This table is intended to illustrate the systems 
through which progress in our understanding of the mechanism 
of steroid hormone action has been made. Where possible, the 
references cited represent recent reviews of the topic.
1. Knowler and Beaumont, (1985).
2. Parker and Scrace, (1978).
3. Higgins at al., (1979).
4. Master and Baulieu, (1984).
5. Rousseau, (1984).
steroid
hormone Tissue
Major induced 
proteins Other effects References
Oestrogens Chick
oviduct
Ovalbumin
Conalbumin
lysozyme
Cell growth and 
differentiation 1.
Avian liver Vitellogenin - 1.
Amphibian
liver Vitellogenin - 1.
Mammalian
uterus - Cell growth/ 
hypertrophy 1.
Mammalian
breast -
Cell growth/ 
hypertrophy 1.
Androgens Rat ventral 
prostrate
Prostatic
steroid
binding
proteins
Cell growth/ 
hypertrophy 2.
Rat seminal 
vesicle
Secretory 
glycoproteins 
»F* and 'S'
Cell growth/ 
hypertrophy 3.
Progestins Chick
oviduct Avidin 4.
Mammalian
uterus
Uteroglobin Cell differentiation 4.
Gluco­
corticoids
Rat liver Enzymes 
associated 
with gluco- 
neogenesis 
globulin
Hypertrophy 5.
Figure 2. Oestrogen effects in the rat uterus.
(a) Cross sectional diagram showing structure and cell types of 
the rat uterus.
(b) Seguence of events in oestrogen-induced growth of the uterus 
of the immature rat.
The various steps illustrated in this model are discussed 
in the text.
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1.2 Oestrogen effects in the rat uterus
1.2.1 The overall response
Figure 2(a) illustrates a diagrammatic cross section of 
the rat uterus. Briefly, the uterus can be sub-divided into 
two main components, the myometrium, consisting of longitudinal 
and circular muscle and connective tissue, and the endometrium, 
consisting of stromal packing tissue and glandular and luminal 
epithelial cells, the latter forming the lining of the lumen. 
Oestrogen receptors are found predominantly in the endometrial 
cells (McCormack and Classer, I98O). Because of the complexity 
of cell types and different hormones acting on the uterus, it 
has been difficult to determine the specific effects of 
oestrogens. This problem has been partly overcome by studying 
the effect of administered oestrogen on ovariectomized animals 
and on immature rats between I5 and 30 days old.
Administration of a single injection (l ]xg) of oestradiol- 
I7R to 20 day old female rats results in hypertrophy and 
subsequent hyperplasia of the endometrial cells. Thus, during 
the first 12 h of the response increased uptake of glucose 
and RNA precursors, imbition of water with subsequent increase 
in wet weight and increased RNA and protein synthesis are all 
observed (Knowler, 1983a). Between 12 and 2h h after hormone 
administration, RNA and protein synthesis remains elevated 
and DNA synthesis and subsequent cell division of all cell 
types occurs. After 24 h uterine dry weight is increased.
Immature rats less than I3 days old do not respond to 
oestrogen despite the presence of receptors and apparent 
nuclear translocation (Kaye, I983). In ovariectomised mature
rats, a single injection of oestradiol 17P produces a response 
similar to the aforementioned. However, hypertrophy and 
hyperplasia appear to be confined to epithelial cells, 
particularly the luminal epithelium. Essentially similar 
events have been shown to occur in the uterus of other mammalian 
species.
1.2.2 The heterogeneity of oestrogen binding sites
Multiple binding sites for steroid hormones have been 
reported to exist in the cytoplasm and nucleus. In the rat 
uterus, Eriksson aT. (1978) reported oestrogen binding sites 
other than the classical receptor in the cytoplasm and nuclear 
fractions. In the cytoplasm, type I sites (the classical 
receptor) have high affinity (k^ 1 nm) and low capacity 
(ipmol/uterus) for oestrogen. Type II sites are present at h 
times the level of type I sites and have a lower affinity for 
oestrogen (k^ 30 nm). Although their function is not known, 
it may be that type II sites serve to concentrate oestrogen 
in the target tissue. Nuclear type II sites also have lower 
affinity (k^ 10-30 nm) and higher capacity than the normal 
nuclear receptor (nuclear type I sites). They do not originate 
from either type I or type II cytoplasmic sites. The 
accumulation of nuclear type II sites is stimulated by oesthogen, 
and high levels are maintained for up to 72 h. Type I nuclear 
sites decline to low levels by 24 h after oestrogen treatment 
(Markaverich and Clark, 1979)* It was hypothesized that 
stimulation of type II sites correlated with long term uterine 
growth responses but not with early responses. Their increase 
is dependent on long term (6 h) nuclear occupancy of type I
sites. The sub-optimal inducer oestriol, which fails to 
elicit the full growth response, also fails to stimulate 
long term retention of type I sites or increased levels of 
type II sites. Further, nuclear type II sites are absent 
from the target tissues hypothalamus and pituitary, neither 
of which grow in response to oestrogen (Kelner and Peck,
1981).
Secondary sites for oestrogen have now been described 
for mouse and human mammary tissue (Watson and Clark, I98O;
PankG ejt aT. , I98I) and chick oviduct (Smith ejfc aT. , 1979)*
1.2.3* The hypertrophic response
In the oestrogen-stimulated rat uterus, increased 
transcriptional activity results in the synthesis of a broad 
spectrum of proteins. The stimulation of abundant secretory 
proteins has not been detected. It is possible that the 
synthesis of some proteins is repressed by oestrogen, although 
this has yet to be clearly demonstrated.
Uptake of RNA precursors and subsequent RNA synthesis 
are among the earliest responses observed in the rat uterus 
(Means and Hamilton, 1966a: Means and Hamilton, 1966b).
Synthesis of hnRNA becomes detectable 13-30 min after administratio 
of oestrogen (Aziz and Knowler, I980). Maturation of early 
hnRNA to mRNA and subsequent translation by pre-existing 
ribosomes occurs during the first h h of stimulation (Merry- 
weather and Knowler, I980). Stimulation of hnRNA correlates 
with increased RNA polymerase II activity (Classer ^  oA..
Synthesis of rRNA and tRNA is first detectable 1-2 h post­
stimulation and continues up to 12 h. This stimulation
correlates with increased RNA polymerase I and III activity, 
(Weil ejfc ad., 1977)* A second peak of hnRNA and mRNA synthesis 
occurs between 4-12 h post-stimulation, and translation of 
this RNA depends on newly synthesized ribosomes (Merryweather 
and Knowler, I980). Studies with a-amanatin, an inhibitor of 
RNA polymerase II, and with cycloheximide, an inhibitor of 
translation, indicated that translation of early mRNA is a 
pre-requisite for the continuation of the response, i.e. the 
synthesis of rRNA, tRNA and the second peak of mRNA (Borthwick 
and Smellie, 1973; Baulieu et al., 1972). These observations 
have led to the hypothesis that some of the proteins encoded 
by early mRNA's are involved in stimulation of rRNA, tRNA, 
and mRNA production. This hypothesis is summarised in the 
model presented in Figure 2b.
R^t analysis of uterine RNA has been used to compare 
the RNA populations at various stages of the oestrogen 
response (McCormack and Classer, I98O; Aziz and Knowler,
I98O; Aziz e_t aT. , 1979a; Aziz _et al. 1979b). Briefly, 4 h 
after oestrogen—stimulation, between 8000 and 12000 diverse 
mRNA species were present. Of these sequences approximately 
llfo were present in unstimulated uteri and approximately 36% 
were present 2 h after stimulation. cDNA derived from 4 h 
mRNA was fractionated into abundance classes and subsequent 
heterologous hybridization with 2 h mRNA revealed that the 
main differences between these populations resided in the 
intermediate abundance species. Homologous hybridization 
indicated the presence of approximately I30 diverse sequences. 
The proteins encoded for by these species of mRNA are likely 
to be important in the regulation of late events and hence
in the maintenance of the oestrogen response.
Amongst the candidates for proteins encoded by early 
mRNA's are those involved in stimulation of the genes coding 
for rRNA's, tRNA's and ribosomal proteins (Merryweather and 
Knowler, I98O; Muller and Knowler, 1984), non-histone chromatin 
proteins, which have been shown to be induced between 30 min 
and 12 h after oestrogen-stimulation (Barker, 1971; Pollard 
and Martin, 1977), and the oestrogen receptor, which is 
synthesized 6-I2I1 after stimulation (Korach and Ford, 1978).
The proteins involved in the stimulation of late mRNA synthesis 
are likely to be included amongst the non-histone chromatin 
protein fraction. Recent work in our laboratory has demonstrated 
that the mRNA encoding the proto-oncogene c-myc was induced 
2-4 h after oestrogen-treatment (Travers and Knowler, 1985)»
The protein product of the c-myc gene is a DNA binding protein 
which is induced early in the response of a number of cells 
and tissues to mitogenic stimuli (Robertson, 1984). It is 
tempting to speculate that in the rat uterus, c-myc protein 
plays a role in the stimulation of late RNA synthesis.
Early studies on the oestrogen response in the rat uterus 
identified a protein that is induced very early in the response 
(Notides and Gorski, I966). This protein, originally designated 
I.P. (induced protein) was later found to be creatine kinase, 
an enzyme involved in storing excess ATP generated by glycolysis. 
Walker and Kaye (198I) demonstrated that creatine kinase is 
induced, at least partly, at the transcriptional level.
Candidate proteins encoded by mRNA appearing between 
4-12 h include those proteins required for DNA synthesis 
and subsequent mitosis. Induction of DNA polymerase a has 
been demonstrated to occur I6-I8 h after stimulation (Harris 
and Gorski, 1978). The mRNA coding for the proto-oncogenes 
c-Ha-rasand c-sis was induced 12 h post-stimulation (Travers 
and Knowler, 1983)* The protein product of c-Ha-ras is a 
GTP binding membrane protein implicated in the maintenance of 
the mitogenic response in a number of tissues and cell lines. 
(Bishop, 1983)* The protein product of c-Sis is platelet 
derived growth factor (Heldin and Westermark, 1984). The 
induction of a growth factor in the rat uterus is suggestive 
of an autocrine mechanism involved in regulating the growth 
response of the uterus.
Studies on the mechanism of action of steroid hormones 
have generally been directed towards genes/proteins that are 
induced in response to a given hormone. Little attention has 
been given to the possibility that steroid hormones may also 
repress the levels of specific proteins.
One exception to this is the studies carried out on 
the cytoplasmic ribonuclease inhibitor protein of the rat 
uterus. Zan-Kowalczewska and Roth (l973) observed that 
ribonuclease inhibitor activity, readily detectable in the 
uteri of immature rats, was absent in the uteri of mature rats. 
Furthermore, ovariectomy of mature rats resulted in some 
restoration of inhibitor activity, suggesting that the re­
pression of this protein was brought about by oestrogen action. 
McGregor ejt aT. (198I), demonstrated that the inhibitor
activity of immature rat uteri was lost within 2-3 days of 
administration of oestrogen implants, whilst Munro and 
Knowler (1982) confirmed that inhibitor activity disappeared 
during the normal sexual maturation of female rats.
McGregor et al. suggested that the ribonuclease inhibitor 
may represent a protein whose levels are repressed by oestrogen. 
However, work to be presented in this thesis, (also Brockdorff 
and Knowler, 1984 and I983), indicated that the loss of 
inhibitor activity is caused by increased cytoplasmic ribo­
nuclease, thus saturating the inhibitor activity found in 
untreated immature rats.
As indicated, the uterus is a difficult system to work 
with, it contains many cell types and its response to oestrogen 
and other hormones is complex. Despite these drawbacks it 
is a key mammalian target tissue, and its study is relevant 
to the use of oestrogens and anti-oestrogens in the control 
of the ovarian cycle and in cancer chemotherapy. In addition, 
the uterus provides a suitable system in which to study the 
mitogenic effect that oestrogens exert on certain target 
tissues. It will be interesting to see whether the induction 
of a broad spectrum of proteins in the uterus is achieved 
by the same mechanism to that which has been proposed to 
occur with the activation of specific genes in other classical 
steroid hormone systems, or whether a distinct mechanism is 
operating under these conditions.
1.3 RNA metabolism in eukaryotic cells 
1.3*1 Stability of eukaryotic mRNA
Much of the mRNA of eukaryotic cells is synthesized in 
the nucleus in the form of high molecular weight precursors, 
(hnRNA). As far as is known, processing of these precursors 
to mature cytoplasmic mRNA occurs solely in the nucleus (for 
a recent review see Knowler, 1983b).
The mechanism whereby processed mRNA is transported 
from the nucleus to the cytoplasm and polyribosomes is poorly 
understood (Nevins, I983)* It is however of interest to note 
that this mechanism represents a possible site for the regulation 
of gene expression, as evidenced by the observation that 
adenovirus infected cells show decreased levels of host mRNA 
transport, despite the continuance of mRNA synthesis (Babich 
et ^ .  , 1983)*
In contrast to the rapidly degraded mRNA of prokaryotes 
(Datta and Niyogi, 1976), it is known that a number of 
eukaryotic mRNA's are remarkably stable. Perhaps the best 
known example is the reticulocyte in which mRNA for globin 
continues to function for a number of days after its synthesis 
has ceased.
Studies on the stability of mRNA in cell cultures 
(Greenberg, 1972) revealed that the mRNA of exponentially 
growing mouse L cells turned over with first order kinetics 
and had a mean half-life of 10 h. This stochastic decay of 
mRNA implied that new and old chains have an equal probability 
of being degraded. First order kinetics for mRNA degradation 
have been demonstrated in a number of systems (Greenberg,
1973)* Singer and Penman (l973) reported that the mRNA of
HeLa cells consisted of two populations, one third having a 
mean half-life of 7 h^and two thirds with a mean half-life of 
24 h. The aforementioned studies utilized techniques such as 
pulse labelling or steady state labelling in the presence of 
transcriptional inhibitors to calculate the half-life of 
mRNA populations. One problem with this approach is that 
the values obtained may mask more subtle differences in the 
stability of specific mRNA species.
The advent of recombinant DNA technology has facilitated 
the analysis of stability of specific mRNA's, using cloned 
DNA/cDNA probes. Thus, it was demonstrated that the mRNA 
coding for chick ovalbumin had a half life of 24 h in the 
presence of oestrogen. Withdrawal of hormone however resulted 
in a 20-fold decrease in ovalbumin mRNA stability (Cox, 1977)» 
Similarly, the stability of casein mRNA in the mouse mammary 
gland was increased by up to 23-fold by the hormone prolactin 
(Guyette ejt aT. , 1979)* Generally speaking, it appears that 
mRNA'5 coding for major secretory proteins are highly stable.
In contrast, the mRNA's coding for certain other proteins 
are rapidly degraded. Examples include the mRNA coding for 
the proto-oncogenes c-myc and c-fos, which have half lives 
of less than 30 min (Muller aT. , 1984).
The high stability of a number of eukaryotic mRNA's 
implies that the proteins encoded by these species cannot be 
regulated simply by termination of transcription. It therefore 
seems likely that the control of expression of some of these 
gene products occurs at the post-transcriptional level. 
Expression of c-myc and c-fos genes can presumably be 
regulated at the transcriptional level due to the low stability
of their mRNA's. Some of the ideas concerning control of 
mRNA stability and translation are detailed in the following 
sections.
1.3*2. The role of Poly (a ) in mRNA stability
mRNA chains from a number of biological sources contain, 
in addition to coding sequences, regions located at the 3* 
and 5' termini that are not translated. The non-translated 
region at the 3* terminus is often followed by a tract of 
adenosine residues, designated the Poly (a) tail. The 
structure and function of the Poly (a) tail has been reviewed 
by Littauer and Soreq (1982). Briefly, polyadenylation of 
mRNA has been demonstrated to occur in the nucleus and 
cytoplasm. The size of the Poly (a) tail varies from 20-200 
residues and appears to show no constancy for a given mRNA.
It has been proposed that the Poly (a ) tail plays a role in 
translation, transport and/or control of stability of mRNA. 
Recent evidence indicates that the latter possibility is 
most likely.
Evidence indicating that the Poly (a ) tail is involved 
in the control of mRNA stability falls into two classes: 
Firstly, microinjection of adenylated and de-adenylated globin 
mRNA into xenopus laevis oocytes revealed that de-adenylation 
resulted in a marked destabilization of this mRNA (Huez 
et al., 1974; Nudel ejfc al., 1976). Re-addition of Poly (a ) 
to de-adenylated globin mRNA resulted in complete restoration 
of functional stability (Huez ejfc aT., 1975)* Histone mRNA, 
which is naturally de-adenylated was rapidly degraded when
injected into HeLa cells. However, addition of a Poly (a) 
tail to histone mRNA resulted in a marked increase in 
stability (Huez ejt ad. , 1978). Secondly, the addition of 
Poly (a) iji vivo can be inhibited by Cordycepin, without 
any short term effects on RNA processing and transport (Zeevi 
et al., 1981). RNA synthesized under these conditions did 
not accumulate in the cytoplasm although almost normal 
amounts were transported (Zeevi jet al. , I982). These findings 
have been taken to imply that Poly (a) stabilizes cytoplasmic 
mRNA.
The mechanism whereby Poly (a ) can selectively stabilize 
mRNA is poorly understood. The observation that the Poly (a ) 
tract of specific mRNA's is progressively shortened during 
the mRNA's lifetime has led to the idea that Poly (a ) may 
serve to protect mRNA from a 3 *-^5’ exonuclease (Sheiness 
and Darnell, 1973)* However, the stochastic decay of cyto­
plasmic mRNA would seem to disqualify this possibility.
Evidence against a role of Poly (a) in the control of 
mRNA stability includes the observation that the stability 
of interferon mRNA, after microinjection into Xenopus laevis 
oocytes, was unaffected by de-adenylation (Sehgal et al., 
1978). Microinjection of naturally de-adenylated histone 
mRNA from sea urchin eggs revealed that whilst most histone 
mRNA decayed stochastically with a half-life of 3 h , a 
small fraction (1-39°) remained stable in the oocytes for 
up to h weeks (Woodland and Wilt, I98O). This fraction of 
histone RNA may represent mRNA that has been sequestered 
by the stable free mRNP pool. (See Section 1.3*4). It 
therefore seems that the Poly (a) tail is involved in the
control of mRNA stability, but that other mechanisms may 
also be operative.
1.3*3» The role of 5* 'cap' in mRNA stability
Most eukaryotic mRNA's contain a 5V terminal 'cap',
M*^ G (3*) ppp (5')“X, (Shatkin, 1976). It is known that the 
'cap' site is required for the formation of stable translation 
complexes between the mRNA and ribosomes. (Kozak and Shatkin,
1976).
Microinjection of mRNA devoid of a 'cap' structure 
into Xenopus laevis oocytes, or incubation of this RNA in 
cell free protein synthesizing extracts of wheat germ or 
mouse L-cells revealed that this mRNA was rapidly degraded 
(Puruichi e_t aT. , 1977; Shimotohno £t aT. , 1977)* It was 
proposed that this degradation was the result of the action 
of a 3 ’ exoribonuclease. The fact that the 'cap' site is 
present on most mRNA's indicates that it is unlikely to be 
involved in the regulation of mRNA stability. However, 
these findings illustrate the point that both the 3* aud 3' 
termini of eukaryotic mRNA are protected from exonucleolytic 
attack (the former due to the presence of Poly (a ) binding 
proteins; see Section 1*3*4). This observation indicates 
that degradation of eukaryotic mRNA is likely to be initiated 
by an endoribonuclease, with subsequent hydrolysis occurring 
through the action of an exoribonuclease. Kumagai e_t al.
(1983 a , 1983 b ) have purified an endoribonuclease and 
a 3* exoribonuclease from rat liver microsomes. They propose 
that these enzymes are involved in mRNA degradation.
1.3.4. The role of mRNP particles in the control of mRNA 
stability
That the mRNA of eukaryotic cells can exist in the 
form of nucleoprotein complexes, (mRNP’s), was first reported 
after studies on the mRNA of sea urchin eggs (Spirin and 
Nemer, 1965)* Since that time extensive studies have revealed 
that two major types of mRNP are found in the cytoplasm of 
eukaryotic cells; free mRNP's, isolated from the post- 
microsomal supernatant, and polyribosome bound mRNP’s that 
can be dissociated from polyribosomes by treatment with EDTA. 
Some of the major proteins associated with mRNP’s appear to 
be common to free and polyribosomal particles (Bag, 1983)*
Of particular note are two polypeptides (m.¥. 75,000 and 
50,000) that bind to Poly (a) tails with a high affinity.
These proteins have been detected in the mRNP’s from a variety 
of biological sources (Spirin and AJtkhozhin, I985)* The 
protein to RNA mass ratio of free mRNP’s is about 3:1 whilst 
that of polyribosomal mRNPs is about 2:1.
The mRNA associated with free mRNP’s is untranslatable 
in cell free extracts unless the particles are deproteinized 
(Spirin, I969)* This observation has led to the proposal 
that mRNP’s contain a protein factor that represses 
translation. A translational repressor activity has been 
detected in the free mRNP particles of duck reticulocytes 
(Civelli ejfc aT., I980), but the repressor protein itself 
has not been isolated. The function of other proteins found 
in free mRNP particles is largely unknown. One possibility 
is that some of these proteins bind to specific regions of
mRNA, such as double stranded RNA, and thereby protect the 
mRNA from nucleolytic attack. It has recently been demonstrated 
that ribonuclease and ribonuclease inhibitor protein are 
bound to the free cytoplasmic mRNP’s of human placenta 
(Gileadi ejfc aA., 1984). The possible significance of this 
finding is discussed in Section 1.4.4.
Spirin and Ajtkhozin (1983) proposed that the RNA 
found in free mRNP particles could represent one or more of 
the following;- ’masked’ mRNA which is to be translated only 
at a later stage in cell differentiation, temporarily un­
translated RNA on its way from nucleus to polyribosomes, or 
’run off’ mRNA released from a translational complex.
In addition to the tightly bound proteins of polyribosomal 
mRNP’s, there exist many loosely associated proteins that 
seem to be in dynamic equilibrium with a cytoplasmic pool 
of free proteins (Spirin and Ajtkhozhin, 1983)* Some of the 
candidates for this group of proteins are the elongation 
factors EF-1 and EF-2, ADP-ribosyl transferases, and amino-acyl 
tRNA synthetases.
One of the systems in which mRNP’s have been most 
extensively studied is the duck reticulocyte (Vincent et al.,
1981). The findings of these studies have led to the proposed 
model, illustrated in Figure 3, indicating the inter-relationship 
of the different mRNP particles. In this model, ’transfer 
mRNP’s’ represent a putative particle, as yet undetected.
The free mRNP’s are further divided into three groups; 
Pretranslation mRNP’s represent particles containing repressed 
mRNA that is in equilibrium with its counterpart in poly­
ribosomal mRNP’s. Long term repressed mRNP’s represent
stable mRNA sequences with no counterpart in the polyribosomal 
fraction. An example of this type of particle is the 
maternal mRNP of sea urchin eggs. This mRNA is stable for 
up to 60 days and is only sequestered by polyribosomes after 
fertilization of the egg (Spirin and Nemer, 1965)* Short 
term repressed mRNP’s represent a fraction that appears to 
decay in a stochastic manner with an intrinsic half-life. 
Because the reticulocyte represents a high level of special­
ization, it is likely that variations in this model occur 
in other systems.
Studies carried out on HeLa cells (Spohr ejfc aT., 1970) 
revealed that 40-60^ of the total mRNA is present in free 
mRNP particles. Only a small fraction of this RNA was 
chaseable into polyribosomes. Mauron and Spohr (l9’?’8) 
reported that the mean half-life of mRNA in free particles 
was 1-2 h, whilst that of RNA associated with polyribosomal 
mRNP was 24 h. These findings are reminiscent of the report 
of Singer and Penman (l973), who found that one third of 
HeLa cell mRNA decays with a half-life of 7 h whilst the 
remaining two thirds has a half-life of 24 h. The relatively 
short half-life of free mRNP’s may reflect low levels of 
long term repressed mRNA’s or alternatively, the calculation 
of mean half-life may mask a small fraction of highly stable 
free mRNP.
In conclusion, there appear to be two ways in which 
mRNP can affect mRNA stability; Firstly, the proteins of 
mRNP that bind RNA tightly may serve to protect the RNA 
from nucleolytic attack. Secondly, competition between 
different mRNA’s for specific stabilization factors and/or
translational repressors, or sequestration of specific mRNA’s 
by specific mRNP pools, may provide a mechanism whereby mRNA 
stability can be differentially regulated.
Some unusual findings indicate that the translation 
products of certain mRNA’s may be associated with their own 
mRNA in free mRNP particles. Thus, actin and other muscle 
specific proteins were found in the free mRNP fraction of 
cultured muscle cells. Heat shock treatment of the same 
cells resulted in the association of one of the heat shock 
proteins with free mRNP’s (Bergmann ejfc aT., 1982; Bag, I983). 
Babich and Nevins (198I) reported that the 100 kd L4 protein 
of adenovirus acts to selectively stabilize late adenovirus 
mRNA in infected cells. Preliminary studies indicated that 
the L4 protein associates with the free mRNP’s of infected 
cells (Nevins, 1983)* Taken together, these findings 
indicate the existence of a feedback mechanism whereby the 
protein product of a given mRNA can regulate the stability/ 
translation of its own mRNA.
Figure 3 . Tentative flow diagram of mRNA in the cytoplasm of 
duck ervthroblasts.
This figure illustrates the proposed inter-relationship 
of the various mRNP fractions found in the duck erythroblast, 
(Vincent ^  al., 1981). Further details are given in the text.
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1.4 Mammalian ribonucleases and the ribonuclease inhibitor
1.4.1 Classification of mammalian ribonucleases
Vj^rious attempts have been made to classify the vide 
range of known mammalian ribonucleases on the basis of a 
number of properties. For the purpose of this report, the 
classifications employed by Sierakovska and Shugar (197?) 
will be utilized. The most clear cut distinction is that 
between endoribonucleases, enzymes that cleave RNA at specific 
residues yielding oligonucleotide fragments, and exoribo- 
nucleases, enzymes that digest RNA sequentially from the 3* 
or 3* terminus. The latter group of enzymes are not affected 
by the endogenous ribonuclease inhibitor proteins and have 
therefore been omitted from this discussion.
Endoribonucleases can be further sub-divided into type I 
and type II endoribonucleases. Type I endoribonucleases are 
defined as enzymes optimally active at neutral or alkaline 
pH, that cleave RNA endonucleolytically via the formation 
of products with terminal pyrimidine nucleoside 2',3V“Cyclic 
phosphates. They also share other common properties such 
as acid thermostability and sensitivity to the endogenous 
ribonuclease inhibitor protein.
Type II endoribonucleases are optimally active at 
pH 3-6, show no base specificity and are thermolabile. They 
are found exclusively in the lysosomal fraction of mammalian 
cells and are insensitive to the endogenous ribonuclease 
inhibitor (Roth, I967).
JJ-
A number of other endoribonucleases do not fall into 
either of these categories. These include the nucleases 
involved in processing of rRNA, hnRNA^ and tRNA, nucleases 
active towards double stranded RNA, hybrid nuclease (RNase H) 
that digests the RNA moiety of DNA:RNA hybrids, and an 
endoribonuclease activated in response to interferon. None 
of these enzymes are sensitive to the endogenous ribonuclease 
inhibitor (Sierakowska and Shugar, 1977)*
Type I endoribonucleases can be further sub-divided 
into secretory and non-secretory types. Predominant among 
the secretory type I enzymes are the well characterized 
pancreatic ribonucleases A and B (RNase A and RNase B).
Bovine RNase A has been the subject of intensive research, 
and as a consequence its primary structure, tertiary 
structure, and catalytic mechanism have been elucidated.
(For review see Blackburn and Moore, I982). RNase B has 
the same primary sequence as RNase A, but has a higher level 
of glycosylation (Blackburn and Moore, I982). It has been 
observed that the highly glycosylated RNase B is more 
resistant to proteolytic digestion, suggesting that it is 
probably the main form of RNase that is secreted by the 
pancreas into the duodenum (Birkeland and Christenson,
1975).
Pancreatic type ribonucleases are secreted by the 
pancreas and salivary glands of all mammals and are found 
in the duodenal contents, serum, kidney and urine. Generally, 
the pancreatic type ribonucleases have a molecular weight in 
the region of l4,000. However, under certain conditions
aggregation can occur resulting in the formation of dimers 
and higher oligomers (Crestfield jet al. , I962). Some non- 
pancreatic type I ribonucleases, such as that isolated from 
bovine semen (D’Alessio ejfc al. , 1975), form natural dimers 
by sulfhydryl cross linking of two RNase A like subunits.
In addition to the secretory type I ribonucleases, all 
mammalian tissues contain small quantities of non-secretory 
type I ribonucleases. It is this group of enzymes that 
associate with the endogenous ribonuclease inhibitor vivo.
A detailed account of these enzymes is presented in Section
1.4.3*
1.4.2 Ribonuclease inhibitor proteinV-Purification and properties
Roth (1936) first described the occurrence of a ribo­
nuclease inhibitor in the high speed supernatant fraction 
prepared from the liver and other tissues of the rat. The 
inhibitor was detected by its ability to inhibit the digestion 
of RNA by exogenously added bovine pancreatic RNase A. 
Preliminary studies (Roth, 1936; 1938a; I962 and Shortman,
1961, 1962) revealed that the inhibitor is a labile protein, 
readily inactivated by heat or acid. Its activity was dependent 
on the integrity of one or more sulfhydryl groups, and it 
could therefore be inactivated by heavy metal ions (Hg  ^and 
Pb^^)j and sulfhydryl blocking reagents, p-choro-mercuribenzoate 
(pCMB/pHMB) and others (Roth, 1938b). In most tissues studied 
the inhibitor is present in a molar excess over cytoplasmic 
type I ribonuclease, and as a consequence the latent ribo­
nuclease activity can only be detected when the inhibitor 
is inactivated.
The ribonuclease inhibitor has since been detected in 
the cytoplasmic fraction of a wide range of mammalian tissues, 
including those of marsupials (Kraft and Shortman, 1970a)•
A similar activity has also been reported to exist in the 
liver of avian (Kraus and Scholtissek, 1974) and amphibian 
species (Malicka-Blaskiewicz, 1978). Further evidence 
for the ubiquity of ribonuclease inhibitor is provided by
the report (Aoki and Natori, I98I) of a similar activity in
ik t
the larvae of^flesh fly (sarcophaga peregrina).
Preliminary attempts to purify the inhibitor of rat 
liver utilized a combination of ammonium sulphate fractionation 
of the post-mitochondrial supernatant, followed by ion 
exchange chromatography and gel filtration (Gribnow e_t aT. , 
1969)» The partially purified protein (3,000 fold) was found 
to have a molecular weight near to 50,000 as estimated by 
gel filtration. This purification procedure was extended 
by using affinity chromatography on RNase A coupled to 
carboxymethyl-cellulose (Gribnow ejfc al., 1970, Gagnon and 
de Lamarinde, 1973)* This approach gave near homogeneous 
preparations, but with a low yield. Gribnow et al. (1969)
demonstrated the importance of maintaining the level of 
free thiol (either l^-mercaptoethanol or Dithiothreitol) and 
EDTA throughout the purification procedure. Homogeneous 
inhibitor was purified from human placenta using ion exchange 
chromatography and affinity chromatography on RNase A - 
sepharose 4B (Blackburn ejfc al. , 1977)*
A simplified purification procedure utilized only 
ammonium sulphate precipitation and affinity chromatography 
(Blackburn, 1979). High yields (40-60^) were obtained with 
this procedure. A similar approach has now been used to 
purify the inhibitor from bovine brain (Burton ejfc al., I980) 
and the livers of five mammalian species (Burton and Fucci, 
1982). The molecular weight of the inhibitor, derived from 
a number of mammalian sources, has been found to be approximately 
50,000 as determined by gel filtration and SDS-PAGE.
The human placental inhibitor is an acidic protein 
(pi 4.5 - 4.8), that forms a 1:1 complex with bovine pancreatic 
RNase A, resulting in apparent non-competetive inhibition 
(K^ 3 X 10”^^ M) of the enzyme. (Blackburn ejfc aT., 1977)*
Similar findings were reported for the inhibitor of bovine 
brain (Burton ejfc al., I98O), and rat liver (Bartholeyns and 
Baudhin, 1977)* However, Turner ejfc aT. (1983) suggested that 
Michaelis-Menton kinetics were not applicable to the ribo­
nuclease inhibitor and that the inhibition of RNase A was 
better described using the kinetic procedures for slow 
tight-binding inhibitors (Morrison, I982). Application of 
these procedures to the inhibition of RNase A by porcine 
inhibitor protein indicated that the inhibition was competetive. 
Further, the authors point out that when kinetic analysis is 
carried out under the conditions described by those authors 
claiming non-competetive inhibition (enzyme : inhibitor ratio 
approaches unity and K^), Lineweaver-Burke plots
invariably indicate non-competetive inhibition, even though 
the inhibition may well be otherwise. Finally, a non-
competetive mode of inhibition would predict the existence 
of enzyme;substrate:inhibitor complexes. Such complexes 
have never been detected.
The ribonuclease inhibitor is generally assayed by its 
ability to inhibit RNase A. One unit of inhibitor is defined 
as the quantity required to inhibit the RNAse A catalysed 
digestion of RNA by 509^ » One unit approximates to 10-12 ng 
of purified protein.
Amino acid analysis of inhibitor from human placenta 
(Blackburn ejb al. , 1977), bovine brain (Burton ejfc al• , I98O), 
and the livers of five mammalian species (Burton and Pucci,
1982), revealed few significant differences in these proteins. 
Antiserum raised against human placental inhibitor cross 
reacted to some extent with the inhibitors from bovine, murine, 
porcine, rat and sheep liver (Burton and Fucci, I982). Taken 
together, these results indicated that the mammalian inhibitor 
protein exhibits some degree of evolutionary conservation.
All of the inhibitor proteins analyzed contained a high 
level of cysteine + I/2 cysteine residues (between 26-31 
per molecule). Blackburn et aX» (l977) calculated that at 
least 8 of these were present as free sulfhydryl groups but 
has subsequently amended this figure to approximately 23 
(Blackburn, personal communication). The inhibitor from 
non-mammalian sources has not been characterized so extensively. 
That of rooster liver (Djikstra a^., 1978) does not inhibit 
mammalian RNase A, but does inhibit chicken type I ribonucleases. 
The inhibitors from other non-mammalian species share the 
common characteristic of being dependent on the maintenance
of free sulfhydryl groups for their activity (Aoki and 
Natori, I98I; Malicka-Blaskiewicz, 1978).
The structure of bovine pancreatic RNase A has been 
the subject of extensive studies for a number of years (for 
a recent review see Blackburn and Moore, I982). The mass 
of data on the primary, secondary and tertiary structure of 
this enzyme, along with detailed knowledge of the mechanism 
of catalysis have facilitated studies on the interaction of 
this enzyme with human placental ribonuclease inhibitor 
(Blackburn and G a v i l a n e s ,  198O and I982; Blackburn and 
Jailkhani, 1979)* Information regarding the interaction of 
enzyme with inhibitor was obtained either by modifying 
specific residues on the enzyme, and examining the effect 
on inhibitor binding utilizing a competition assay, or by 
determining the degree of protection afforded to specific 
residues by binding of the inhibitor. Some of the main 
points to emerge from these studies were as follows :
Modification of the active site residues His-12 and His-119, 
or the auxiliary residues Phe-120, Asp-121 and Ser-123 did 
not affect inhibitor binding. Although Blackburn and Moore 
(1982) cited these observations as supporting a non-competetive 
mode of inhibition, competetive inhibition does not necessarily 
involve direct blocking of the active site, but may arise 
through a partial blockage of the active site or a conformational 
change that alters the juxtaposition of residues involved in 
either catalysis or substrate binding. Protection studies 
indicated that a number of Lysine residues in the enzyme are 
involved in inhibitor-enzyme binding. Specific carboxymethyl-
ation of Lys 4l, a residue whose modification results in a 
959^  loss of enzyme activity (Carty and Hirs, I968), reduced 
significantly the strength of the interaction between enzyme 
and inhibitor. Circular dichromism measurements on a number 
of derivatives of RNase A indicated that one or more tyrosine 
residues are important for its interaction with inhibitor.
A summary of the data obtained from these studies 
(Blackburn and Moore, I982) indicated that there are at least 
three regions on the three dimensional model of RNase A that 
are involved in the interaction with inhibitor. The first 
region includes Lys - 7, Lys - 4l, Pro - 42, Val - 43, Lys-91, 
iyr-92 and Pro-93* The second region includes Lys-31 and 
Lys-37, and the third region is represented by Lys-6l and 
adjacent residues. A key ionic interaction involves the 
positively charged ^ -NH^ group of Lys-4l, probably through 
an interaction with a negatively charged group of the inhibitor. 
Blackburn suggested that this interaction may account for the 
inactivation of the enzyme, since modification of the 
group of Lys-4l abolishes enzyme activity.
y More recently, Blackburn et al. (personal communication, 
1985) utilized a similar approach to define the role of the 
free sulfhydryl groups of the inhibitor on its interaction 
with RNase A. Briefly, they found that of the 25 free 
sulfhydryl groups of human placental inhibitor, at least 
twelve were exposed to solvent and reacted readily with 
alkylating agents. Of 4-6 of the most rapidly reacting 
sulfhydryl groups, 2 appeared to be most important for full 
inhibitor activity.
Further studies on the interaction of inhibitor with 
RNase A will be facilitated when the primary structure of 
the inhibitor is known. Given our extensive knowledge of 
the structure of RNase A, such studies could provide an 
interesting model for the detailed analysis of protein- 
protein interactions.
1.4.3. Ribonucleases associated with the inhibitor in vivo 
Acid-thermostable endoribonucleases optimally active 
at neutral or alkaline pH have been reported to occur in a 
wide range of tissues, cells and sub-cellular fractions (for 
reviews see Shugar and Sierakowska, I967; Sierakowska and 
Shugar, 1977)* Evidence that some of the non-secretory 
type I ribonucleases are distinct from their secretory 
counterparts comes from immunological studies (Gordon, I965) 
and studies on differential activity towards the synthetic 
substrate uridine 3'-(a-napthyl)phosphate (Zan-Kowalczewska 
et al.. 1974; Harden ^t al., 1976). Further evidence has been 
provided by comparison of properties such as pH optima, 
metal ion requirements and differential activity towards 
the homopolymers Poly (c) and Poly(u). (Sierakowska and 
Shugar, 1977)*
The wide variety of species and tissues examined, 
together with the variety of cell fractionation and enzyme 
purification techniques used makes it difficult to discern 
any clear cut rules concerning the localization, properties 
and function of these enzymes. The rat liver has perhaps 
been the most extensively studied tissue in this respect, 
and for this reason the following account will concentrate 
on the findings in this system.
Early studies on the ribonucleases of rat liver 
indicated that type I ribonucleases are found in all of 
the major sub-cellular fractions. Beard and Razell (1964) 
reported that a type I ribonuclease is associated with the 
mitochondrial fraction of rat liver. Further analysis by 
Bartholeyns ejfc al. (l975) suggested that this activity may 
actually arise from rat liver lysosomes. Razell (1963) 
obtained a partially purified type I ribonuclease from rat 
liver nuclei. However, the thermolability of this enzyme 
indicated that it is not related to other type I ribonucleases. 
Another thermolabile type I ribonuclease was reported to 
occur in the microsomal fraction of rat liver (Kumagai jet al., 
1985©^}. A type I ribonuclease activity was detected in rat 
liver cytoplasm after inactivation of the endogenous inhibitor 
with pHMB, heat or acid treatment, (Roth, 1958b). Similarities 
between this activity and the mitochondrial type I ribonuclease 
led to the proposal that the cytoplasmic activity represented 
enzyme released by sub-cellular components during growth and 
aging (B<CixrJi <x/\c\ R.a.2^ lL ., 1964).
Gagnon eJb aX» (1974) examined the effect of partially 
purified inhibitor on the acid-thermostable type I ribo­
nucleases associated with nuclear, mitochondrial, lysosomal, 
ribosomal, and cytoplasmic fractions of rat liver. Whilst 
all of these activities were inhibited, albeit to differing 
extents, the problem of cross contamination of sub-cellular 
fractions makes it difficult to draw any concrete conclusions 
from these results. The fact that the ribonuclease inhibitor 
is found exclusively in the cytoplasmic fraction of all 
tissues examined raises doubts about the significance of its
ability to inhibit ribonucleases from other subcellular 
fractions.
Bartholeyns ejfc (l973) proposed that the bulk of
liver type I ribonuclease activity is associated with the 
lysosomal fraction. The observation that pancreatomy 
resulted in reduced levels of this activity, together with 
similarities between the liver and pancreatic/serum ribo­
nucleases, led to the suggestion that the liver enzyme is 
of extrahepatic origination (Bartholeyns and Baudhin, 1977)* 
However, this hypothesis is inconsistent with other findings 
where it has been demonstrated that liver and pancreatic 
type I ribonucleases are distinct enzymes. (Zan-Kowalczewska 
et al. . 1974; Harden ejb aT. , 1976).
A type I ribonuclease, sensitive to the endogenous 
inhibitor, has been reported to be associated with the plasma 
membrane fraction of rat liver ( Gavar d ejt al., 1974; Arons en 
and Yannarell, 1975)* However, the low levels of this 
activity suggested that it may be adsorbed from the cytoplasmic 
fraction.
It is clear from the examples cited thus far that there 
is considerable confusion concerning the number of different 
type I ribonucleases and their intracellular distribution 
in the rat liver. This confusion appears to arise from two 
main problems; Firstly, contamination problems inherent in 
sub-cellular fractionation procedures make it difficult to 
assign a given activity to a given sub-cellular component. 
Further, because different workers have utilized different 
fractionation procedures, it is difficult to relate the 
findings into an overall model. The second problem concerns
the definition of specific activities. Generally, the 
different activities have been differentiated on the basis 
of differences in pH optima, metal ion requirements etc. 
However, whilst some groups have assayed activities in crude
extracts, other groups have used partially purified enzymes.
This latter problem could be overcome to some extent by 
obtaining homogeneous preparations of the enzymes concerned. 
This approach has not been facilitated by the fact that these 
enzymes are present at very low levels relative to other 
liver proteins. Another problem inherent in this approach 
is that most of the purification procedures utilized up to 
recent times have involved an acid extraction step. Bartholeyns 
et al. (1974) have reported that acid extraction results in
changes in the properties of pancreatic RNase A during its 
purification. Specifically, the physiological form exhibits 
a dual pH optimum at pH 4.5 and pH 7»3» The purified enzyme
is devoid of activity at pH 4.5»
On a more optimistic note, recent developments have 
led to the purification to homogeneity of some of the enzymes 
of rat liver without the utilization of acid extraction.
Kumagai ejfc aT. (1983) have developed a lengthy purification 
procedure, involving ion-exchange chromatography, gel 
filtration and affinity chromatography, to purify the 
cytoplasmic type I ribonuclease associated with the inhibitor 
from rat liver. Whilst the yield from this procedure was 
low (8^), sufficient quantities were obtained to characterize 
the enzyme. The purified enzyme was found to have a molecular 
weight of 16,000, being optimally active at pH 7 * 5-8. It 
was shown to differ from rat pancreatic RNase A on the basis
that unlike the pancreatic enzyme, it cleaved the homopolymer 
poly (c) at a greater rate than Poly (u). A second, minor 
species of ribonuclease was detected at an early stage 
of the purification. This species was not further character­
ized.
The idea that more than one type I ribonuclease is 
associated with the inhibitor vivo has been supported by 
recent findings in other systems. Button e_t aT. (1982) 
reported the partial purification of cytosolic ribonuclease 
from porcine thyroid. They found that the activity was 
composed of a variety of species, distinguishable on the 
basis of molecular weight. The major species (399^  of activity) 
had an apparent molecular weight of 31,000 as determined by 
gel filtration. The remainder of the activity was contributed 
by species of molecular weight 13,000 - 28,000. All of the 
activity could be inhibited by the endogenous inhibitor.
The ability of the inhibitor to bind to the high molecular 
weight species is unusual considering the work of Blackburn
CiqeA
ejb a l t h a t  suggested that ribonucleases associated with 
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the inhibitor should bear a close resemblance to pancreatic 
RNase A in order to interact with the inhibitor (see Section 
1.4.1). It is conceivable that the high molecular weight
fuin)
species reported by Button ejfc al.^ arises through aggregation. 
Aoki ejfc aT. (198I) reported that chromatography of intact 
inhibitor/ribonuclease complexes from rat reticulocytes on 
DEAE-cellulose reveals two peaks of latent ribonuclease 
activity. Similarly, Little and Whittingham (198I) reported 
that DEAE-cellulose chromatography of mouse skeletal muscle
inhibitor/ribonuclease complexes reveals two peaks of 
activity. As there have been no reports of heterogeneity 
of the inhibitor from a given species, these differences 
in the behaviour of the complexes presumably reside in the 
ribonuclease moieties.
Other groups have also reported heterogeneity of the 
type I ribonuclease of bovine skeletal muscle (Davies ejfc ad.,
1980) and Ehrlich ascites cells and normal mouse tissues 
(Von Tigerstrom and Manchak, 1977)* However, these studies 
were carried out using whole tissue extracts rather than 
cytoplasmic fractions, and it is therefore not clear which 
of the species observed are associated with the inhibitor 
in vivo.
Finally, recent work on the inhibitor from human placenta 
(p. Blackburn, personal communication) indicated that there 
are two major, and a number of related minor ribonuclease 
species associated with the inhibitor in this system. These 
observations are supported by data presented in the ensuing 
thesis and will be analysed more fully in the discussion 
section.
1.4.4 The ribonuclease/ribonuclease inhibitor system; 
Functional aspects.
In a wide range of cells and tissues in which the 
ribonuclease/ribonuclease inhibitor system has been studied, 
it has been observed that the ratio of inhibitor to ribo­
nuclease increases in cells engaged in active protein 
synthesis and decreases in cells with increased catabolism
(Kraft and Shortman, 1970b). These observations have been 
taken to imply some essential role for the inhibitor in 
the control of RNA metabolism and protein synthesis.
Some examples of tissues showing increased ratios of 
inhibitor to ribonuclease are tumourous and lactating 
mammary glands relative to glands of virgin rats, (Liu ^  al.. 
1975)» the thyroid gland of patients with hyperthyroidism 
relative to normal thyroids (Grief and Eich, 1977), TSH- 
stimulated rat thyroids relative to normal glands (Grief 
and Eich, 1972), in rapidly proliferating mouse spleen 
(Poels, 1976), in the estrogen-stimulated rooster liver 
(Djikstra ejfc al., 1978) and in the regenerating rat liver 
(Moriyama ^t aT., 1969)* Tissues exhibiting a decreased 
ratio of inhibitor to ribonuclease include the muscle of 
dystrophic mice relative to normal muscle (Little and 
Meyer, 1970), the brain of patients suffering from Alzheimers 
disease relative to normal brain (Sajdel-Sulkowska and 
Marotta, 1984), the liver of rats fed on a protein free diet 
(Quirin-Stricker ejfc aJL. , 1968)^  or after adrenalectomy (Liu 
and Matrison, 1976), various tissues of the rat during aging 
(Chesters and Will, 197%),and Ehrlich ascites cells after 
actinomycin D treatment (Von Tigerstrom, 1972).
Other evidence pointing to an essential role of the 
inhibitor in the control of RNA metabolism includes the 
observation that isolation of intact polysomes is facilitated 
in tissues with high levels of inhibitor (Blobel and Potter, 
1966; Takahashi aT. , I966). Purified inhibitor has been 
used to facilitate the isolation of intact polysomes from 
tissues with low inhibitor levels (Burghouts e_t al. , 1970)*
Purified inhibitor has also been used to increase the size 
of polypeptides synthesized in cell free translation systems 
(Hiranyavasit and Kusamran, 1983; Robbi and Lazarow, 1978; 
Scheele and Blackburn, 1979), to improve the yield of high 
molecular weight cDNA obtained in reverse transcription 
reactions (de Martynoff e^t , 198O), and to improve the 
synthesis of RNA in djn vitro transcription systems (Eichler 
et al., 1981).
The evidence linking increased protein synthesis to 
increases in the ratio of inhibitor to ribonuclease is not 
unequivocal. Gauvreau ejfc ad. (1974) reported that the level 
of free inhibitor in Novikoff hepatoma is considerably lower 
than that found in normal rat liver. Roth (1967) reported 
that the level of free inhibitor in Dunning hepatoma and 
the Morris 7288 C hepatoma is higher than that found in normal 
rat liver, but in contrast, he also reported that free 
inhibitor levels in the Morris 4123 D hepatoma was reduced 
compared to normal rat liver. It is apparent from these 
studies that there is no clear cut relationship between the 
level of free inhibitor and increased growth in rat liver 
hepatomas.
The level of free inhibitor in the uterus of immature 
rats is similar to that found in rat liver (McGregor ejb al. ,
1981). Administration of oestrogen or normal sexual maturation 
resulted in the loss of this activity (McGregor ejb ad., I98I; 
Munro and Knowler, I982). Ovariectomy of mature animals 
resulted in partial restoration of inhibitor activity, 
indicating that these effects were due to oestrogen action
(Zan-Kovalszewska and Roth, 1973)* Because the oestrogen- 
stimulated uterus is characterized by elevated levels of 
RNA and protein synthesis, (Section 1.2.3), these findings 
appear to be contradictory to the proposed relationship 
between free inhibitor levels and protein synthesis.
Kraft and Shortman (l970b)suggested that such deviations 
from the general rule may be accounted for by the heterogeneity 
of cell types in the tissues. This point is illustrated by 
studies on regional variations in inhibitor levels in the 
rat kidney (Liu and Matrisan, 1976). High speed supernatants 
prepared from total kidney or kidney cortex have no free 
inhibitor activity. However, high speed supernatants prepared 
from white or red medulla did show some free inhibitor activity. 
It is unlikely that heterogeneity of cell types contributes 
to the loss of free inhibitor in the rat uterus as ovariectomized 
uteri, with the same cell composition as normal uteri, 
displayed restored inhibitor levels.
Another possible source of these discrepancies may lie 
in the definition of "elevated levels of protein synthesis".
In an early review of this topic (Roth, I967), it was 
suggested that there are two distinct situations where 
elevated protein synthesis occurs: Firstly, is the situation
where a fully differentiated cell is producing large 
quantities of abundant secretory/structural proteins. In 
this situation it seems likely that there will be minimal 
breakdown of mRNA such that a given transcript can be 
translated a number of times. Thus, the mRNA coding for 
a number of major secretory/structural proteins has been
found to be relatively stable (Section I.3.I). The 
second situation occurs in a cell that is undergoing rapid 
growth and/or differentiation. In this situation, the 
discontinuation of synthesis of old types of protein and 
the transient expression of some proteins involved in the 
cell cycle might mean that the cell requires increased 
ribonuclease activity. At least some of the mRNAs transiently 
expressed during the cell cycle have been shown to have 
relatively short half-lives (e.g. c-myc and c-fos mRNA;
Muller ejt al. , 1984).
It is interesting to note that tissues associated with 
the synthesis of major abundant proteins often have high 
levels of free inhibitor. Examples include rat liver (Roth, 
1967), where albumin and other major serum proteins are 
synthesized, reticulocytes (Aoki ejfc ad., I981), where the 
globin proteins are synthesized, lactating mammary gland 
(Liu ejb ad. , 1975) where the major milk proteins such as 
casein are synthesized, calf lens (Ortworth and Byrnes, 1971), 
where a-crystallin is synthesized, skeletal muscle (Little 
and Whittingham, I98I) where the major muscle proteins are 
synthesized, and in adrenal (Girija and Sreenivasan, I966), 
thyroid (Grief and Eich, 1977), thymus (Kraft t')
and parotid (Robinovitch ejb al. , I968) glands. In contrast, 
tissues with low inhibitor activity are not associated with 
the synthesis of major abundant proteins, e.g. lung, spleen, 
and kidney (work to be presented in this thesis, and Brockdorff 
and Knowler, I983 )• However, the overall picture is 
complicated by systems where increased cell proliferation is
accompanied by the synthesis of major abundant proteins, 
e.g. the PHA stimulation of lymphocytes, where immunoglobulin 
proteins are synthesized in concert with increased cell 
proliferation. In this system, free inhibitor levels were 
reported to increase (Kraft and Shortman, 1970%^.
Returning to the situation occurring in the rat uterus, 
oestrogen-stimulation results in rapid cell and tissue 
growth preceded by elevated levels of synthesis of all 
classes of RNA, but with no preferential stimulation of 
major abundant proteins. It is conceivable that under 
these circumstances increased cytoplasmic ribonuclease 
activity will be required.
The observations cited thus far indicate that the 
inhibitor/ribonuclease system may play a role in the control 
of protein synthesis. However, at present little is known 
about its precise function. One of the more important 
questions relating to the function of this system concerns 
the role of the enzymes associated with the inhibitor iji vivo 
If, as present evidence indicates, these enzymes are distinct 
from their counterparts in serum etc., then it would seem 
likely that they carry out a specific function. However, 
the fact that in most tissues analysed the enzymes are 
maintained in an inactive form by an excess of inhibitor 
casts some doubt on the significance of this idea.
A number of workers have proposed that there may exist 
circumstances under which the inhibitor is reversibly 
inactivated, thus liberating the ribonuclease activity.
This idea has recently received some support from the
observations of Blackburn ejb al. (Personal communication,
1985)» They have found that oxidized glutathione can 
reversibly inactivate the ribonuclease inhibitor of human 
placenta through thiol-disulphide exchange. Further, they 
argue that this observation may have physiological significance 
based on the observation that calf lens cataractogenesis is 
accompanied by decreased inhibitor and increased ribonuclease 
activity (Maione et al., I968), together with increased 
levels of oxidized glutathione (Reddy , 1976). Further
studies are clearly required to confirm this hypothesis and 
to determine whether a similar mechanism is operative in 
other tissues.
Meyer and Meyer (1979) reported that administration of 
double stranded RNA to mice resulted in increased cytoplasmic 
ribonuclease and decreased inhibitor activity in liver and 
muscle. They suggested that these observations may account 
for the inhibition of cellular protein synthesis caused by 
agents such as viruses. This hypothesis is not supported by 
studies that indicate that increased ribonuclease activity 
in virus infected cells results from the interferon mediated 
activation of a novel ribonuclease species, (Clemens and 
Williams, 1977).
A number of inhibitor insensitive endoribonucleases 
and exoribonucleases have been reported to occur in the 
ribosomal fraction of eukaryotic cells ( ReboUd ejb aT. , 1976; 
Swida ejb aT. , I98I; Kumagai ejb ad. , 1985a,b). It has been 
suggested that these enzymes are responsible for mRNA 
degradation in eukaryotes. If this is indeed the case, then
a function, for inhibitor bound ribonucleases in the control 
of RNA metabolism is doubtful. An alternative hypothesis 
for the role of the inhibitor is that it acts as a scavenger 
protein, inhibiting type I ribonucleases that may be taken 
up into cells from serum or released from intracellular 
organelles.
The recent finding that inhibitor/ribonuclease complexes 
are bound to the free mRNP particles of human placenta 
(Gileadi aT., 1984) indicates a possible function of the 
inhibitor, perhaps in stabilizing long term repressed mRNP's 
(see Section 1.3*4). However, only \Sfo of the total inhibitor/ 
ribonuclease of placental cytoplasm is found in mRNP particles, 
raising some doubts about the significance of this finding.
It will be interesting to see whether the inhibitor/ 
ribonucleasei is also found in polyribosomal mRNP*s. This 
possibility has not been tested as yet.
1.5» Aims of the project
Studies on the mechanism of action of steroid hormones 
have revealed that they elicit their effects by influencing 
the level of specific proteins at the transcriptional level 
and/or at the post-transcriptional level. Generally speaking, 
these studies concentrated on gene products whose levels 
were enhanced by the steroid hormone. The disappearance of 
ribonuclease inhibitor activity from the immature rat uterus 
in response to oestrogen, or during normal development 
provided a putative example of a protein that was repressed 
by a steroid hormone. Therefore, the primary aim of this 
project was to determine the mechanism whereby the ribonuclease 
inhibitor activity was lost in response to oestrogen. There 
are three hypotheses that could account for this effect:
Firstly, oestrogen could cause repression at the transcriptional 
level of the gene coding for the ribonuclease inhibitor. 
Secondly, oestrogen could repress the translation or decrease 
the stability of the mRNA encoding ribonuclease inhibitor,
i.e. a post-transcriptional mechanism. Finally, oestrogen 
could repress the activity of the ribonuclease inhibitor 
protein, perhaps indirectly through the action of a putative 
oestrogen-induced factor or by effects that result in the 
re-localization of the inhibitor to a sub-cellular fraction 
other than the post-mitochondrial supernatant.
As has been discussed in Section 1.4.3 the reduction 
in ribonuclease inhibitor activity in the o e s t r o g e n - stimulated 
uterus, a tissue with elevated levels of RNA and protein 
synthesis, is in contrast to the general finding that tissues
with elevated levels of RNA/protein synthesis have increased 
levels of ribonuclease inhibitor activity. The secondary 
aim of this project was therefore to attempt to explain 
these findings and thereby increase our understanding of 
the precise function of the ribonuclease/ribonuclease 
inhibitor system.
2. MATERIALS AND METHODS
2.1. Suppliers
Unless otherwise specified, all chemicals used were 
AnalaR grade supplied either by BDH Chemicals Ltd., Formachem 
(Research International) Ltd., or Fisons Scientific Apparatus. 
Where chemicals and equipment were obtained from other 
sources, this is indicated in the text, and a list of the 
names and addresses of the suppliers is given below.
BDH Chemicals Ltd., Poole, Dorset, U.K.
Beckman-Spineo Ltd., Palo Alto, California, U.S.A.
Becton, Dickinson and Co., Oxnard, California, U.S.A.
Bio-Rad Laboratories Ltd., Watford, Herts, U.K.
Boehringer Corporation, London, U.K.
B.R.L., Rockville, Bethseda, U.S.A.
Corning Glassworks, New York, U.S.A.
Corning Universal, Palo Alto, California, U.S.A.
Difco Laboratories, Detroit, Michigan, U.S.A.
Eastman-Kodak Co., Rochester, New York, U.S.A.
Eppendorf Geratebau, Hamburg, W. Germany.
Fisons Scientific Apparatus Ltd., Loughborough, Leics., U.K. 
Formachem. Ltd., Strathaven, Scotland, U.K.
Hopkins and Williams, Chadwell Heath, Essex, U.K.
Jencons, Hemel Hempstead, Herts., U.K.
Koch-Light Laboratories Ltd., Colnbrook, Bucks, U.K.
Labsure, Christor Hill Group Ltd., Poole, Dorset, U.K.
L.K.B. Instruments Ltd., S. Croydon, Surrey, U.K.
Miles Laboratories, Stoke Poges, U.K.
Pharmacia (G.B.) Ltd., London, U.K.
Radiochemical Centre, Amersham, Bucks., U.K.
Scottish Antibody Production Unit (SAPU), Glasgow, U.K. 
Schleicher and Schüll, Dassel, W. Germany.
Sigma (London) Chemical Co. Ltd., Kingston-upon-Thames, Surrey, 
U.K.
Whatman Ltd., Maidstone, Kent, U.K.
2.2. Sterile precautions
All glassware used in the handling of ribonuclease was 
decontaminated by soaking in a chromic acid bath. Where 
possible, disposable polyethylene tubes were used.
All solutions used in the handling of nucleic acids 
were autoclaved at 13 p.s.i. for 20-30 min. #-mercaptoethanol 
and dithiothreitol (DTT) were added to solutions after 
autoclaving. Any solutions that could not be autoclaved 
were sterilized by passing the solution through a nitro­
cellulose selectron filter (Schleicher and Schilli, 43 ^m).
Glassware used in the preparation of RNA or DNA, for 
example corex tubes (Corning), was coated with Repelcote 
(Hopkins and Williams) and then autoclaved. Polyethylene 
microfuge tubes were also treated with Repelcote and auto­
claved. Tips for automatic pipettes were autoclaved.
2.3. Glassware
Glass homogenizers with motor driven teflon pestles 
were purchased from Jencons Ltd. Ground glass homogenizers 
were purchased from Kontes glassware. Corex glass centrifuge
tubes were obtained from Corning Glassware. Glass chromato­
graphy columns were purchased from Pharmacia Ltd. All 
other glassware was obtained from laboratory stocks.
2.4. Radiochemicals and scintillation counting
All radioactive isotopes were purchased from the 
Radiochemical Centre, Amersham. AnalaR grade toluene and 
P.P.O. (2,3 diphenyloxazole) were obtained from Koch-Light 
Laboratories Ltd.
Determination of radioactivity for the ribonuclease 
and ribonuclease inhibitor assays (Sections 2.7.2 and 2.7*3) 
was carried out as follows: Dried kieselguhr pads were
incubated at 60°C for 20 min. in the presence of 0.3 ml 
of hyamine hydroxide. 10 ml of toluene/O.3% (w/v) PPO 
was added to each sample and the radioactivity determined 
on a Beckman LS8100 scintillation counter.
Cherenkov counting of nick translated DNA (Section 2.9.8 ) 
was carried out by adding 1 pi of sample to 1 ml of H^O.
The radioactivity was measured on a Beckman LS8IOO 
scintillation counter.
Measurement of was carried out on an LKB 1275
Minigamma counter.
2.5» Experimental animals
All animals were supplied by the departmental animal 
house. The immature female rats used were from the Wistar 
strain and were weaned at 18-21 days after birth. The 
weight of these animals was between 30 g and 40 g. Weanling 
rats were killed by cervical dislocation after ether
anaesthesia.
The adult male and female rats used were also of the 
Wistar strain, and weighed between I30 g and 250 g. These 
animals were killed by concussion.
The adult rabbits used for raising antibodies were 
of the white New Zealand strain and were bled from the 
ear vein.
All animals used were given free access to food (supplied 
by Labsure) and water.
2.6. Preparation and administration of hormone
(a) Intraperitoneal injection
Oestradiol-17# (Sigma) or Oestradiol benzoate (Sigma) 
was solubilized at 10 pg/ml in O.3M NaCl/O.59^ (v/v) ethanol 
by the method of Roberts and Szego (1947). All immature 
rats received 1 pg oestradiol by intraperitoneal injection 
in 0.1 ml of carrier. Control animals received carrier only.
(b) Subcutaneous implantation
50 mg and 10 mg paraffin wax pellets containing either 
109  ^or 1^ estradiol-17  ^ (w/w) were made by the method of 
Clark ^t aT. (1978). Briefly, the required amount of 
oestradiol-17 was added to hot paraffin wax and suspended 
by sonication. The resultant suspension was stirred on a 
heated magnetic stirrer and the required volume pipetted 
onto a cold glass plate. Subcutaneous implantation was 
carried out under light ether anaesthesia. Control rats 
received implants of paraffin wax only.
2.7* Methods
2.7*1* Protein assays
Generally, protein concentrations were determined by 
the method of Lowry/(l95 V) * Various amounts of a 1 mg/ml 
solution of BSA (Sigma) were used as standards. Samples 
containing substances known to interfere with the Lowry 
assay were extensively dialysed against distilled water.
Occasionally protein concentrations were assayed by 
the method of Bradford (1976), using the micro-assay method 
of Spector (1976)*
The protein concentration of fractions from chromato­
graphic columns was estimated by measuring the absorbance 
at 280 nm using a quartz cuvette in a Cecil CE 272 spectro­
photometer. One absorbance unit at 280 nm was taken to be 
equivalent to approximately 1 mg of protein.
2.7*2. Assay of ribonuclease inhibitor
Ribonuclease inhibitor activity was determined by the 
method of McGregor e_t aT. (1981). Various amounts of sample 
were incubated in a final volume of 1.5 ml containing 0.02M 
Tris-HCl pH 7*4, 2 mM EDTA, 125 pg of unlabelled highly 
polymerized yeast RNA (B.D.H . London) and 2-3 x 10^ c.p.m. 
(1.5 - 2.25 pg) of [Pb\ BHK cell RNA.
The reaction, conducted for 20 min. at 37°C was 
initiated by the addition of 10 ng of bovine pancreatic 
ribonuclease A (Sigma), and terminated by the addition of
1.5 ml of 10^ (w/v) trichloracetic acid containing 29^  (w/v) 
Kieselguhr (Celite Hyflo supercell; Koch-Light). Acid
insoluble RNA was collected by filtration on to a pad 
of Kieselguhr, washed with 3 x 10 ml of 59^  (w/v) trichloro­
acetic acid, 2 X 10 ml of methanol and 2 x 5 ml of diethyl 
ether, and prepared for scintillation counting as described 
in Section 2.4.
The above assay conditions were derived for a preparation 
of C^hI BHK cell RNA which lasted for the duration of the 
project. The 20 min. time point for the assay of inhibitor 
was selected because the ribonuclease A catalyzed digestion 
was linear over this length of time, and resulted in conversion 
of approximately 609  ^of the RNA to acid soluble product.
Fresh preparations of L^hI RNA would require recalibration 
and might result in different combinations of labelled and 
unlabelled RNA, RNase A concentration, or incubation times.
The ribonuclease inhibitor activity of cytoplasmic 
fractions and of fractions derived from the purification of 
rat liver inhibitor was determined by measuring the activity 
of 4-6 different sample volumes in duplicate in comparison 
with non-inhibited controls.
Generally, one unit of inhibitor activity is defined 
as the amount required to inhibit by 309  ^the degradation of 
RNA by 3 ng of ribonuclease A. As our assay utilizes 10 ng 
of ribonuclease A, the quantity of inhibitor resulting in 
309  ^inhibition of digestion was taken to be two units.
2.7.3» Assay of ribonuclease activity
Ribonuclease activity in uterine supernatants was 
determined by the method of McGregor e_t aT. (198I). Various 
volumes of uterine cytoplasm prepared as high speed supernatants
were incubated at 37°C for 30 min. in a final volume of
1.5 ml containing 0.02 M Tris/HCl pH 7*4, 2 mM EDTA, I3 pg 
unlabelled yeast RNA (BDH) and 2 x 10^ c.p.m. (I.3 pg) of 
BHK cell -RNA. In order to distinguish between free
and total (free + ribonuclease inhibitor bound) activity, 
samples were incubated in the presence or absence of lO”^ M 
para Hydroxymercuribenzoate (pHMB), a sulfhydryl blocking re­
agent that at this concentration completely inactivates the 
inhibitor, but has no effect on the ribonuclease activity, 
(McGregor ejfc al. , I98I; Roth, 1967). pHMB was added as a 
XI0 concentrate in 0.23 M glycyl glycine (BDH, London), 
pH 7*4. Samples to which pHMB were added were pre-incubated 
at 37°C for 30 min. so that all cytoplasmic inhibitor was 
inactivated. The reaction was initiated by the addition of 
the RNA and terminated by the addition of 1.3 ml of IO9&
(w/v) trichloroacetic acid, 2Pfo (w/v) Kieselguhr. All 
subsequent steps were as described for the assay of ribo­
nuclease inhibitor in the previous section. One unit of 
ribonuclease activity was arbitrarily designated as the 
amount required to digest the ^^hJ -RNA by 309o*
Whilst this assay was suitable for the accurate 
determination of activity in a relatively small number of 
samples, a simpler, more rapid assay was used to measure the 
ribonuclease activity of large numbers of samples e.g. 
fractions from a column during the purification of cytoplasmic 
ribonucleases. This assay was developed by Blackburn ejfc al. 
(personal communication, I983). Various amounts of sample 
were incubated for 30 min. at 37°C in a final volume of 
130 pi containing 0.1 M Tris/HCl pH 7»3> ImM EDTA, 0.02^ BSA
and 500 pg yeast RNA (Sigma). The reaction was initiated 
by the addition of the RNA, and terminated by the addition 
of 50 pi of ice-cold Zhio (v/v) perchloric acid, hO mM in 
lanthanum acetate (Ventron). The samples were then transferred 
to ice for 20 min. and centrifuged for 5 min. at in an
Anderman 34l4 microcentrifuge. Tbe acid soluble nucleotides 
in 100 pi of resultant supernatant were diluted to 1.0 ml 
with water and the absorbance at 26O nm was measured on a 
Cecil CE 272 spectrophotometer. The reaction was carried 
out in 1.5 ml polyethylene microfuge tubes that had previously 
been treated with Repelcote (Hopkins and Williams),and 
sterilised. One unit of ribonuclease activity in this assay 
was designated as being the amount required to give an 
increase in absorbance at 26O nm of one O.D, unit.
The relative activity of purified ribonucleases towards 
the homopolymers Poly(U ) (Miles), Poly(c) (Boehringer),
Poly(a ) and Poly(c) (Sigma) was determined by the same method 
except a 3 mg/ml solution of the homopolymer was used as 
substrate.
Changes in assay conditions for the determination of 
kinetic parameters or pH optima for the purified ribonucleases, 
are detailed in the relevant figure legends.
2.7*4. Preparation of cytoplasmic fractions
(a) Uterus
Uteri were excised and dissected free of adipose tissue 
before being rapidly frozen in a solid CO^/methanol bath.
Groups of uteri were then ground up with a mortar and pestle
and subsequently homogenised in ice-cold 0.05 M Tris/HCl 
pH 7.6 containing 0.35 M sucrose, 0.025 M KOI, 0.01 M Mg 
(CH^COO)^ and 0.01 M P-mercaptoethanol in a Kontes ground 
glass homogeniser. Approximately 7 ml of buffer was used 
per g wet weight of tissue. High speed supernatants were 
prepared by centrifuging the homogenate at 105,000 x g^^ 
for 2 h at 4°C using an S¥ 50*1 rotor in a Beckman model 
L5 5OB ultracentrifuge. The resultant supernatant was 
decanted and stored at -20°C.
(b) Other tissues
Cytoplasmic fractions were prepared from rat liver, 
kidney, spleen, lung, brain or pancreas as follows : All
steps were carried out at 4°C. After removal, the organs 
were washed and chopped into small pieces in homogenising 
buffer (see previous section). The chopped tissue was then 
homogenised with 20 strokes in a glass homogeniser with a 
motor driven pestle. Approximately 3 volumes of buffer 
was used per g wet weight of tissue. The resultant 
homogenate was then centrifuged at 105,000 x g^^ for 2 h 
at 4°C, either in a Beckman SW 27 or SW 50*1 rotor, depending 
on the amount of tissue being processed. The resultant 
supernatant was decanted and either used immediately or 
stored at -20°C,
2.7*5* Purification of rat liver ribonuclease inhibitor protein 
Rat liver inhibitor was purified essentially as described 
by Burton and Fucci (1982). All steps were carried out at 
4°C unless otherwise indicated.
Bovine pancreatic RNase A (Sigma) was covalently linked 
to CNBr. activated sepharose-4B (Sigma) as follows ;
10 mg of enzyme was solubilised in 5 ml of coupling buffer,
0.2 M NaHCO^ pH 8.5, 0.5 M NaCl, and added to an equal volume
of resin. The mixture was shaken for 2 h at room temperature 
on an end to end rotating wheel. After the coupling reaction, 
excess CNBr groups were blocked by mixing the resin with 
an equal volume of 0.2 M glycine, pH 8, for 2 h. The resin 
was then extensively washed with coupling buffer, followed 
by 0.1 M sodium acetate pH 4, 0.5 M in NaCl.
(a) Preparation of hifji speed supernatants
High speed supernatants were prepared as described 
in Section 2.7.4. In a typical preparation the livers of 
25 mature male rats were processed, yielding approximately 
1 litre of homogenate.
(b) Ammonium sulphate precipitation
The high speed supernatant was brought up to 359° 
ammonium sulphate saturation by the gradual addition of 
solid ammonium sulphate. The resultant solution was stirred 
for 30 min. and then centrifuged at 16,000 x g^ _^  for 15 min. 
in a Sorvall RC-5 centrifuge. The supernatant was then 
brought to 609  ^ammonium sulphate saturation, stirred for 
30 min. and centrifuged as above. The supernatant was 
discarded and the pellet resuspended in a minimum volume of 
45 niM potassium phosphate buffer, pH 6.4, and dialysed 
overnight against 2 x 20 volumes of the same buffer.
(c) Sepharose-RNase A affinity chromâtography
The dialysed 35-60% ammonium sulphate fraction was 
centrifuged at 50»000 x g^^ for 1 h , in order to remove 
particulate matter, and passed through a bed of sepharose- 
RNase A at a flow rate of 25 ml/h. 1 ml of sepharose-RNase A 
has a capacity of approximately 100,000 units of RNase 
inhibitor activity, and a column bed volume was used so as 
to permit saturation of the column by inhibitor. The run 
through from this step was retained and stored at -20°C 
for use in the purification of latent cytoplasmic ribonuclease 
(see Section 2.7*6). The column was then washed with 40 ml 
of starting buffer followed by 40 ml of the same buffer 
0.3 M in NaCl. Bound RNase inhibitor was eluted with O.O5 M 
Borate buffer, pH 6, 4 M  NaCl, 1 mM EDTA, 1 mM P-mercapto- 
ethanol and 15% (’v/v) glycerol. Elution was carried out 
at a flow rate of 10 ml/h , and 1 ml fractions were collected 
and assayed for inhibitor as described in Section 2.7*2., 
and for protein by measuring absorbance at 280 nm. Purified 
inhibitor from the first elution was found to contain 
contaminating proteins (as judged by SDS-PAGE) and it was 
therefore necessary to rechromatograph the eluate on Sepharose- 
RNase A. Peak fractions from the first eluate were dialysed 
overnight against 45 mM potassium phosphate buffer, pH 6.4,
15% (’v/'v) glycerol and re-chromatographed on sepharose-RNase A 
as described above. Inhibitor from the second elution was 
found to be homogeneous as judged by SDS-PAGE. Purified 
inhibitor was dialysed against 20 mM Tris/HCl buffer, pH
7.5, 15% (v/v) glycerol and O.I3 M NaCl, and stored at -20°C.
2.7*6. Purification of cytoplasmic ribonucleases associated 
with the inhibitor in vivo
Ribonucleases were purified from the cytoplasm of rat 
liver and mature rat uterus using a modification of the 
procedure used by Blackburn ejfc ad. (personal communication, 
1985) to purify the latent ribonucleases of human placenta.
The method employed for liver and uterus was identical, 
although due to the small quantity of material available from 
the latter there was no extensive characterization of the 
purification steps.
The starting material for the purification of liver 
ribonuclease was the run-through fraction from the sepharose- 
RNase A affinity chromatography step of the inhibitor 
purification (Section 2.7*5)* This fraction contains 
ribonuclease/inhibitor complexes, but no free ribonuclease 
or inhibitor. The starting material for the purification 
of uterine ribonuclease was a 35-60% ammonium sulphate 
precipitate of uterine cytoplasm.
(a) BE-52 cellulose chromatography
Ribonuclease/inhibitor complexes have a slightly acidic 
pi and are therefore retained by anion exchange chromatography 
resins such as DE 52 cellulose (Whatman). This step has 
the major advantage that most of the basic proteins in the 
mixture are eluted through the column. Subsequent inactivation 
of the complexes means that the highly basic ribonucleases 
represent a large part of the total population of basic 
proteins.
Approximately 10 g of protein from rat liver, or 
approximately 1 g of protein from mature rat uterus was 
dialysed against 20 mM Tris-HCl, pH 7*5> 1 niM EDTA; 1 mM
1^-mer cap to ethanol. The dialysate was centrifuged at
50.000 X  g^^ for 1 h in order to remove particulate matter, 
and applied to a column (2.3 x 30 cm) of DE-32 cellulose.
The column was washed with two sample volumes of starting 
buffer and then eluted with a linear gradient of 0 - O.3 M 
NaCl in the same buffer (400 ml).
(b) Inactivation of ribonuclease/inhibitor complexes
Peak fractions of latent ribonuclease activity from 
step (a) were pooled and dialyzed against 2 x 20 volumes of
20 mM Tris-HCl, pH 7*5, 1 mM EDTA. The solution was then
“4 omade 10 M in pHMB and incubated at 37 C for 2 h. After
incubation, the solution was cooled to 4°C and the pH
adjusted to pH 3 by the dropwise addition of 20% (v/v)
acetic acid. This resulted in the formation of a heavy protein
precipitate which was removed by ultracentrifugation at
30.000 X g^^ for 1 h. The pH of the supernatant was adjusted 
to pH*8.3 by the dropwise addition of 3M NaOH.
(c) SP-sephadex chromatography
In this step, the basic ribonucleases released from 
inhibitor/ribonuclease complexes were further purified by 
cation exchange chromatography.
Protein from step (b) was applied to a column (2.3 x 
30 cm) of SP-sephadex (Pharmacia). The column was washed 
with three sample volumes of 20 mM NH^HCO^, pH 8.3, and 
the ribonucleases eluted with 3OO mM NH^HCO^, pH 8.3*
(d) Heparin-sepharose chromatography
Linear gradient elution from Heparin-sepharose was 
utilized to separate the total ribonuclease activity into 
its constituent peaks.
Peak fractions of ribonuclease activity from step (c) 
were pooled and dialysed against 20 mM NH^^HCO^, pH 8.5»
The dialysate was applied to a column (l»5 x 10 cm) of 
heparin-sepharose (Pharmacia). The column was washed with 
three sample volumes of starting buffer, and eluted with 
a linear gradient of 20-500 mM NH^HCO^, pH 8.5 (300 ml).
(e) Affinity chromatography on uridine 2*(3')5*-diphosphate- 
agarose
This step, although not included in the original protocol 
of Blackburn _et aT. was found to be necessary to obtain a 
homogeneous preparation of ribonuclease. Each separate peak 
of ribonuclease activity from step (d) was processed 
separately.
The enzyme solution was dialysed against 2 x 20 volumes 
of 20 mM sodium acetate, pH 5»5> 1 mM EDTA. The dialysate 
was applied to a column (l x 3 cm) of uridine 2*(3*)3’“ 
diphosphate-agarose (Sigma) . The column was then washed with 
50 ml of XI0 starting buffer and subsequently eluted with 
10 mM Tris-HCl, pH 7*9; O.5 M NaCl; 0.5% (v/v) glycerol.
Peak fractions of ribonuclease activity were pooled, aliquoted^ 
and stored at -20°C.
2.7«7* Polyacrylamide gel electrophoresis (PAGE)
Discontinuous SDS-PAGE
SDS-PAGE was performed essentially as described by 
Laemmli (l970), using the procedure of Le Stourgeon and 
Beyer (1977).
Stock solutions;
Acrylamide; 30% acrylamide (w/v), 0.8% bis-acrylamide (w/v). 
Resolving gel buffer; I.5 M Tris-HCl (pH 8.8), 0.4% SDS (w/v). 
Stacking gel buffer; O.3 M Tris-HCl (pH 6.8), 0.4% SDS (w/v). 
Electrophoresis buffer: 0.025 M Tris, O.I9 M glycine (pH 8.3)
0.1% SDS (w/v).
Sample buffer: O.O625 M Tris-HCl (pH 6.8), 2% SDS (w/v) 5% 
P-mercaptoethanol (v/v), 10% glycerol (v/v) 
abd 0.001% Bromophenol blue (w/v).
Procedure
Samples containing substances that interfere with SDS-PAGE 
were dialysed against distilled water. When necessary, proteins 
were concentrated by lyophillization. After addition of 
sample buffer, samples were heated to 100°C for 2 min.
10% or 12.5% slab gels were prepared by mixing the 
required amounts of stock solutions in a Buchner flask, and 
degassing the mixture under vacuum. Polymerization was 
initiated by the addition of TEMED and ammonium persulphate.
The resultant gels (imm thick, I5 x 18 cm) were electrophoresed 
on a BRL horizontal slab gel apparatus at 20-40 mA until 
the tracking dye reached the bottom of the gel. Gels were 
stained in 0.5% (w/v) Coomassie blue G (Sigma), 50%
methanol (v/v), 10% (v/v) acetic acid for 1-2 h. The 
background was destained by diffusion in 40% (v/v) methanol,
10% (v/v) acetic acid.
High pH discontinuous non-denaturing PAGE
Non-denaturing PAGE was performed essentially as described 
by Davis (1964), using the procedure of Hames (198I). This 
system electrophoreses at pH 9*3•
Stock solutions;
Acrylamide: 30% acrylamide (w/v), 0.8% bis-acrylamide (w/v). 
Resolving gel buffer; 3*0 M Tris-HCl (pH 8.8).
Stacking gel buffer; O.5 M Tris-HCl (pH 6.8).
Electrophoresis buffer; 0.025 M Tris, O.I9 M glycine (pH 8.3)» 
Sample buffer; O.O5 M Tris-HCl (pH 6.8), 10% sucrose (w/v),
1 mM -mer cap to ethanol, 0.001% (w/v) bromophenol 
blue (added immediately before sample loading).
Procedure
Due to the lability of the ribonuclease inhibitor protein, 
it was necessary to take various precautions to ensure the 
maintenance of inhibitor activity prior to electrophoresis. 
Therefore, samples of purified rat liver inhibitor and high 
speed supernatants from various tissues were dialysed against 
sajnple buffer at 4°C immediately after preparation. Samples 
were then aliquoted and stored at -20°C. Re-freezing of 
samples led to some loss of inhibitor activity and was 
therefore avoided.
7%, 9%, 10%, 11% and 13% polyacrylamide slab gels 
were prepared by mixing the required amount of stock solutions 
in a Buchner flask and degassing the mixture under vacuum. 
Polymerisation was initiated by the addition of TEMED and 
ammonium persulphate. The resultant gels were electrophoresed 
for 2-4 hours at 4°C using a current of 20-30 mA. Staining 
for protein was performed as described for SDS-PAGE.
Extraction of gel slices after non-denaturing PAGE
This method was utilized to determine the position of 
latent and free ribonuclease activities after electrophoresis. 
Individual tracks from the gel were cut out and sliced into 
3 mm pieces. Each gel slice was placed in a 1.3 ml polyethylene 
microfuge tube containing 100 pi of 0.1 M Tris-HCl pH 7«5j 
1 mM EDTA; 0.02% (w/v) BSA. When free ribonuclease activity 
was to be determined, 1 mM ^-mercaptoethanol was included 
in the buffer in order to reduce the inactivation of inhibitor/ 
ribonuclease complexes. The gel slices were then homogenized 
and the tubes mixed overnight at 4°C on a rotating end to 
end wheel. Fragments of polyacrylamide were ex elided by 
centrifugation for 10 min. in an Anderman microcentrifuge.
The supernatant was decanted and assayed for total or free 
ribonuclease activity as described in Section 2.7»3*
Ribonuclease activity gels
Ribonuclease activity was detected in polyacrylamide 
gels using the method described by Blank et al. (1982).
Lyophilized samples were resuspended in SDS-PAGE sample buffer
from which 1^-mercaptoethanol was omitted. 10% SDS poly­
acrylamide gels were prepared as has already been described, 
except that highly polymerized yeast RNA (Sigma) was added 
to the gel mixture at a concentration of 0.3 mg/ml. It was 
found that some leakage of sample occurred at the junction 
of stacking gel and resolving gel. Therefore, stacking gels 
were usually omitted from this procedure. Electrophoresis 
was for 2.3 h at 4°C using a current of 30-60 mA.
After electrophoresis, the gels were washed in 10 mM 
Tris-HCl pH 7.4; 23% (v/v) isopropanol (23O ml) in a shaking 
water bath (2 x I3 mins). The isopropranol was included to 
aid in the removal of SDS. The gel was then washed in buffer 
alone (2 x I3 min., 23°C), before being incubated for 2 h 
at 37°C in 100 mM Tris-HCl, pH 7*4. After incubation, the 
undigested RNA remaining in the gel was stained in 10 mM 
Tris-HCl, pH 7*4, 0.2% (w/v) toludine blue ’O' (Sigma) for 
10 mins.
The gel was destained in buffer alone on a shaking water 
bath. Usually, destaining took approximately 1 h and was 
taken to be complete when ribonuclease activity, detected 
as clear bands against a blue background, was clearly 
discernable. The resultant gel could be stored for a number 
of days prior to photography if wrapped in cling film and 
kept at 4°C.
2.8. Immunological methods
Phosphate buffered saline (PBS) used in many of the 
following methods contained the following; 0.l4 M NaCl,
2.7 mM KCl, 1.5 mM KH^PO^ and 1.8 mM Na^HPO^.
2.8.1. Immunization schedule
Primary immunizations were prepared hy mixing 0.3 ml 
of PBS containing 100-200 p.g of purified protein with 0.3 ml 
of Freunds complete adjuvant (Difco). An emulsion was formed 
by sonicating the mixture for 3 x 10 s. The emulsion was 
injected sub-cutaneously in 3-8 sites on the rVs back
(0.1 - 0.2 ml per site). Booster immunizations, made using 
Freunds incomplete adjuvant (Difco) were given every 10-14 
days until a reasonable titre was obtained. The titre was 
assessed by ELISA (Section 2.8.2). Complement proteins in 
the immune serum were inactivated by heating the serum to 
30°C for 1 h. Particulate matter was removed by centrifugation 
at 16,000 X g^^ for 10 min. in a Sorvall RC-3 centrifuge.
2.8.2. Enzyme linked immunesorbant assay (ELISA)
The ELISA system, performed essentially as described by 
Voiler jet al. (1976), was used to measure antibody levels 
in samples of immune serum.
Antigen, in 100 p.1 of PBS. was allowed to bind to the 
bottom of a well of a Falcon microtitre plate, either for 
2 h at 23^C or overnight at 4°C. The plate was then washed 
with washing buffer (PBS; 0.03% TWEEN 20 v/v), for 2 h at 
23^0. Serum, diluted l/lO^' t to l/lO'^ in washing buffer,
was placed in the wells, again for 2 h at 23°C. Once 
again the plate was washed. A sample of goat anti-rabbit 
gamma globulin, conjugated to horseradish peroxidase (Miles), 
was diluted I/3OO in washing buffer and 100 pi added to 
each well. After 2 h at 23°C the plate was extensively
I V
washed. The quantity of peroxidase activity bound to the 
plate was determined spectrophotometrically using 100 pi 
per well of 36 mM citric acid, 128 mM Na^HPO^, 0.04% (w/v) 
0-phenylene diamene (Sigma) and 0.04% (v/v) hydrogen 
peroxide. The reaction was allowed to develop for 20 min. 
in the dark at 25°C, after which time it was stopped by the 
addition of 50 pi of 4N H^SO^. The absorbance at 492 nm 
was determined for each well using a Titertek multiscan 
spectrophotometer.
The titre of immune serum was determined by finding 
the dilution at which immune serum and pre-immune serum from 
the same animal gave an equal absorbance at 492 nm.
2.8.3» Immunoelectrophoresis
This method, performed essentially as described by 
Johnstone and Thorpe (1982), was used to assess the specificity 
of antiserum raised against the ribonuclease inhibitor.
Samples of protein were loaded into the wells of a 1 mm 
thick agarose immunoelectrophoresis plate (Corning Universal), 
and electrophoresed for 2 h at 3 v/cm^using Barbitone 
electrophoresis buffer, pH 8.2. After electrophoresis,
2 0 pi of antiserum was loaded into the troughs of the plate 
and the plate was left for 24 h at 4^C. Precipitin bands 
were visualised by staining the plates with 0.025% (w/v) 
Coomassie brilliant blue R in methanol; water; acetic acid 
(50;45:5 by volume), and destaining in water; acetic acid; 
methanol (87:8:5 by volume).
2.8.4. Immuno ads orp ti on
This method, performed essentially as described by 
Johnstone and Thorpe (1982), was employed in order to improve 
the specificity of antiserum raised against the ribonuclease 
inhibitor.
Protein from the run through fraction of RNase-sepharose 
affinity chromatography (Section 2.7*5), was covalently 
linked to activated sepharose-4B (Sigma) essentially as 
described in Section 2.7*5* Approximately 20 mg of protein 
were bound per ml of swollen resin. Immune serum was passed 
through an 8 ml bed of resin at a flow rate of 10 ml/h , 
and 1 ml fractions were collected and monitored for specificity 
by ELISA and immunoelectrophoresis. The column was regenerated 
by eluting bound antibody with O.5 M ammonium hydroxide 
containing 3 M potassium thiocyanate. It was found that an 
8 ml bed of resin was sufficient to remove contaminating 
antibodies from 10 ml of immune serum.
2.8.3* Immuno (western) blotting
Immunoblots were performed on proteins resolved on both 
SDS-PAGE and high pH non-denaturing PAGE, using a modification 
of the method of Towbin ejt aJ. (l979)* After electrophoresis 
the proteins were electrophoretically transferred onto 
nitrocellulose filters (Schleicher and Schüll) at 350 mA 
for 2 h in a Bio-Rad electroblotting apparatus. All subsequent 
steps were carried out at 37°0 in a shaking water bath. The 
filters were washed for 2 h in 100 ml of washing buffer 
(20 mM Tris-HCl, pH 7.2, O.I5 M NaCl and 0.5% (v/v) TWEEN 20
(sigma)), and then incubated for 2 h in 100 ml of washing 
buffer containing 5% (v/v) inactivated goat serum (SAPU) 
and 0.5 - 1% (v/v) immune serum. After extensive washing, 
bound antibody was decorated with Protein A (Sigma, U.K.) 
labelled with by the lodogen method of Salinzinski
et al. (1981). Approximately 3 x 10^ c.p.m. of 
labelled Protein A in 100 ml of washing buffer was used per 
filter. Once again, the filters were extensively washed and 
then dried and autoradiographed for 24-48 h with an 
intensifier screen.
Densitometric analysis of autoradiographs was carried 
out using an LKB ultrascan, linked to a recording integrator.
2.9* Nucleic acids
2.9*1' Preparation of labelled BHK cell RNA
BSS; 6.8% NaCl, 0.4% KCl, 0.2% MgSO^ TH^O, 0.l4%
NaH^PO^ 0.39% CaCl *6H 0, 0.0015% phenol red (all w/v)
0.1% Chloroform (v/v).
RSB; 10 mM Tris-HCl, pH 7*4, 10 mM NaCl and I.5 mM MgCl^* 
Procedure ;
250 pCi of 5 - 6 uridine (Amersham) in 50 ml of Eagles 
M.E.M. (Busby ejfc aT. 1964) was added to each of two burlers 
of BHK cells grown to near confluence. After 18 h , the 
medium was discarded and the cells washed twice with BSS, 
scraped off into 3 x 10 ml of BSS, and centrifuged at 4,000 x g^^ 
for 2 min. The pelleted cells were resuspended in 8 ml of 
ice cold RSB, and homogenized in a teflon glass homogenizer 
with a motor driven pestle. The homogenate was then centrifuged
at 16,000 X for 5 min. and RNA vas prepared from the
supernatant by extraction with an equal volume of water 
saturated phenol: chloroform: isoamyl alcohol (50:48:2) at 
room temperature. The aqueous phases from two extractions 
were pooled and the RNA precipitated overnight at -20°C by 
the addition of 2.5 volumes of ethanol. The RNA was 
quantitated by measuring the absorbance at 26O nm, and the 
specific activity calculated by scintillation counting,
(Section 2.4 ).
2.9*2. Source of plasmids and routine analysis of nucleic acids
Plasmid pCXP6-105 was a kind gift from Dr R.MacDonald, 
Department of Biochemistry, University of Texas. pCXP6-105 
contains an insert of approximately 550 bp, corresponding to 
most of the coding region of rat pancreatic ribonuclease A 
mRNA, in the Pst I site of pBR 322. It is therefore tetra- 
cyline resistant and ampicillin sensitive. Plasmid p8749 
(a kind gift from Dr D.P. Leader, Department of Biochemistry, 
University of Glasgow) contains a 5OO b.p. cDNA insert of 
rat skeletal muscle actin mRNA. The insert is in the Pst I 
site of pBR322.
All restriction enzyme digests were performed according 
to the supplier's recommendations.
Rapid analysis of DNA and RNA samples was carried out 
using a Uniscience minigel apparatus.
The agarose used for all gels was from Miles Laboratories 
Ltd., code No. 95200-2.
2.9»3* Transformation of E.Coli
L-Broth; 1% Bactotryptone (Difco), 1% NaCl, 0.5% yeast 
extract (Difco), (all v/v).
L-Agar; 1.5% (w/v) Agar (Difco) in L-Broth.
Tetracyline; 13 ^g/ml for transformation or 20 pg/ml for 
routine growth.
Competent E.coli HBlOl cells were prepared by growing 
500 ml cultures until the absorbance at 6OO nm was 0.2.
The cells were harvested by centrifuging at 5,000 x g^^ for 
15 min., resuspended in 250 ml of cold 100 mM CaCl^, and 
left on ice for 20 min. The cells were then centrifuged 
again and resuspended in 5 ml of 100 mM CaCl^. 0.5 ml of 
sterile glycerol was added and aliquots of 1 ml were frozen 
in liquid nitrogen and stored at -70°C. Transformation was 
effected by adding 0 . 2 - 1  ng of plasmid DNA to a series of 
100 pi aliquots of competent cells (thawed for 30 min. in 
water-ice mix). The cells were left on ice for 30 min. 
before being heat shocked (37°C for 2 min.), and then plated 
directly on tetracycline plates.
2.9*4. Isolation of plasmid DNA
Large scale plasmid purification was carried out using 
the method of Birnboim and Doly (l979)* A single colony of 
transformed bacteria was transferred to 25 ml of L-Broth 
containing tetracycline at 20 pg/ml, and grown up overnight. 
2 x 5  ml of overnight culture were used to innoculate 2 x 
800 ml of L-Broth. The bacteria were grown until the 
absorbance at 6OO nm was approximately 0.8, at which time
Choroamphenicol (sigma) , at a concentration of I65 pg/ml was 
added. The cultures were then left overnight in an orbital 
shaker. The bacteria were harvested by centrifugation at 
3000 X g^^ for 10 min. in a Sorvall GS3 rotor, and then 
resuspended in 10 ml of alkaline lysis buffer I (30 mM glucose, 
10 mM EDTA, 23 mM Tris-HCl, pH 8), containing 2 mg/ml lysozyme 
(Sigma grade l). After 30 min. at 0°C, 20 ml of alkaline 
lysis buffer II (0.2 M NaOH, 1% (v/v) SDS) was added, and 
the mixture left for a further 3 min. at 0°C. Finally, 13 ml 
of alkaline lysis buffer III (3 M Na Acetate, pH 4.8) was 
added and the mixture left for 1 h at 0°C, before being 
centrifuged for 30 min. at 70,000 x g^^ in a Beckman Ti 60 
rotor (4°C). Total nucleic acid was precipitated from the 
resultant supernatant by the addition of 0.6 volumes of 
isopropanol. After centrifugation (13 min. at 16,000 x g^^ ) 
the precipitate was resuspended in 30 ml of T.E. buffer (lO mM 
Tris-HCl, pH 8, 1 mM EDTA). Plasmid DNA was purified by 
CsCl density centrifugation; 28.9 g of CsCl and 1.8 ml of 
ethidium bromide (lO mg/ml) were added, and the solution 
clarified by centrifugation (30 min. at 2000 x g). The 
solution was then carefully transferred to VTi 30 sealable 
tubes (Beckman) and centrifuged overnight at 50,000 r.p.m. 
in a Beckman model L3-30B ultracentrifuge (20°C). After 
centrifugation the plasmid DNA could be visualised as a 
dark band using a long wave U.V. lamp. The plasmid DNA was 
collected into a syringe after piercing the tube with a 21 g 
needle. A second CsCl spin was carried out using the Beckman
VTi 65 rotor at 65,000 r.p.m. overnight. Plasmid DNA 
was isolated as described above. Ethidium bromide was 
extracted - :-r. with isoamyl alcohol (3 methyl-l-butanol;
Kooh-Light) and the DNA precipitated by the addition of 
0.1 volumes of 3 M NaAc. pH 6 and 2.5 volumes of cold ethanol. 
Precipitated DNA was resuspended in T.E. buffer and stored 
at -20°C.
2.9.5» Preparation of total RNA
(a) Isolation of pancreatic RNA
Pancreatic RNA was prepared essentially as described by
Chirgwin ^t al. (1979)» The pancreas was removed from two
mature male rats, teased free of fatty tissue and rapidly
frozen in liquid nitrogen. The tissue was then ground to a
fine powder using a mortar and pestle and added to I6 ml of
guanadidium thiocyanate solution, (5 M guan , : thiocyanate
(BDH) ; 59^  (^y^) ^-mercaptoethanol; 50 mM Tris ; (w/v)
sarkosyl (Sigma U.K.)). The ground tissue was then homogenized
in a glass/teflon homogenizer with a motor driven pestle.
Genomic DNA in the homogenate was sheared by taking the
solution up into a 10 ml syringe, 10 times through a 19 g
needle and a further 10 times through a 23 g needle. The
homogenate was then heated to 50°C for 5 min. before being
centrifuged for 10 min. at l6,000 x g • CsCl was added to' ^av.
the solution at a concentration of lg/2.5 ml homogenate.
The homogenate was then layered onto a 1.2 ml cushion of
5.7 M CsCl; 50 mM EDTA, pH 7, in a Beckman SW 50.I ultra- 
centrifuge tube, and centrifuged at 115,000 x g^^ for 12 h
at 20^C, After centrifugation, the supernatant was discarded 
and the RNA pellet resuspended in 200-300 p,l of sterile 
distilled water. The RNA was stored at -70°C after the 
addition of 0.1 volumes of 3 M sodium acetate, pH 6 and 
2.5 volumes of ethanol.
(b) Isolation of uterine RNA
Groups of uteri from hormone-treated and untreated 
immature rats were excised, teased free of adipose tissue, 
and rapidly frozen in liquid nitrogen. The tissue was then 
ground up into a fine powder and added to a ^0:^0 mixture 
of Calouria buffer (30 mM NaCl; 50 mM sodium acetate; 10 mM 
EDTA; 19^  SDS (w/v), pH 5) and phenol; chloroform; isoamyl 
alcohol (25:24;l). 32 ml of the mixture was used per g 
wet weight of tissue. The mixture was then heated to 60°C 
for 3 min., with constant shaking, and the phases separated 
by centrifugation at 5,000 x g for 20 min. The phenol phase 
was re-extracted with calouria buffer, and the aqueous 
phases pooled and re-extracted with phenol; chloroform: 
isoamyl alcohol. Total nucleic acid was precipitated from 
the aqueous phase by the addition of 0.1 volumes of 3 M 
sodium acetate, pH 6, and 2.5 volumes of ethanol, overnight 
at -20°C. The precipitate was redissolved in k ml of 19°
(w/v) sarcosyl; 100 mM EDTA, pH 7, and the genomic DNA 
sheared by taking the solution into a 5 ml syringe, ten 
times through a 19 g needle, and a further ten times through 
a 23 g needle. h g. of CsCl was added to the solution, 
which was then divided into two, and layered onto 2 ml
cushions of 5»7 M CsCl; 50 mM EDTA, pH 7, iu Beckman SW40 
ultracentrifuge tubes. The tubes were filled to the top 
with paraffin oil and then centrifuged at 35,000 x g^^ 
for 17 h at 20^0. After centrifugation, the supernatant 
was discarded and the pellet resuspended in sterile distilled 
water. The RNA was stored at -70°C as an ethanol precipitate.
2.9.6. Preparation of Po1y(A}^ and Poly(aT fractions from total 
RNA
Total RNA was resuspended in binding buffer (lO mM Tris- 
HCl, pH 7.5, 0.5 M LiCl; 1 mM EDTA) at a concentration of 
0.5 mg/ml, heated to 60°C for 5 min. and rapidly cooled on 
ice. The solution was then chromatographed through a 0.2 ml 
bed of oligo dT cellulose (BRL) at a flow rate of 10 ml/h 
The run through was re-heated, cooled and reapplied to the 
column. The second run through (Poly(Aj fraction) was 
ethanol precipitated and stored at -70°C. The column was 
then washed with binding buffer 0.19^(w/v) in SDS, until 
the absorbance of the èluate at 26O nm was less than O.O5. 
Poly(A^ RNA was eluted from the column with 1 ml aliquots of 
elution buffer (lO mM Tris-HCl, pH 7.5» i mM EDTA). The 
absorbance at 260 nm of each fraction was measured and the 
peak fractions pooled, ethanol precipitated, and stored at 
-70°C. Typically, approximately 59^  of the total RNA was 
recovered in the PoTy(AT fraction.
2.9.7» Isolation of DNA from agarose gels
Plasmid DNA, digested with the relevant restriction 
enzyme, was electrophoresed on a ISfo agarose gel for 3-4 h. 
Excised insert DNA was visualised under U.V. light after 
staining with ethidium bromide, and the required band cut 
out with a scalpel. The agarose slice was placed in a piece 
of dialysis tubing (3/8” - 9 mm) with a minimal volume of 
running buffer (0.04 M Tris-acetate, pH 7*8; 0.002 M EDTA). 
The dialysis tubing was sealed with plastic clips and placed 
on the central platform of the electrophoresis apparatus, 
at right angles to the direction of the current. Electro­
phoresis was performed for 2 h at 60 V, after which time 
the solution was removed from the dialysis bag. Agarose 
debris was removed from the solution by centrifugation in a 
microcentrifuge. The DNA was precipitated overnight after 
the addition of 0.1 volume of 3 M sodium acetate, pH 6, and 
2.3 volumes of ethanol. This DNA was suitable for the nick 
translation reaction described in the following section.
2.9.8. Nick translation of DNA
A typical reaction contained the following;
1 mCi/lOO 111 a - P^p] dATP - 5 (50 iiCi)
100 mM Tris-HCl, pH 7»4; 100 mM MgSO^
500 mM NaCl; 100 mM DTT - 1.8 \il
DNA at approximately 1 mg/ml - O.3 - 1 P-l
DNA Polymerase I (Boehringer-Mannheim)
3 units/]il - 1 p,l
100 %M dCTP - 0.3 ^1
100 p,M dTTP - 0.5 p.1
100 iiM dGTP - 0.5 111
H^O to give final volume of 18 p,l.
Due to DNase I contamination of the DNA polymerase,
it was not necessary to add exogenous DNase I.
The reaction was allowed to proceed for h h at 13°0, 
after which time the labelled DNA was purified by chromato­
graphy through a small column of Biogel P-60 (Biorad).
The radioactivity incorporated was determined by Cherenkov 
counting. Nick translated DNA was stored at -20°C.
The specific activity of DNA labelled by this method
7 8 /was between 3 x 10 and 10 c.p.m./p,g DNA.
2.9.9. Northern blotting
Between 1 and 23 p-g of Poly(A^ or Poly (A) RNA was 
solubilized in running buffer, (20 mM MOPS (Sigma), 3 mM 
sodium acetate, 1 mM EDTA, pH 7), 309^  formaldehyde (v/v). 
The RNA was then heated to 6o°C for 3 min., rapidly cooled 
and electrophoresed on ~SJfo agarose/formaldehyde gels as 
described by Seed (1981). Electrophoresis was
for 3-4 h at 60 V. 18 s and 28 s rRNA’s were used as 
M.W. markers.
After electrophoresis the gel was soaked in 20 x SSC 
(3 M NaCl, 3 M sodium citrate, pH 7) for 30 min. and the 
RNA transferred to nitrocellulose filters (Schleicher and 
Schüll) as described by Southern (l975)« After blotting, 
filters were air dried and then baked for 2 h at 80°C in
a vacuum oven.
The baked filters were pre-hybridized for 6-8 h at 
42°C in sealed plastic bags containing 10 ml of hybridization 
buffer ( 3 X SSPE*; 10 x Denhardts^; 0.1^ (w/v) SDS; 309^
(v/v) formamide; 10 p,g/ml in Poly(A) and Poly(c) and 
100 pg/ml sonicated salmon sperm DNA). Filters were then 
hybridized in the same volume of hybridization buffer 
containing 3 x 10^ - 10^ c.p.m. of heat denatured probe 
(specific activity approximately 10 c.p.m./pg). The
filters were hybridized for 24-48 h at 42°C in a shaking 
water bath. Filters were then washed, first in 2 x SSC;
0.19^  SDS (w/v) at 23°C, and then in 0.1 x SSC; 0.1% SDS (w/v) 
at 30°C (low stringency)• Filters were then autoradiographed 
for 2-14 days in the presence of an intensifier screen.
*20 X  SSPE; 3 M NaCl, 0.2 M NaH^PO^.H^O, 20 mM EDTA, pH 7.4.
^30 X Denhardts; 1% Ficoll (Sigma) w/v, 1% Polyvinylpyrolidone 
(Sigma) w/v, 1% BSA (Pentax fraction V, Sigma) w/v.
3. RESULTS
3.1.1. The effect of oestrogen on the activity- of uterine 
cytoplasmic ribonuclease inhibitor 
As has been outlined in Section 1.4.3, cytoplasmic 
preparations from the uterus of the immature rat contained 
ribonuclease inhibitor activity at a similar level to that 
found in rat liver (McGregor et al.. I98I). Within three 
days of administration of oestrogen implants, this activity 
disappeared. The loss of inhibitor activity also occurred 
during normal sexual maturation of female rats. Figure 4 
illustrates a repeat of the original experiments that formed 
the basis of this project. It can be seen that under these 
conditions, uterine inhibitor activity disappeared after 
only 24 hours. The difference between this result and that 
presented by McGregor e^t a^. (198I), where inhibitor activity 
was not completely lost until three days after administration 
of oestrogen, was probably due to the use of a smaller 
quantity of carrier RNA in the assay (l25 Tig as opposed to 
230 lig), thus increasing its sensitivity to the exogenously 
added pancreatic RNase A. Figure 4 also confirmed that 
the uterus of mature rats contained no detectable inhibitor 
activi ty.
In a previous experiment, the effect of 30 mg and 10 mg 
paraffin wax implants, (either 10% (w/v) or 1% (w/v) in 
oestradiol-17^), on uterine inhibitor levels was tested.
It was found that only the 30 mg/lO% or 10 mg/lO% implants 
elicited the full response. Therefore, in this experiment 
and all further experiments described in this thesis, 10 mg/lO% 
implants were utilized.
Experiments using a single injection of oestradiol-17P 
or oestradiol benzoate failed to produce any significant 
change in inhibitor activity, (data not shown). The reason 
for this observation remains unclear but presumably implies 
that continued exposure to oestrogen, or a higher dose than 
that obtained with single injections is required to elicit 
the response. The fact that inhibitor activity is lost 
during normal development of the uterus indicates that the 
changes brought about by administration of oestrogen implants 
do reflect a normal response to the hormone.
Figure 4 . The effect of DBstradiol-17P and stage of development
on the activity of uterine ribonuclease inhibitor.
High speed supernatants were prepared from groups of 
uteri as described in Section 2.7.4. The inhibitor activity of 
each sample was determined as described in Section 2.7.2. The 
protein content of the samples was determined by the method of 
Lowry (Section 2.7.1). The cytoplasm was derived from mature 
female rat ( A )  or from immature rats which were untreated (# ) 
or given oestrogen implants 1 day (o), two days (■ ), or four 
days ( d ) before death.
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3.1.2. Qualitative and quantitative analysis of ribonuclease 
inhibitor in the rat uterus using antibodies to the 
purified protein 
In order to determine whether the loss of inhibitor 
a c t i v i t y  observed was due to a coincident reduction in the 
level of the protein, it was necessary to obtain antibodies 
to purified inhibitor for use in quantitative analysis.
Rat liver was chosen as a source of inhibitor protein 
due to its high level of inhibitor activity and availability 
(Roth, 1967)» There have been no reports of heterogeneity 
of ribonuclease inhibitor within a given species and it was 
therefore considered likely that antibodies raised to liver 
inhibitor would cross react with uterine inhibitor. This 
assumption was later confirmed.
The purification procedure adopted was that of Burton 
and Fucci (1982). (See Section 2.7*5)• The first step, 
preparation of a 35-^0^ ammonium sulphate precipitate from 
rat liver cytoplasm, resulted in a purification factor of 
approximately I.5 (Table 2). Blackburn (l977) has demonstrated 
that the 35-^0^ ammonium sulphate precipitate of human 
placental cytoplasm contains inhibitor/ribonuclease complexes, 
as well as free inhibitor. Evidence that inhibitor/ribonuclease 
complexes are also present in the ammonium sulphate precipitate 
of rat liver is presented in Section 3*3*1*
The second step, affinity chromatography using sepharose- 
RNase A, resulted in an overall purification of approximately
25,000 fold (Table 2). The run through from this affinity
chromatography step was retained and used in the purification 
of cytoplasmic ribonuclease, as described in Section 2.7*6.
In the remainder of this text the ammonium sulphate fraction 
will be referred to as the AmSO^ + I fraction whilst the run 
through from the affinity column will be referred to as the 
AmSO^ - I fraction.
The profile of a typical affinity chromatography 
fractionation is illustrated in Figure 3a. SDS-PAGE analysis 
of inhibitor after this step (Fig. 5^) revealed the presence 
of a single major band corresponding to a molecular weight 
of 48,000. This is in agreement with previous reports of 
the molecular weight of inhibitor from rat tissues (Burton 
and Fucci, I982). It was also possible to detect a number 
of minor bands in this fraction, indicating the presence of 
contaminating proteins. This was particularly apparent if 
the gel was overloaded, (data not shown). In order to reduce 
the level of contaminating proteins the eluate from the 
first affinity fractionation was re-chromatographed on 
.sepharose-RNase A. SDS-PAGE analysis of inhibitor after 
two passages through the affinity column revealed that this 
precaution resulted in the removal of most contaminating 
protein (Fig. lanes 3 and 6). Details of the progress
of a typical purification are given in Table 2. The overall 
yield was typically in the range of 33-40^. 1 unit of
inhibitor was equivalent to approximately 10 ng of purified 
protein.
Antiserum was raised to the purified inhibitor as 
detailed in Section 2.8.1. The titre of the immune serum 
was determined by ELISA analysis (Section 2.8.2), and was 
defined as the dilution required for immune serum to give 
the same reading at 492 nm as did pre-immune serum. Of 
the four animals immunized, two gave antiserum with a 
workable titre (l/50,000 to l/l00,000).
The specificity of the immune serum was tested by 
immunoelectrophoresis. In this method, proteins are electro­
phoresed on thin layer agarose gels, and then reacted with 
antiserum placed in a trough running parallel to the direction 
of electrophoresis. Recognition of proteins by the antiserum 
is detected by the formation of precipitin arcs. When this 
was carried out using AmSO^ + I as antigen, at least two 
precipitin arcs were detected in addition to that corresponding 
to inhibitor (Fig. 6, lane b). The precipitin arc corresponding 
to inhibitor was identified by comparing the pattern obtained 
using AmSO^ + I and AmSO^^ - I as antigen. (Compare lane b 
and lane c). If the serum was to be used to assay for 
inhibitor in crude cytoplasm,it was necessary to remove the 
contaminating antibodies. This was achieved by immune- 
adsorption (Section 2.8.4). Proteins from the AmSO^ - I 
fraction were covalently attached to sepharose-4B, and 
immune serum was passed through a bed of this resin, the 
run through being collected in fractions and tested for 
specificity by ELISA and immunoelectrophoresis. Figures 6 
and 7 illustrate the results obtained. ELISA assay of the 
fractions collected from the column employed AmSO^-I as
an antigen, and showed that the first 8 ml of eluent did 
not elicit a reaction greater than the pre-immune serum, 
i.e. contaminating antibodies appeared to have been removed. 
Thereafter the eluents reactivity increased (fractions 3”9) 
to a level similar to that obtained with pre-adsorbed immune 
serum. This increase in reactivity was presumed to be due 
to saturation of the column, and only fractions 1-4 were 
taken as adsorbed serum. Figure 6 illustrates an assessment 
of the adsorbed serum using immunoelectrophoresis. The 
precipitin bands corresponding to contaminating antibodies 
using pre-adsorbed serum (lane b, trough II), were not 
detected using adsorbed serum (lane d, trough III). All 
experiments detailed hereafter were performed using the 
adsorbed antiserum.
Confirmation of the specificity of the antiserum was 
obtained by immunoblotting (Section 2.8.3)* An analysis of 
cytoplasmic preparations from various tissues of the rat 
is shown in Figure 8. A single band, corresponding to a 
molecular weight of 48,000 was seen in most of the tissues 
analysed; the one exception being an extra band (molecular 
weight 60,000) in the proteins of the cytoplasm of rat 
pancreas. Because of the high level of secretory RNase A 
found in this tissue, it is possible that this band corresponds 
to inhibitor/ribonuclease complexes that were not fully 
dissociated by the denaturing conditions used. This has not 
however been investigated any further.
Comparison of the level of inhibitor in the immature 
rat uterus (lU) and the oestrogen-treated uterus (EU) 
indicated that there was little or no difference in the level 
of inhibitor. This observation is addressed more fully in 
the following experiment; Quantitation of inhibitor levels 
was achieved by densitometrie analysis of immunoblots (Fig. 9)« 
Various known amounts of purified inhibitor were used to 
generate a standard curve (Fig. 9 (A), lanes 1-4). The 
relationship between density and inhibitor concentration was 
essentially linear over the range used (Fig. 9 (B)). The 
density obtained with the various unknowns (lanes 6-10) was 
read off the standard curve and after allowing for differences 
in the width of the bands, an estimate of inhibitor levels 
was obtained. The average result obtained from two separate 
experiments is shown in Table 3(a), and demonstrated that 
inhibitor levels had increased by approximately 50?^ four 
days after treatment with oestrogen. The level of inhibitor 
in mature rat uterus was similar to that found in oestrogen- 
treated immature animals.
An approximate quantitation of inhibitor levels in the 
tissues analysed in Figure 8 was obtained by comparing the 
density of the autoradiographic signal with that obtained 
from the uterus. It was assumed that the relationship between 
density and concentration of inhibitor was linear, as was 
found with the quantitative analysis of uterine inhibitor 
levels (Fig. 9 (h)). This data is presented in Table 3(B).
The level of free inhibitor in uterine cytoplasm was 
calculated by converting units of activity into ng of protein 
(Table 3 (a ), column 2). Comparison of this figure with the 
total inhibitor concentration indicated that in untreated 
immature rats the ratio of free inhibitor to bound inhibitor 
is about 3:1* In treated rats however there was no free 
inhibitor.
Taken together, these experiments demonstrated that 
the loss of inhibitor activity associated with oestrogen- 
treatment or normal development was due to inactivation of 
the protein rather than its loss. It was therefore necessary 
to investigate how the inhibitor was being inactivated.
Figure 5(a). Sepharose-RNase A affinity chromatography of rat 
liver ribonuclease inhibitor.
Chromatography was performed as described in Section 
2*7.5. Ribonuclease inhibitor activity ( # )  was determined as 
described in Section 2.7.2. Protein concentration (O) was determined 
by absorbance at 280 nm. The eluent at A was 45 mM potassium 
phosphate buffer, pH 6.4, and at B was changed to the same buffer 
made 0.5 M with respect to NaCl. At C the buffer was changed to 
0.05 M Borate, pH 6: 4 M  NaCl: 1 mM EDTA: 1 mM 1^-mercaptoethanol:
15^ (v/v) glycerol.
(b). SDS-PAGE analysis of purified rat liver inhibitor.
Samples were electrophoresed on a 10^ SDS-polyacrylamide 
gel as described in Section 2.7.7. Lane 1 contained 100 p,g of rat 
liver cytoplasmic protein. Lane 2 contained 100 p, g of protein from 
a 35-60^ ammonium sulphate precipitate of rat liver cytoplasm.
Lane 3 contained 5 p-g of purified inhibitor after one passage thrcugh 
the sepharose-RNase A affinity column. Lanes 5 and 6 contained 5 ^g 
of purified inhibitor after two passages through the sepharose- 
RNase A affinity column, (two separate experiments). The molecular 
weight markers used were BSA (67,000), ovalbumin (43,000) and 
chymotrypsinogen (28,000).
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Table 2. Purification of rat liver ribonuclease inhibitor.
The data was derived from a typical experiment. 
Ribonuclease inhibitor was assayed as described in Section 
2.7.2. Protein concentration was assayed by the method of 
Lowry (Section 2.7.1.).
*1 unit of inhibitor was defined as the quantity
3
required to inhibit the digestion of H-RNA by 5 ng of 
RNase A by 50^.
Total
protein
(mg)
Total
activity
(units)
Specific
activity
(units/mg)*
Purification
factor
Yield
Rat liver 
cytoplasm 81,500 300,000 3.68 0 100^
35-60^
ammonium
sulphate
precipitate 43,680 236,500 5.42 1.47 79%
Affinity 
chromato­
graphy eluate 
(1st passage) 1.3 126,500 97,400 26,500 A2%
Affinity 
chromato­
graphy eluate 
(2nd passage) 1.1 107,400 97,700 26,500 36%
Figure 6 . Assessment of the specificity of anti-ribonuclease 
inhibitor serum; Immunoelectrophoresis.
Immunoelectrophoresis was performed as described in 
Section 2.8.3. (A) illustrates a photograph of the stained
immunoelectrophoresis plate. (O) illustrates a diagrammatic 
representation of (A), indicating the major precipitin arcs 
observed.
Key.: (1) Antigen loaded in wells.
(a) Purified inhibitor protein (3 ]i9 ) •
(b) AMSO^ + I (25 ixg).
(c) AMSO^ - I (25 iig).
(d) AMSO^ + I (25 iig).
(e) AMSO^ - I (25 )ig).
(f) Purified inhibitor protein (3 ]ig).
(9) AMSO^ + I (25 Tig).
(h) AMSO^ - I (25 Tig).
(2) Antiserum added to troughs.
I and II - Pre-adsorbed serum 
III - Adsorbed serum
(20 ]il) 
(20 ]il)
IV - Potassium thiocyanate column washing (20 p^ l).
Cl
C
Cl
TD
C
00
■o
g#) ^  c#
Figure 7. Assessment of the specificity of antiserum raised 
to ribonuclease inhibitor: ELISA of fractions 
from immunoadsorption column.
ELISA was performed as described in Section 2.7.5. 
AMSO^-I diluted l/lOOO in PBS was used as antigen. Fractions 
from the immunoadsorption column, diluted l/lOOO in PBS, were 
used as antiserum. The absorbance values shown were derived 
from the average of duplicate samples. *A* designates the 
absorbance at 492 nm obtained with pre-adsorbed immune serum. 
*B* designates the absorbance at 492 nm obtained with pre- 
immune serum.
Immunoadsorption was performed as described in 
Section 2.8.4.
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Figure 8. Immunoblot analysis of ribonuclease inhibitors in 
various tissues of the rat.
High speed supernatants were prepared as described 
in Section 2.7.4. 150 p-Q of protein from the uteri of immature
rats (lU), the uteri of rats that had received oestrogen implants 
four days before death (EU), rat liver (Li), spleen (Sp), 
kidney (Ki), brain (Br), Lung (Lu) and pancreas (P) were 
electrophoresed on a 10^ SDS-polyacrylamide gel as described 
in Section 2.7.7. Lanes X and Y contained 5 pg and 25 ng of 
purified rat liver inhibitor respectively.
One half of the gel (a) was stained for protein, 
whilst the other half (b) was immunoblotted as described in 
Section 2.7.4. The autoradiograph was exposed for 24 h.
The molecular weight markers used in this, and all 
subsequent SDS-PAGE experiments, (unless otherwise indicated), 
were phosphorylase b, (90,000), BSA, (67,000), ovalbumin, 
(43,000), Carbonic Anhydrase, (30,000), Soybean Trypsin 
inhibitor, (20,000), and a-lactaglobulin (14,000). These 
markers were obtained in the form of a kit from Pharmacia Ltd.
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Figure 9. Quantitation of ribonuclease inhibitor in uterine
cytoplasm by immunoblottino.
(a ) Samples were electrophoresed on a 10^ SDS-
polyacrylamide gel and immunoblotted as described in Sections
2.7.7. and 2.7.4. Lanes 1-4 contained 50 ng, 25 ng, 10 ng and
5 ng of purified inhibitor respectively. Lane 5 contained a 
125
I-labelled 28,000 molecular weight marker. Lanes 6-10 
contained 150 p,g of uterine cytoplasmic protein which was 
derived from immature rats (lane 6), immature rats that had 
received oestrogen implants 1 day (lane 7), 2 days (lane 8) 
and 4 days (lane 9) before death. Lane 10 contained 150 -jig 
of cytoplasmic protein from mature rat uteri. The autoradiograph 
was exposed for 24 h.
(B) Plot of the density of the autoradiograph (lanes 
1-4) against the concentration of purified inhibitor. Error 
bars indicate the degree of variation in the densitometric 
reading obtained from two separate regions of each band. The 
level of inhibitor in the various uterine samples was determined 
using this plot.
The molecular weight markers used, (BSA - 67,000, 
ovalbumin - 43,000,and chymotrypsinogen - 28,000), were labelled 
with by the method of Salanzinski et al. (1981). 17,000
c.p.m. of labelled protein were used per lane.
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Table 3. (A). Uterine ribonuclease and ribonuclease inhibitor 
levels.
(a) Estimated from average of two separate immunoblot experiments 
(Fig. 9).
(b) Determined from inhibitor assay, (two experiments).
1 unit = approximately 10 ng inhibitor.
(c) Assayed in the presence of 10 pHMB, (two experiments).
(d) Assayed in the absence of pHMB, (two experiments).
1 unit of ribonuclease was designated as the amount 
required to digest the H RNA by 50% under the conditions _ 
described (Figure 10).
(B). Approximate inhibitor levels in various tissues 
of the rat.
The intensity of the bands seen in the autoradiograph 
(Fig. 8) was measured by laser densitometry. The density 
obtained with each band was expressed as a percentage of the 
signal obtained with oestrogen-treated uterine cytoplasm, (EU), 
and extrapolated, using the quantitation shown in Table 3(A), 
to give a value for inhibitor concentration in ng/mg cytoplasmic 
protein.
(A)
Time after
oestrogen
treatment
Ribonuclease inhibitor, 
ng/mg cytoplasmic protein 
Total'^) Free(b)
Cytoplasmic ribonuclease 
units/mg cytoplasmic protein 
Total(c) Free(d)
Untreated 165 - 3.5 125 i 5 14.7 i 1.7 0
1 day 235 ± 15 0 69 i 3 21 i 6
2 day 251 i 8.5 0 91 i 3 17 i 3
4 day 260 - 7 0 107 - 3.5 32 i 1
Mature
animals 239 - 5.5 0 93 i 1 35 i 1
(B)
Tissue Intensity of band 
in Figure 8 
(% of EU band)
Approximate inhibitor 
concentration 
(ng/mg cytoplasmic protein)
Liver 48% 125
Spleen 90% 234
Kidney 73% 190
Brain 40% 104
Lung 36% 94
Pancreas 68% 177
3»2.1. The effect of oestrogen on uterine cytoplasmic 
ribonuclease activity 
One possible explanation for the above findings was 
that the loss of inhibitor activity resulted from an increase 
in the level of cytoplasmic ribonuclease(s) and their 
association with the inhibitor. The original experiments 
carried out by McGregor ejt aT. (I98I) and Munro and Knowler 
(1982), demonstrated that the loss of inhibitor was accompanied 
by an increase in cytoplasmic ribonuclease activity. However, 
the increase did not appear sufficiently dramatic to account 
for the loss of inhibitor activity. Further, the assay 
conditions utilised in these experiments were such that 
it was difficult to discern the degree of change. It was 
decided to repeat and extend these studies under conditions 
where changes in ribonuclease activity were clearly discernable. 
This was achieved by using carrier RNA to decrease the 
sensitivity of the assay (Section 2.7*3)* Further, it was 
decided that both free and total (free plus inhibitor bound) 
ribonuclease activities should be measured in order to gain 
a clearer understanding of the changes occurring in the 
oestrogen-stimulated uterus. Total ribonuclease activity 
was assayed after the inhibitor had been inactivated by 
treatment with pHMB. The results obtained are illustrated 
in Figure 10. In the untreated uterine cytoplasm there was 
little or no free ribonuclease activity detected. Treatment 
with pHMB revealed the presence of some latent ribonuclease 
activity. After various periods of oestrogen-treatment
free ribonuclease appeared in the uterine cytoplasm. Treatment 
with pHMB revealed even higher levels of ribonuclease activity, 
indicating that active enzyme was being released from inhibitor 
complexes. One unit of ribonuclease activity was arbitrarily 
designated as the amount required to digest the \PbJ RNA 
by 50%> and the total ribonuclease activity of each sample 
was calculated on this basis. The average result obtained 
from two separate experiments is shown in Table 3(a). The 
results showed that, by four days after oestrogen—treatment, 
the increase in ribonuclease activity was approximately 
eight fold. An approximate calculation, taking into account 
the ratio of inhibitor to ribonuclease in untreated animals, 
and the small increase in levels of inhibitor in response 
to oestrogen, indicated that an 8 fold increase in ribonuclease 
would be more than enough to account for the loss of inhibitor 
activity. This calculation is only an approximation, and is 
subject to at least two assumptions. Firstly it is assumed 
that all of the induced ribonuclease activity results from 
enzyme that can associate with the inhibitor. This assumption 
was tested by titrating oestrogen-stimulated uterine cytoplasm 
with purified inhibitor to see if all the free ribonuclease 
activity could be saturated. This was found to be the 
case (data not shown). The second assumption was that the 
increase in ribonuclease activity was paralleled by a similar 
increase in the quantity of ribonuclease protein present. 
Investigation of the validity of this assumption is the 
subject of the following sections.
Figure 10. The effect of Qestradiol-17|3 on total and free 
uterine cytoplasmic ribonuclease activity.
Uterine cytoplasm was prepared as described in 
Section 2.7.4. The ribonuclease assay was carried out in
the presence (---0---0--- ) and absence (— # — #-) of pHMB
as described in Section 2.7.3. Protein determinations were 
carried out using the method of Lowry (Section 2.7.1).
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3«2.2. Characterisation of* the ribonuclease ( s ) found in 
uterine cytoplasm 
The first method used to gain more information on the 
nature of uterine cytoplasmic ribonuclease(s) was ribonuclease 
activity staining. Total cytoplasmic protein was electrophoresed 
on SDS-polyacrylamide gels impregnated with yeast RNA. The 
resultant gels were washed and incubated, and regions 
containing ribonuclease activity were detected as clear bands 
on the gel after staining with an RNA specific dye. As little 
as 100 pg of bovine pancreatic RNase A could readily be 
detected using this method (see Fig. 23)»
An analysis of uterine cytoplasm from adult rats and 
from immature rats before and after oestrogen-treatment is 
illustrated in Figure 11. Two bands of ribonuclease activity 
were detected corresponding to molecular weights of l4,000 
and 18,000. The lower molecular weight band was seen in 
untreated rats and appeared to intensify with time after 
oestrogen—treatment or during normal development. The higher 
molecular weight band was barely detectable in untreated 
animals and intensified considerably with time after oestrogen- 
treatment or during normal development.
Investigation by other groups (Kumagai ejb al. , 1983;
P. Blackburn, personal communication) indicated that cytoplasmic 
ribonucleases are similar in properties and molecular weight 
to pancreatic RNase A. An attempt was therefore made to 
use antibodies raised to bovine pancreatic RNase A to 
detect and quantitate the enzymes of uterine cytoplasm.
Antiserum was raised to commercially available 
pancreatic RNase A (Sigma), essentially as was described 
for the raising of antisera to ribonuclease inhibitor 
(Section 2.8.1). Immunoblot analysis of this antisera using 
pancreatic RNase A as antigen (Fig. 12a) revealed that the 
antiserum detected a major band of molecular weight 14,000 
and a minor band of molecular weight 16,300. The former 
corresponds to the molecular weight of pancreatic RNase A, 
whilst the latter probably represents pre-RNase A, an active 
pre-secretory form of the enzyme that has been detected by 
in vitro translation experiments (Haugen and Heath, 1979)* 
Pre-RNAse A has a reported molecular weight of 16,300. It 
can be seen that 23 ug of RNase A was readily detected using 
this antiserum. As little as 10 ng could be detected (data 
not shown).
Figure 12b illustrates an attempt to detect the ribo­
nucleases of uterine cytoplasm using this antiserum. No 
bands were detected in the molecular weight range 14,000 - 
20,000, despite the fact that the gel was overloaded with 
300p,g of cytoplasmic protein. A band of molecular weight 
23,000 was detected, but was present at similar levels in 
untreated and treated uterine cytoplasm. Another band of 
molecular weight 100,000 was detected in untreated uterine 
cytoplasm and was absent in oestrogen-treated animals. It 
is not known whether these bands correspond to species of 
ribonuclease and no attempt was made to characterize them 
further. The failure to detect those species observed using
the activity staining method was presumably due to low 
immuno-crossreactivity of the antiserum with rat cytoplasmic 
ribonucleases, coupled with the low abundance of these 
enzymes in cytoplasmic preparations.
Figure 11. Analysis of uterine cytoplasmic ribonuclease by 
activity staining.
Electrophoresis and the detection of ribonuclease 
activity was carried out as described in Section 2.7.7. Lanes 
1-5 contained 200 p-g of cytoplasmic protein from the uterus of 
untreated animals (lane l), animals having received oestrogen 
implants 1, 2 and 4 days before death (lanes 2, 3 and 4 
respectively) and from mature animals (lane 5).

Figure 12. Immunoblot analysis of uterine cytoplasmic protein
using antiserum raised to bovine pancreatic RNase A .
(a) 25 ng of bovine pancreatic RNase A was electro­
phoresed on a 12.5% SDS-polyacrylamide gel and immunoblotted as 
described in Sections 2.7.7. and 2.8.5. The autoradiograph was 
exposed for 24 h,
(b) Electrophoresis and immunoblotting were performed 
as described above. Lane 1 contained 500 pg of cytoplasmic 
protein from the uteri of immature rats. Lane 2 contained 500 pg 
of cytoplasmic protein from the uteri of immature rats given 
oestrogen implants 4 days before death. The autoradiograph was 
exposed for 48 h.
The bands detected in (a) and (b) are discussed in
the text.
The radioactive molecular weight markers were the 
same as those described in the legend to Figure 9.
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3«2.3« Studies on the mode of induction of uterine cytoplasmic 
ribonucleases by oestrogen
The following experiments illustrate an attempt that 
was made to use a rat pancreatic ribonuclease A cDNA 
recombinant to detect the mRNA coding for the cytoplasmic 
ribonucleases of rat uterus. The rationale behind this 
approach was that homology between the pancreatic and cyto­
plasmic ribonuclease proteins may be reflected at the nucleic 
acid level. Specifically, regions of the pancreatic RNase A 
molecule that are required for inhibitor binding (Section 1.4.1) 
are likely to be conserved in the cytoplasmic ribonucleases. 
Furthermore, it seems likely that the overall three-dimensional 
shape of both enzymes should be similar in order for interaction 
with the inhibitor to occur. Taken together with other 
similarities between the two enzymes, such as the mode of 
cleavage of RNA, molecular weight, and pH optima, it seems 
likely that these enzymes are the product of evolutionarily 
related, or even identical genes. Finally, a recent report 
of the amino acid composition of a cytoplasmic ribonuclease 
from human placenta (P. Blackburn aT. , personal communication), 
revealed that there are few differences between this enzyme 
and human pancreatic RNase A.
It was hoped that the recently isolated cDNA recombinant 
of rat pancreatic RNase A (MacDonald et al., 1982) could be 
used to detect the mRNA coding for uterine cytoplasmic 
ribonuclease. Thus, it would be possible to determine whether 
the oestrogen-induced stimulation of cytoplasmic ribonuclease 
was due to transcriptional enhancement or some other mechanism.
Furthermore, if successful this approach would provide a 
method by which information on the primary sequence of 
cytoplasmic ribonucleases could be obtained.
It was decided that the best approach to this problem 
would be to carry out northern blot analysis of uterine RNA 
before and at various times after oestrogen-treatment using 
the cDNA recombinant as a probe. Before proceeding with 
these experiments it was necessary to determine the exact 
time at which oestrogen-induced cytoplasmic ribonuclease 
first appears in uterine cytoplasm. This was achieved by 
assaying the total cytoplasmic ribonuclease activity of 
uterine cytoplasm at various times within the first 24 h 
of oestrogen-stimulation. The results obtained are shown 
in the table below.
first 24 h of oestrogen-stimulation.
Time after oestrogen- Cytoplasmic ribonuclease
stimulation (h) activity (units/mg of protein)
0 15.5
6 20
12 17.5
18 68.5
24 72
This experiment demonstrated that oestrogen-induced 
cytoplasmic ribonuclease is detectable between 12 h and 18 h 
after hormone treatment. If this induction resulted from 
transcriptional enhancement, the mRNA coding for the 
cytoplasmic ribonucleases should appear in uterine cytoplasm 
between 12 h and 18 h after hormone treatment.
3*2.4. Characterization and isolation of insert DNA from 
PcXP6-105
Figure 13 presents a diagrammatic illustration of the 
rat pancreatic RNase A cDNA recombinant plasmid (pcXP6-103)«
The host plasmid (pBR322) contains a 530 b.p. insert in the 
Pst 1 site, representing the entire coding region of rat 
pancreatic RNase A mRNA. Analysis of pcXP6-105 with restriction 
enzymes however revealed that the structure of the plasmid 
was not as originally described by MacDonald ^t aT. (1982), 
and that a Pst I site flanking the insert appeared to have 
been replaced by an EcoRI site.
The evidence for this, presented in Figure l4 was as 
follows: A single digestion with Pst I linearized the plasmid 
but did not excise the insert (Fig. l4a, lane J5) • A single 
digestion with EcoRI, that should have only linearized the 
plasmid, excised a 730 b.p. fragment (Fig. l4b, lane 6).
A double digestion with EcoRI and Pst I yielded two fragments 
of 730 b.p. and 530 b.p. (Fig. l4b, lane 7)« It seemed likely 
that the 730 b.p. fragment corresponded to the segment of 
host plasmid lying between the Pst I and EcoRI sites, while 
the 530 b.p. fragment was the insert cDNA sequence. If this 
interpretation was correct, then the 330 b.p. fragment should 
contain sites for the restriction endonucleases Bgl I and Hinf I 
while the 730 b.p. fragment should contain no sites for either 
enzyme. Figure l4c confirms that this was the case, and the 
fragment lengths generated from the 530 b.p. fragment by the
two enzymes were consistent with its identification as the 
cDNA insert encoding RNase A mRNA. Possible reasons for 
the conversion of the Pst I site to an EcoRI site are given 
in the discussion of this thesis.
Figure 13. Diagrammatic representation of rat pancreatic RNase A 
cDNA recombinant (p c XP6-105).
Representation of pc XP6-105 showing some of the 
restriction sites in the 550 bp insert.
*One of the Pst I sites flanking the insert has been replaced 
by an EcoRI site.
EcoRI
*Pst I (EcoRI)
750bp
Bgl I 
Hae II_
550bp (Insert DNA)
IKbp
Pst I
PCXP6-105
2Kbp3Kbp
Figure 14. Characterization and preparation of insert DIMA 
from PC XP6-105.
Restriction enzyme digests, electrophoresis of DNA 
on minigels, and electroelution of DNA from agarose were performed 
as described in Sections 2.9.2 and 2.9.7 respectively. DNA was 
visualized under U.U. light after staining the gels with 0.5 pg/ml 
ethidium bromide for 30 min.
Key; Lane DNA Restriction enzyme
(a)
(b)
(c)
2 500 ng of pBR322 -
3 500 ng of pBR322 Pst I
4 500 ng of pcXP-105 -
5 500 ng of pcXP-105 Pst I
2 500 ng of pBR322 -
3 500 ng of pBR322 Eco RI
4 500 ng of pBR322 Eco RI + Pst I
5 500 ng of pcXP6-105 -
6 500 ng of pcXP6-105 Eco RI
7 500 ng of pcXP6-105 Eco RI + Pst I
2 200 ng of 550 b.p.* -
3 200 ng of 550 b.p. Bgl I
4 200 ng of 550 b.p. Hinf I
5 200 ng of 550 b.p. Bgl I + Hinf I
6 200 ng of 750 b.p.'*' -
7 200 ng of 750 b.p. Bgl I
8 200 ng of 750 b.p. Hinf I
9 200 ng of 750 b.p. Bgl I + Hinf I
* - 550 b.p. fragment seen in (b), lane 7.
- 750 b.p. fragment seen in (b), lane 7.
Lane 1 in (a), (b) and (c) contained DNA from a Hinf I digest of 
pBR322. The size of the fragments generated are 1631, 517, 506, 
396, 344, 298, 221,220, 155 and 75 b.p.
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3*2.3» Northern blot analysis
A preliminary experiment is illustrated in Figure 13a.
In order to determine the integrity of Poly(A)^ RNA 
isolated from untreated and oestrogen-treated uteri, the 
RNA was analysed by northern blotting using a rat skeletal 
muscle actin cDNA probe (p 8749)* A single major band, 
corresponding to the known size of rat skeletal muscle mRNA 
(l400 bases) was detected in oestrogen-treated and control 
uterine RNA (Fig. 13a, lanes 1 and 2). The same RNA was 
also probed with nick translated pcXP6-103 insert DNA. 13 Pg 
of poly(A)^RNA was used in this experiment. Both 24 h and 
seven day exposures of the filter are shown (Fig. 13a, lanes 
3-4 and 6-7). Careful examination of the 7 day exposure 
revealed that the probe recognized two bands in both control 
and oestrogen-treated RNA. However, these bands corresponded 
in size to IBs and 28s rRNA, indicating that this signal 
may arise through non-specific binding to these abundant 
species. Whilst it was not possible to detect any clear 
band that was induced in the oestrogen-treated RNA, a faint 
putative band was seen in the position indicated by an ’X ’. 
Lane 3 contained 1 p,g of Poly (A) ^ RNA from rat pancreas. 
Analysis with pcXP6-103 insert as probe revealed a single 
major band corresponding in size to rat pancreatic RNase A 
mRNA (783 bases).
Whilst the above experiment was not very encouraging 
with respect to detecting uterine cytoplasmic ribonuclease 
mRNA, it was decided to attempt a more extensive experiment.
(Fig. 13b). In order to increase the possibility of 
detecting the uterine mRNA, larger quantities of Poly(A)*
RNA were utilized (30 ]ig as opposed to I3 P-g) • In addition, 
a wider range of time points were used, as it was possible 
that the l4 h time point utilized in the previous experiment 
was too early to detect the putative induced mRNA. Finally, 
Poly(A)*’ RNA (30 pg) from each time point was analysed to 
allow for the possibility that the putative ribonuclease 
mRNA was de-adenylated. The first point to emerge from this 
experiment was that the bands recognized by the probe that 
corresponded in molecular weight to 18s and 28s rRNA were 
seen using both Poly(A)^ and Poly(A) RNA. This observation 
supported the contention that these signals arose through 
some sort of association between rRNA and the probe. When 
similar quantities of uterine RNA were probed using nick 
translated pBR322 (data not shown), no non-specific binding 
to rRNA occurred. This would seem to indicate that the 
association between the pcXP6-103 insert and rRNA involves 
some weak homology. Once again it was not possible to detect 
a clear cut example of a band induced by oestrogen. There 
did appear to be more binding of the probe to oestrogen- 
stimulated Poly(A)^ RNA in the region below the l8s rRNA 
marker, but it was not possible to define a specific band.
At this point in these studies, it was decided to 
discontinue this approach and to attempt to analyse the 
oestrogen-induced cytoplasmic ribonucleases by other means.
Figure 15. Northern blot analysis of uterine RNA and 
pancreatic RNA.
RNA was prepared and fractionated into Poly (A)^ 
and poly (A) as described in Sections 2.9.5 and 2.9.6. The 
RNA was electrophoresed, blotted and hybridized as described 
in Section 2.9.9.
(a) Lanes 1 and 2 contained 1 pg of poly (A)^ RNA 
from immature rat uteri, before (lane 1) and 14 h. after 
oestrogen-treatment (lane 2). The RNA was probed with nick 
translated p8749 (rat skeletal muscle actin cDNA recombinant). 
Lanes 3,4,6 and 7 contained 15 pg of poly (A)^ RNA from immature 
rat uteri, before (lanes 3 and 6) and 14 h. after oestrogen 
treatment (lanes 4 and 7). Lanes 5 and 8 contained 1 pg of 
poly (A)^ RNA from rat pancreas. The RNA was probed with nick 
translated insert DNA from pc XP6-105 (rat pancreatic RNase A 
cDNA recombinant).
(b) Lanes 1-4 contained 30 pg of poly (A)^ RNA from 
the uteri of immature rats before (lane l) and 12 h. (lane 2)
16 h. (lane 3) and 20 h. (lane 4) after oestrogen-treatment. 
Lanes 5-8 contained 30 pg of poly (A)” RNA from the same time 
points. Nick-translated insert DNA from pcXP6-105 was used as 
probe.
The time of exposure is indicated above each filter.
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3.3.1. Detection of iTxtiibitor/ribonuclease complexes by 
immunoblotting from non-denaturing gels
In the previous sections, evidence was presented 
demonstrating that the loss of inhibitor activity in the 
immature rat uterus exposed to oestrogen or during normal 
sexual maturation resulted from a marked increase in the 
level of endogenous cytoplasmic ribonucleases, such that 
all the inhibitor was present as inhibitor/ribonuclease 
complexes. To analyse this further, a method was developed 
to detect inhibitor/ribonuclease complexes after electrophoresis 
on non-denaturing polyacrylamide gels.
The acidic inhibitor protein (pi 4.8) and the Islightly 
acidic inhibitor/ribonuclease complexes were resolved on 
non-denaturing polyacrylamide gels, run at alkaline pH 
(pH 9.3)* The activity of the inhibitor protein, and hence 
inhibitor/ribonuclease complexes is dependent on the maintenance 
of free sulfhydryl groups, and is sensitive to heat or acid 
pH. The following precautions were taken to minimise the 
possibility of losing inhibitor activity prior to or during 
electrophoresis: Fresh homogenates were processed rapidly
and stored at -20°C. Samples were not re-frozen after use.
Free thiol levels were maintained at all times by the 
inclusion of P-mercaptoethanol, and electrophoresis was 
carried out at low temperature (4°C).
Figure l6a illustrates a preliminary experiment in which 
cytoplasmic protein from immature rat uteri before (lane 2) 
and 4 days after oestrogen-treatment (lane 3) was analysed.
Lanes 1 and 4 contained purified rat liver inhibitor. In 
the untreated uterus, free inhibitor (A) and two putative 
inhibitor/ribonuclease complexes (B,C) were detected. After 
oestrogen-treatment free inhibitor was no longer detectable 
but three putative inhibitor/ribonuclease complexes were 
seen (B, C and D).
Figure l6b illustrates an experiment in which purified 
rat liver inhibitor was incubated in the presence of bovine 
pancreatic RNase A prior to electrophoresis. It was observed 
that pre-incubation with RNase A resulted in the loss of the 
band corresponding to free inhibitor, and the appearance of 
a diffuse band(s) closer to the origin of the gel. The 
relative weakness of this diffuse band indicated that some 
of the total inhibitor was lost under these conditions. The 
reasons for this are unclear. Figure l6c illustrates an 
analysis of the AmSO^ + I and AmSO^ - I fractions of rat 
liver cytoplasm. In the AmSO^ + I fraction free inhibitor
(a ), and a putative inhibitor/ribonuclease complex (c) 
were seen. In the AmSO^ - I fraction, free inhibitor was 
absent, and a faint putative complex (b ) was seen in 
addition to the putative complex C.
In order to confirm that the bands B, C, and D shown in 
Figure l6a were indeed inhibitor/ribonuclease complexes, gel 
slices from a non-denaturing gel were analyzed for free and 
latent ribonuclease activity (Fig. 17)• Latent ribonuclease 
activity, detected by assaying in the presence of pHMB, was 
recovered from the gel slices containing the presumed inhibitor/
ribonuclease complexes but could not be detected in the 
slices containing free inhibitor or from other areas of the 
gel. Free ribonuclease activity was not detected in any part 
of the gel. It was presumed that this was because the basic 
ribonuclease proteins did not electrophorese beyond the 
stacking gel. It can be seen that the pattern of bands 
detected by immunoblotting in this experiment was more 
complex than that shown in Figure l6a. Thus, the band 
designated B in Figure l6a resolved into a doublet (B, B'), 
as did the band designated C in Figure l6a (C, C ’). In 
addition a faint band, designated E, was observed in oestrogen- 
treated uterine cytoplasm. The detection of this more complex 
pattern of bands was found to be repeatable in subsequent 
experiments.
Figure 16. Analysis of inhibitor/ribonuclease complexes by
immunoblottino from non-denaturino polyacrylamide 
gels.
Samples were electrophoresed and immunoblotted as 
described in Sections 2.7.7 and 2.8,5.
(a) Lanes 1 and 4 contained 150 ng of purified rat 
liver inhibitor. Lanes 2 and 3 contained 150 pg of cytoplasmic 
protein from the uteri of immature rats before (lane 2), and 
four days after oestrogen-treatment (lane 3). A,B,C and D 
refer to bands discussed in the text. The autoradiograph was 
exposed for 36 h.
(b) Lane 1 contained 25 ng of purified rat liver 
inhibitor. Lanes 2 and 3 contained the same quantity of 
inhibitor, pre-incubated for 30 min. at 37°C in the presence 
of 25 ng (lane 2) and 50 ng (lane 3) of bovine pancreatic 
RNase A. The autoradiograph was exposed for 3 days.
(c) Lane 3 contained 25 ng of purified rat liver 
inhibitor. Lane 1 contained 150 p g of the AmSO^ + I fraction 
of rat liver. Lane 2 contained 150 pg of the AmSO^ - I 
fraction of rat liver. The autoradiograph was exposed for
24 h.
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Figure 17. Detection of inhibitor/ribonuclease complexes 
by assay of oel slices after non-denaturino 
PAGE.
Duplicate samples of 200 pg of cytoplasmic protein 
were loaded on either side of a 10^ polyacrylamide gel, and 
electrophoresed as described in Section 2.7.7. One half of 
the gel was immunoblotted (Section 2.8.5), whilst the other 
half was sliced and analysed for ribonuclease activity, as 
described in Section 2.7.7.
(a) Protein from immature rat uterus.
(b) Protein from immature rat uterus 4 days 
after oestrogen treatment. A,B,B*,C,C*, D and E refer to 
bands on the immunoblot discussed in the text.
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3.3.2. Ferguson plot analysis of inhibitor/ribonuclease complexes
Information regarding the molecular weight and charge 
of the inhibitor/ribonuclease complexes electrophoresed on 
non-denaturing gels was obtained by constructing a Ferguson 
plot (Ferguson, 1964; Hedrick and Smith, I968). The Rf 
of each complex was calculated after electrophoresis through 
gels of four different polyacrylamide concentrations (Fig. 18).
A plot was then constructed of log Rf against aczylamide 
concentration (Fig. 19 )• The slope of the plot is inversely 
proportional to the molecular weight of the protein.
Information regarding the charge of the various proteins is 
derived from the point of intersection with the *Y’ axis.
For instance, a number of proteins with identical charge but 
different molecular weights (e.g. the conditions pertaining 
in SDS-PAGE) would have different slopes on a Ferguson plot, 
but would converge at or very near the 'Y’ axis. In contrast, 
a group of proteins with identical molecular weight, but 
differing in charge would have identical slopes and would not 
converge at or near the 'Y' axis.
Analysis of uterine cytoplasm (Fig. 18) revealed the 
presence of a number of bands; A, B, B ’, C, C', D and E.
In the untreated uterus bands A, B, B^, C ’ and D were detected 
(Fig. 18, 99^  lU lane). In the oestrogen—treated uterus bands 
B, B ’, C, C ’, D and E were detected (Fig. 18, 99^  EU lane).
Band 'E* was only seen clearly in the 139^  and 119^  gels.
Band ’A' corresponds to free inhibitor.
A Ferguson plot was constructed for each of the bands 
indicated (Fig. I9). The plots derived for each of the 
inhibitor/ribonuclease complexes were nearly parallel to 
each other. This observation indicated that the major 
difference between the various complexes resided in differences 
in charge. It was assumed that these differences resided 
in the ribonuclease moiety of the complexes, as purified rat 
liver inhibitor gave a single band under these conditions,
(Fig. 16). Therefore, it seemed likely that the enzymes that 
give rise to the complexes B through to E have increasing 
basicity, due to the increased retardation of the complexes 
that they formed.
The molecular weight of a given protein is inversely 
proportional to the slope of its Ferguson plot (slope = =
retardation coefficient; Hedrick and Smith, I968). The 
was calculated for each of the bands seen in Figure 18, and 
is shown in the table below.
complexes.
Band from Fig. 18 Retardation coefficient
A 0.5
B 0.45
B ’ 0.43
C 0.44
C ’ 0.43
D 0.47
E 0.47
This data indicated that the highest molecular weight 
complex was C, followed by B, B*, and C’, and then by D 
and E. Free inhibitor (a ) had the lowest relative molecular 
weight.
Figure IB. Ferguson plot analysis of inhibitor/ribonuclease
complexes: Non-denaturino PAGE.
Duplicate samples of 150 p-g of cytoplasmic protein 
from the uteri of immature rats (lU) and immature rats which 
had received oestrogen implants 4 days before death (EU), were 
electrophoresed on 13%, 11%, 9% and 7% polyacrylamide gels as 
described in Section 2.7.7. Immunoblotting was performed as 
described in Section 2.8.5. The autoradiograph was exposed 
for 36 h. A,B,B* ,C,C*, D and E refer to bands discussed in 
the text.
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Figure 19. Ferguson plot analysis of inhibitor/ribonuclease
complexes; Plot of log.Rf against % acrvlamide.
The Rf of each of the bands A, B, B*,C, C*, D 
and E was calculated from the autoradiograph shown in Figure 
18. A plot of log Rf against acrylamide concentration was 
constructed for each band: A(X ), B (A), B*(B), C (#),
C* (A), D ( O )  and E (o). A best fit linear function was 
derived for each set of points by regression analysis, using 
the MINITAB statistics package on Glasgow University’s GUME 
2976 computer.
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3•3•3• Analysis of inhibitor/ribonuclease complexes in 
various tissues of the rat.
Figure 20 illustrates an analysis of the inhibitor/ 
ribonuclease complexes found in various tissues of the rat.
In the uterus of the mature rat (MU), the pattern of bands 
was identical to that found in the oestrogen-treated immature 
uterus (EU). This observation supported the idea that the 
induction of ribonuclease activity after oestrogen-treatment 
also occurred during normal development of the uterus. The 
pattern of bands seen in the brain (Br) and Liver (Li) was 
similar to that found in the untreated^uterus (lU), although 
very little free inhibitor was detected in brain. No bands 
were detected using pancreatic cytoplasm (Pa), contrary to 
the findings using immunoblot analysis after electrophoresis 
on SDS-PAGE (Fig. 8). The reason for this is not clear. In 
the kidney (Ki), spleen (Sp) and lung (Lu) the pattern of 
bands seen resembled that found in the oestrogen-stimulated 
or mature uterus. In addition to the major bands A, B, B ’,
C, C D  and E seen in the various tissues, a region close 
to the origin of the resolving gel appeared to contain some 
ribonuclease inhibitor. The reason for this is not known, 
although one possibility is that this region represents 
ribonuclease inhibitor associated with cytoplasmic mRNP 
particles.
Figure 20. Detection of inhibitor/ribonuclease complexes in
various tissues of the rat.
Duplicate samples of cytoplasmic protein from the 
various tissues were electrophoresed on a 10% polyacrylamide 
gel as described in Section 2.7.7. One half of the gel (a) 
was stained for protein, whilst the other half (b) was 
immunoblotted as described in Section 2.8.5.
Most of the lanes contained 150 p.g of cytoplasmic 
protein, and are identified as follows: Immature rat uteri,
(lU), 4 day oestrogen-treated immature rat uteri (EU), liver 
(Li), Brain (B), Kidney (Ki), Spleen (Sp) and Lung (Lu). Due 
to the low protein concentration of the original homogenates 
of mature rat uteri (MU) and pancreas (P), it was only possible 
to load 75 "p-g of these preparations. Lane 1 contained 25 ng 
of purified rat liver inhibitor. The autoradiograph was exposed 
for 48 h. A , B , B *, C , C ’, D and E designate bands detected 
on the immunoblot that are discussed in the text.
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3.4.1. Purification and characterization of cytoplasmic 
ribonucleases
The demonstration that multiple forms of ribonuclease 
associate with the inhibitor vivo raises a number of 
questions concerning the function of these enzymes. It is 
not as yet clear whether the differences in properties 
observed (i.e. molecular weight and charge heterogeneity) 
reflect differences in function for all or some of these 
enzymes.
Recent work on the inhibitor found in human placenta 
(p. Blackburn ejb al. , personal communication) has demonstrated 
that at least five distinct species of ribonuclease are 
associated with the inhibitor in this tissue. These enzymes 
have been purified and to some extent characterised. Briefly, 
it emerges that there are two distinct major species of 
ribonuclease present, differing in their amino acid composition 
and their differential activities towards the homopolymers 
Poly (u) and Poly (c). One of these species closely resembles 
human pancreatic ribonuclease A whilst the other is similar 
to a ribonuclease purified from human liver (Frank and Levy, 
1976). The other species appear to resemble one of the two 
major species.
The following sections illustrate an attempt to purify 
and characterise the ribonucleases associated with the 
inhibitor in rat liver and uterus. Whilst the main interest 
of this work was in the ribonucleases found in the uterus, the 
difficulty in obtaining workable quantities of material from 
this tissue meant that it was more practical to determine the 
conditions for the purification using a more readily available 
tissue i.e. rat liver.
3*4.2. Purification of cytoplasmic ribonucleases from rat liver.
The purification of rat liver cytoplasmic ribonucleases 
essentially followed the three steps described by Blackburn 
et al. (personal communication) for the human placental 
ribonucleases. However, the activities recovered still 
contained considerable contamination (as determined by SDS-PAGE) 
which was removed by the inclusion of a final step, affinity 
chromatography on agarose-2’(3')5' UDP.
The starting material for this purification was the run 
through fraction from the affinity purification of the 
inhibitor (Section 2.7*5)• This fraction contained inhibitor/ 
ribonuclease complexes, but no free inhibitor (Fig. l6c).
The first step of the purification procedure was chromatography 
of the starting material through the anion exchanger, DEAE- 
cellulose. The rationale for this was that the slightly acidic 
enzyme/inhibitor complexes would be retained by the column, 
whilst basic proteins, including any basic ribonucleases not 
associated with the inhibitor, would pass through the column.
The complexes were eluted from the column with a linear salt 
gradient of 0-500 mM NaCl in starting buffer. This step is 
illustrated in Figure 21a* The elution of complexes was 
assayed after the release of ribonuclease activity by pHMB.
The latent enzyme was eluted as a single peak when the salt 
concentration reached approximately 220 mM.
The peak fractions from DEAE-cellulose chromatography 
were pooled and the complexes dissociated, firstly by removing 
free thiol by dialysis, and subsequently by incubation in the
presence of pHMB. The liberated ribonucleases, being 
basic proteins, were further purified by chromatography on 
the strongly acidic cation exchanger SP-sephadex. This step 
is illustrated in Figure 21b. The ribonucleases were eluted 
with 500 mM ammonium bicarbonate, pH 8.5» Although, in this 
figure, the ribonuclease activity appears to be eluted as 
two overlapping peaks, this result was not consistently 
repeatable and no attempt was made to separate the two 
components when they were seen.
The next step in the purification procedure employed 
chromatography on heparin-sepharose, as described by Blackburn 
et al. (personal communication), to separate the constituent 
ribonuclease species from one another. Heparin has been 
used as a specific inhibitor of ribonucleases due to its 
ability to bind small basic proteins through cation exchange. 
The bound ribonucleases were eluted from the heparin-sepharose 
column using a linear salt gradient of 20-500 mM ammonium 
bicarbonate. The elution profile of a typical experiment is 
illustrated in Figure 22a. The bulk of the ribonuclease 
activity was eluted as a single peak at a salt concentration 
of 120 mM. A second, minor peak was eluted at a higher salt 
concentration (220 mM). These two activities were designated 
rat liver cytoplasmic ribonuclease I and II (RLC I and II) 
respectively. RLC I represented approximately 98% of the 
total activity.
Analysis of RLC I by SDS-PÀGE (Fig. 23, lane 4), 
revealed that the preparation was not entirely homogeneous 
at this stage. In order to improve the purification, an 
extra step, affinity chromatography using agarose-UDP, was 
added to the purification procedure of Blackburn ejb al. 
Affinity chromatography of RLC I is illustrated in Figure 22b. 
SDS-PAGE analysis of the main peak of eluted protein (Fig. 23 
lane 5) showed that the ribonuclease had been purified to 
homogeneity. The molecular weight of this enzyme, as judged 
by SDS-PAGE, was 20,000. This figure is not in agreement 
with the findings of Kumagai at al. (1983) who quote a 
molecular weight of 16,000 for the purified rat liver 
cytoplasmic ribonuclease. However, bovine pancreatic 
ribonuclease A also had an anomalous molecular weight in 
Figure 23 (lane 6), i.e. 16,500 as opposed to the known 
molecular weight of approximately 14,000. These differences 
may arise from the anomalous behaviour of some highly basic 
proteins in SDS-PAGE (Hames, I98I).
A full analysis of the purification of rat liver 
ribonuclease is presented in Table 5» The enzyme(s) was 
purified 125,000 fold with a yield of approximately 609 .^
Figure 21 (a). Chromatography of inhibitor/ribonuclease complexes 
from rat liver on DEAE-cellulose.
Approximately 5 g of protein from a 35-60% ammonium 
sulphate precipitate of rat liver cytoplasm (after removal of free 
inhibitor by affinity chromatography, Section 2.7.5) was chromato­
graphed on DEAE-cellulose as described in Section 2.7.6. The 
figure illustrates the elution step, using a linear salt gradient 
of 0-500 mM NaCl in starting buffer. 7 ml fractions were collected 
and assayed for latent ribonuclease activity (O), using the 
micro-assay described in Section 2.7.3, and for protein ( # )  
by measuring the absorbance at 280 nm.
(b). Chromatography of cytoplasmic ribonuclease from
rat liver on SP-sephadex.
Peak fractions of latent ribonuclease activity
from DEAE-cellulose chromatography were pooled and prepared for
chromatography on SP-sephadex as described in Section 2.7.6. The 
buffer was changed to 20 mM IMH^HCO^ at (A) and to 500 mM NH^HCOg 
at (B). 10 ml fractions were collected and assayed for ribo­
nuclease activity (o) and protein concentration ( # )  as above.
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Figure 22 (a)• Chromatography of cytoplasmic ribonucleases from 
rat liver on heparin-sepharose.
Peak fractions of ribonuclease activity from SP- 
sephadex chromatography were pooled and prepared for chromatography 
on heparin-sepharose as described in Section 2.7.6. The figure 
illustrates the elution step, using a linear salt gradient of 
20-500 mM NH^HCOg, (300 ml). 5 ml fractions were collected and 
assayed for ribonuclease activity (O) as described in the previous 
figure legend. Two peaks of activity were detected, and have been 
designated RLC I and RLC II. ('RLC* stands for rat liver cytoplasm).
(b). Affinity chromatography of RLC I on Uridine 2*(5*)5* 
diphosphate-agarose.
Chromatography was performed as described in 
Section 2.7.6. The buffer was changed to 200 mM sodium acetate;
10 mM EOTA, pH 5.5 at (A), and to 10 mm Tris-HCl, pH 7.9: 5% 
glycerol (v/v) at (B). 2 ml fractions were collected and assayed
for ribonuclease activity (O) as previously described.
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Figure 23. Analysis of the purification of rat liver cytoplasmic
ribonuclease by SDS-PAGE.
The samples were electrophoresed on a 12.5% SDS- 
polyacrylamide gel as described in Section 2.7.7. Lane 1 
contained 200 ]ig of protein from the AMSO^-I fraction. Lane 2 
contained 200 ng of protein from the ribonuclease peak recovered 
from DEAE-cellulose. Lane 3 contained 100 p,g of protein from the 
ribonuclease peak recovered from SP-sephadex. Lane 4 contained 
25 pg of protein from the RLC I peak recovered from heparin- 
sepharose. Lane 5 contained 3 pg of protein from the RLC I peak 
recovered from agarose-UDP affinity chromatography. Lane 6 
contained 5 pg of bovine pancreatic RNase A. The lanes designated 
M contained molecular weight markers.
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Table 6 . Purification of cytoplasmic ribonuclease from 
rat liver.
1 unit of ribonuclease is defined as the amount 
required to give an increase in absorbance of one absorbance 
unit using the micro-assay described in Section 2.7.3. 
Protein concentration was estimated by the method of Lowry 
(Section 2.7.1.).
The final step of this purification, UDP-agarose 
affinity chromatography was performed on the major peak 
(RLC I) from the previous step.
Total
Protein
(mg)
Total
units
Specific
activity
(units/mg)
Purification
factor Yield
Rat liver 
cytoplasm 12,300 31,300 2.55 0 100%
AmSO^ 3,900 24,500 6.3 2.47 78%
DEAE-
cellulose 350 23,200 66.2 25.9 74%
SP-sephadex 4.2 22,500 5,360 2,100 72%
Heparin-
sepharose 0.47 19,700 41,840 16,400 63%
UDP-agarose 0.057 18,100 317,980 124,700 58%
3*4.3» Purification of cytoplasmic ribonucleases from the 
uterus of mature rats.
Uterine cytoplasm from approximately 100 rats was 
accumulated over a period of time and kept frozen at -20°C.
A 35~60% ammonium sulphate precipitate of the uterine 
cytoplasm was prepared and used as the starting material 
for the purification of ribonuclease. All the steps in the 
purification were the same as those already described for 
the purification of liver ribonuclease. Because of the limited 
availability of uterine tissue, no attempt was made to conduct 
a full analysis of the various stages of purification.
Figure 24 illustrates the result obtained with heparin- 
Sepharose chromatography of the uterine ribonucleases.
Three distinct peaks of activity were eluted from the column 
and were designated rat uterine cytoplasmic ribonucleases I,
II and III (rug I, II and III). RUG I was eluted at a 
similar salt concentration to RLG I (I30 mM ammonium 
bicarbonate), and was the smallest of the three peaks. RUG II 
was eluted at a similar salt concentration to RLG II (225 mM 
ammonium bicarbonate). RUG III was by far the largest peak 
and was eluted when the salt concentration reached approximately 
350 mM. The data obtained using immunoblotting from non­
denaturing gels (Section 3»3»2) suggested that as many as 
six different ribonuclease species are present in uterine 
cytoplasm. It therefore seemed likely that due to the close 
similarity of these enzymes, heparin-sepharose chromatography 
did not completely resolve some of the species, and that
the peaks observed may be composed of more than one distinct 
species. Evidence that this is indeed the case is presented 
in the following sections.
Further purification of each of the three ribonuclease 
peaks from heparin-sepharose was achieved by affinity chromato­
graphy on agarose-UDP. The yield for each activity was 
similar to that obtained with RLC I (between 90% and 95% for 
this step alone). Sufficient protein was not however available 
for analysis on stained gels and further characterization was 
based solely on enzyme activity.
3*4.4. Comparison of the properties of the purified ribonucleases
In the following sections, a number of experiments are 
described that were intended to highlight any differences or 
similarities in the properties of the purified ribonucleases, 
and to compare them with the properties of the cytoplasmic 
ribonucleases of human placenta, purified and characterised 
by Blackburn ejfc aT. (personal communication). The following 
experiments were carried out for each purified enzyme:
Comparison of the molecular weight and assessment of the 
homogeneity of each activity by ribonuclease activity staining, 
(Fig. 25)* Estimation of and for each activity (Fig*
26). Determination of the pH optimum for each activity (Fig.
27) and comparison of the relative rates of digestion using 
RNA, Poly(c), Poly(u), Poly(c) or Poly(A) as substrate 
(Table ?)*
Figure 24. Chromatography of cytoplasmic ribonucleases from 
mature rat uteri on heparin-sepharose.
The ribonuclease of mature rat uteri were purified 
using the same procedure as that described for rat liver 
(Section 2.7.6). This figure illustrates the third step in 
the purification procedure, chromatography on heparin-sepharose. 
The ribonucleases were eluted from the column with a linear 
salt gradient of 20-500 mM NH^HCO^, pH 8.5, (200 ml). 2 ml 
fractions were collected, and assayed for ribonuclease activity 
as previously described (See Figure 22a).
Three major peaks of activity were detected and 
have been designated RUC I, RUC II and RUC III. (RUC stands 
for rat uterine cytoplasm).
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Figure 25» Analysis of purified ribonucleases by activity
staining.
Ribonuclease activity staining was performed as 
described in Section 2.7.7, except that a 12.5^ polyacrylamide 
gel was used. Lanes 1 and 9 contained 100 p.g of bovine 
pancreatic RNase A. Lane 2 contained 200 pg of cytoplasmic 
protein from rat liver. Lanes 3 and 4 contained 10 units of 
RLC I and RLC II respectively. Lane 5 contained 200 pg of 
cytoplasmic protein from mature rat uteri. Lanes 6, 7 and 
8 contained 10 units of RUC I, RUC II and RUC III respectively,
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Figure 26. Lineweaver-Burke plots for the purified cytoplasmic
ribonucleases RLC I. RLC II. RUC I, RUC II and RUC III
One unit of each of the enzymes was assayed in 
triplicate using a variety of substrate concentrations (0.75 - 
5 mg/ml yeast RNA) by the micro-assay procedure described 
in Section 2.7.3.
A best fit linear function was derived for each 
set of points by regression analysis on MINITAB. The 
apparent Kjyj and of each enzyme is presented in Table 7.
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Figure 27. pH optima of the purified cytoplasmic ribonucleases
of rat liver and rat uteri.
The purified ribonucleases, RLC I (O), RLC II (G),
RUC I (•), RUC II (■), and RUC III ( A )  were assayed in 
duplicate at each pH value shown, using the micro-assay 
described in Section 2.7.3.
The buffers used were 100 mM sodium acetate buffer
(a), 100 mM potassium phosphate buffer, (B), and 100 mM Tris 
buffer (C). The pH of the buffers was adjusted with acetic 
acid, (a), sodium hydroxide, (B), and HCl, (c).
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Table 7 . Comparison of the properties of purified cytoplasmic 
ribonucleases.
(a) The relative activity refers to the ratio of activity 
towards the homopolymer compared with that obtained 
with yeast RNA. The relative activity of the human 
placental enzymes was derived from the ratio of 
activity towards the homopolymer, compared with that 
obtained with yeast tRNA (Blackburn at al., personal 
communication, 1985).
(b) The figures in brackets refer to those obtained by 
Kumagai j[t al. (1983) for what is assumed to be the 
same enzyme (RLC l).
(c) HP designates * human placental* (Blackburn et al., 
personal communication, 1985).
K and M values were obtained from Figure 26. 
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Characterisation of rat liver cytoplasmic ribonuclease I
(RLC I )
Figure 25 compares the activity of the purified ribonucleases 
with total activity of the tissue of origin, and with bovine 
pancreatic ribonuclease A. RLC I (lane 3) appeared to contain 
four bands of activity. The main band corresponded to the 
major band seen in total liver cytoplasm (lane 2) and had a 
molecular weight slightly higher than pancreatic RNase A 
(lanes 1 and 9)* A second species, barely detectable in 
total liver cytoplasm, and with an identical molecular weight 
to pancreatic RNase A was also present. Two very faint bands 
of higher molecular weight were also detected. The K and
3
V of RLC I were calculated and found to be 1.2 x 10 ug max
RNA/ml and 4.3 x 10  ^ /unit enzyme respectively.
These figures agree fairly well with those determined by 
Kumagai ejb al. (1983), for what is assumed to be the same 
enzyme (Table ?)• The pH optimum of RLC I was pH 8 - 8.5 
(Fig. 26). This was also in agreement with the findings of 
Kumagai e_t al. (1983)» The relative rate of digestion of 
homo-ribo polymers compared with that of yeast RNA is 
presented in Table ?• RLC I shows a preference for Poly(c) 
over Poly(u) and yeast RNA. In this respect it was similar 
to human placental ribonuclease IV and V (HP RNase IV and V,
Table ?).
3»4«6. Characterisation of rat liver cytoplasmic ribonuclease 
II. (RLC II).
Activity stain analysis of RLC II revealed the presence 
of four equally intense bands, (Fig. 23, lane 4). Th®se 
bands appeared to migrate at slightly different rates to 
those seen with RLC I (lane 3).
3
The K and V of this activity were 2 x 10 and m max
4.1 X 10  ^respectively. This indicated that RLC II has a 
slightly lower affinity for yeast RNA than does RLC I.
Unlike RLC I, RLC II exhibited a broad pH optimum over 
the range pH 3-9* Minor peaks were seen at pH 3*5 and 7*5 
(Fig. 27).
RLC II exhibited little activity towards Poly(c), and 
no activity towards the other homopolymers tested (Table 7)*
3.4.7* Characterisation of rat uterine ribonuclease I (RUC I)
Ribonuclease activity stain analysis of total uterine 
cytoplasmic protein revealed the presence of four bands 
(Fig. 23, Lane 3)* Previously, it was suggested that the 
ribonuclease activity of mature uterine cytoplasm consisted 
of two species as determined by activity staining (Section 
3*2.2, Fig. 11). It is however apparent from this experiment 
that each of the two bands described in Figure 11 consists of 
two closely separated bands.
RUC I contained two of these bands in similar positions
to those seen with RLC I (compare lanes 3 and 6, Fig. 23)*
However, unlike RLC I it was the lower molecular weight band
that predominated in RUC I.
The for RUC I was found to be 1.8 x 10^ RNA/ml, 
indicating a lower affinity for substrate than RLC I 
(Table 7) * The of RUC I was 3.8 x 10 ^ -^ 260 ^tiits/min. /
unit enzyme.
RUC I was found to have a broad pH range (3*5 - 8.3), 
with the main peak of activity at pH 6 and a minor peak at
pH 7*5 (Fig. 27)*
RUC I showed a preference for Poly(c) over Poly(u), 
but unlike RLC I, activity towards Poly(c) was less than 
towards yeast RNA. In this respect RUC I most closely 
resembled human placental RNase I (HP RNase I, Table 7)*
3*4.8. Characterisation of rat uterine cytoplasmic ribonuclease
II (RUC II).
Activity stain analysis of RUC II (Fig. 23, lane 7) 
revealed the presence of three major bands of activity. One 
of these bands had a similar molecular weight to pancreatic 
RNase A. The other two bands were of higher molecular weight, 
and corresponded to the high molecular weight band that was 
induced in response to oestrogen (Fig. 11)•
The kinetic parameters and rates of cleavage of Poly(u) 
and Poly(c) for RUC II were similar to those of RLC II 
(Table 7)* The pH optimum of RUC II occurred over a broad 
range with dual peaks at pH 3*5 and pH 8 (Fig. 27)*
3.4.9* Characterisation of rat uterine cytoplasmic ribonuclease
III (RUC III).
Activity stain analysis of RUC III (Fig. 23, lane 8)
revealed a similar pattern to that seen with RUC I, with 
a predominant band corresponding in molecular weight to 
pancreatic RNase A, and a minor band corresponding to the
predominant band of RLC I.
Like RLC II, RUC I, and RUC II this preparation displayed 
activity over a broad pH range, and a of approximately
2.0 X 10^ lig RNA/ml. However, unlike the other activities,
RUC III showed a preference for Poly(u) compared with Poly(c)
(Table 7). In this respect it most closely resembles the
placental enzyme HP RNase II (Table 7)*
Before concluding this report, it is necessary to 
remark that the interpretation of the activity strain data 
(Fig. 25) is subject to some criticism due to the indistinct­
ness of some of the bands. Further experiments of this nature 
would have been desirable, but the small quantities of the 
uterine enzymes available, together with restrictions on 
the time available made this impossible.
4. DISCUSSION
4.1 The effect of method of administration and dose of
oestrogen on uterine inhibitor activity
The preliminary studies of McGregor et al. (198I)
demonstrated that the effect of a single injection (l p-g) 
of oestradiol 17-P on immature rat uterine ribonuclease 
inhibitor was small and highly variable. The inhibitor 
activity was assayed at various times up to I6 h after 
hormone treatment. In this study the effect of a single 
injection was reexamined. No significant change in inhibitor 
activity was seen during the 48 h post-treatment period 
that was tested. Taken together with the observation that 
administration of oestrogen implants resulted in the complete 
loss of inhibitor activity, these results suggested that 
either prolonged exposure to oestrogen, or a higher dose 
than that obtained with a single injection, was required 
to elicit the response. The former hypothesis was investigated 
by examining the effect of oestradiol benzoate on uterine 
inhibitor activity. Unlike oestradiol-17P, oestradiol 
benzoate is metabolised slowly vivo. Once again, no 
significant change in inhibitor activity was observed within 
48 h of hormone-treatment. The effect of hormone dose was 
tested by examining the effect of paraffin wax/oestradiol 17^ 
implants of different sizes (lO mg or 50 mg), and oestrogen 
content (l% or lO^o). Under the conditions utilized, inhibitor 
activity was completely lost within 24 h using 30 mg/lO^ 
or 10 mg/10% implants, but the l%/50 mg and 1%/10 mg caused 
only a small decrease in inhibitor activity. Taken together
these results suggested that the loss of uterine cytoplasmic 
inhibitor activity required a high dose of oestrogen.
It seemed likely that the level of circulating 
oestrogen obtained with these implants would be considerably 
higher than physiological levels of the hormone. Clark _et al. 
(1978) compared the effect of a single injection of 
oestradiol-17  ^with that of 50 mg/lO% implants. Animals 
treated with implants showed increased long-term nuclear 
retention of oestrogen receptor, increased RNA polymerase 
activity, and increased hypertrophy of luminal epithelial 
cells relative to animals receiving a single injection.
Waters and Knowler (198I), compared the effect of a single 
injection and oestrogen implants on RNA synthesis in immature 
rat uteri. A peak of uterine RNA synthesis occurring between 
2 and 12 h after administration of a single injection was 
less prevalent in implanted animals, whilst a peak of uterine 
RNA synthesis, occurring between 8 and 24 h after administration 
of implants, was not detectable in animals receiving a 
single injection. The aforementioned observations presumably 
relate to the differential effect of single injections and 
oestrogen implants on uterine ribonuclease inhibitor.
That the response to implants was physiological was 
indicated by the disappearance of inhibitor activity during 
normal sexual maturation of the rat (Munro and Knowler, 1982 
and work presented in this thesis), and the partial restoration 
of inhibitor activity after ovariectomy of mature rats 
(Zan-Kowalszewska and Roth, 1975)*
4.2 Quantitative analysis of uterine ribonuclease inhibitor 
Experiments illustrating the quantitation of inhibitor, 
using antiserum raised to purified rat liver inhibitor, were 
described in Section 3.1.2. In order to obtain a good mono- 
specific antiserum, it was first necessary to purify the 
inhibitor to homogeneity. Initially the procedure described 
by Blackburn (l979) to purify the inhibitor from human 
placenta was utilized. This employed ammonium sulphate 
precipitation followed by affinity chromatography on 
sepharose-RNase A, and in the author’s hands yielded an 
apparently homogeneous inhibitor with an overall yield of 
40-60%. When this procedure was applied to the purification 
of rat liver inhibitor, contaminating proteins were detected 
in the final preparation. The problem was overcome by re­
chromatographing the purified inhibitor on sepharose-RNase A. 
Burton and Pucci (1982) also found that it was necessary 
to take this precaution in obtaining homogeneous inhibitor 
from the liver of a number of mammalian species. Further, 
they demonstrated that a more homogeneous preparation was 
obtained by ensuring that the sepharose-RNase A column became 
saturated with inhibitor. Presumably this was due to non­
specific binding of other liver proteins to the RNase A 
moiety of the resin. Burton and Pucci reported yields of 
purified inhibitor between 60-80%. In this study the yield 
was never greater than 40%. The reason for this anomaly 
remains unclear.
The antiserum raised to purified inhibitor was found 
to contain some contaminating antibodies. This was unexpected 
in view of the apparent homogeneity of the inhibitor 
preparation. The most probable explanation is that the 
inhibitor preparation contained low levels of contaminating 
proteins, not detected by SDS-PAGE, but nonetheless present 
in sufficient quantities to elicit an immune response. 
Contaminating antibodies were removed by adsorbing the 
antiserum with the antigens present in the run through fraction 
of the sepharose-RNase A affinity column. The adsorbed 
antiserum was found to be mono-specific and was considered 
suitable for use in quantitation experiments.
The conclusions to emerge from the quantitation of 
uterine inhibitor (Table 3A) were as follows:
(i) The concentration of total inhibitor increased gradually 
with time after oestrogen—treatment and, 4 days after oestrogen— 
treatment, reached levels 50% greater than those of control 
animals.
(ii) A similar increase was observed in mature rat uteri.
(iii) The ratio of free to bound inhibitor in immature rat 
uteri was approximately 3:1»
(iv) No free inhibitor was detected in oestrogen-treated 
or mature animals.
(v) The observed increase in total uterine cytoplasmic 
ribonuclease activity, and the appearance of free ribonuclease 
in oestrogen-treated and mature uteri indicated that the
loss of inhibitor activity resulted from saturation of the 
inhibitor by endogenous ribonuclease.
From the data in Table 3(a ) it was possible to calculate 
the ribonuclease activity associated with a given quantity 
of inhibitor. Thus, as there was no free enzyme in immature 
uteri, the quantity of bound inhibitor was divided by the 
total enzyme activity. This yielded a figure of approximately 
2.6 units/ng inhibitor. Conversely, in the oestrogen-treated 
uterus a similar calculation for bound enzyme yielded an 
average figure of 3» 8 units/ng inhibitor. Thus it was apparent 
that there were differences either in the specific activities 
and/or the stoichiometry of interaction between the ribonucleases 
and the ribonuclease inhibitor present in untreated and 
oestrogen-treated/mature animals.
The aforementioned data was expressed on the basis of 
units of ribonuclease or ng of inhibitor per mg of cytoplasmic 
protein. Because oestrogen-treatment results in elevated 
levels of total uterine protein, (Billing ejt s^. , I969), 
the actual increase in inhibitor and ribonuclease would be 
higher than indicated. This however is offset by the increased 
cell content of oestrogen-stimulated uterus, as evidenced by 
a two-fold increase in uterine DNA content, (Waters and Knowler, 
1981). Thus, the results presented in Table 3(a) should 
approximate to the inhibitor and ribonuclease levels per cell.
The immature rat uterus has been estimated to contain 13 
different cell types distributed through three different 
tissues;- the epithelium, myometrium and stroma. The data 
presented in Table 3(a ) obviously takes no account of the 
possibility that the observed differences may reside in 
different cells.
4.3 Analysis of ribonuclease inhibitor in other rat tissues
The total inhibitor content of various tissues of the 
rat was estimated by densitometric analysis of the immunoblot 
shown in Figure 8 (see Table 3(b )), The inhibitor content 
of spleen, kidney and pancreas was similar to that found 
in untreated immature uteri, whilst that of liver, brain and 
lung were relatively low. This experiment did not give any 
indication of the ratio of free to bound inhibitor in these 
tissues, as inhibitor/ribonuclease complexes were dissociated 
under these conditions.
In a later experiment, (Figure 20), the same tissues were 
analyzed by immunoblotting from non-denaturing gels. In 
this manner it was possible to gain information on the ratio 
of free to bound inhibitor. Apart from immature rat uteri, 
the only tissues with detectable levels of free inhibitor 
were liver and brain. The free inhibitor of liver appeared 
to constitute approximately 309  ^of the total liver inhibitor, 
whilst that of brain was barely detectable.
Previous comparisons of inhibitor levels in various 
tissues have relied on the assay of inhibitor activity rather 
than direct quantitation of the protein. Roth (1956) found 
that inhibitor activity was highest in rat brain, followed 
by liver, lung, spleen and kidney. The activities of lung, 
spleen and kidney were approximately 50% of those found in 
brain and liver. There was however considerable variation 
in the activities of all of the tissues except liver. In a 
later study, Bartholeyns and Baudhin (1977) reported that
the inhibitor activity of rat brain and kidney were 
insignificant compared with that of liver. They also reported 
that the activity of lung and spleen were relatively high.
Once again, considerable variation was seen about the mean 
value obtained from a number of determinations. The results 
of Bartholeyns and Baudhin (1977) are subject to some 
criticism: It was claimed that the inhibitor activities
were corrected for the ribonuclease content in the tissue 
concerned, but the method by which this correction was derived 
was not stated. As a consequence it is not clear whether 
the inhibitor activities quoted by these workers referred to 
free inhibitor or free plus bound inhibitor.
The determination of the ratio of free to bound inhibitor 
has previously been calculated by assuming that the cytoplasmic 
ribonucleases have a similar specific activity, molecular 
weight and stoichiometric interaction with the inhibitor as 
has bovine RNase A. Thus, Roth (1967) calculated that the 
ratio of free to bound inhibitor in rat liver is approximately 
5:1.
Clearly the ratios of Roth (1967), as well as some of 
the data of other workers mentioned above, differ considerably 
from the results presented in Figure 20. Some possible reasons 
for these discrepancies are as follows
(i) Chesters and Will (1978) reported that the inhibitor 
activity of various rat tissues decreases with ageing and 
in animals fed on a restricted diet. Thus, some of the 
variation seen in the inhibitor activity of various tissues
may be attributable to differences in the age and diet of 
the animals used. The tissues analysed in Figure 20 were 
derived from ex-breeding stock female rats and may therefore 
have unrepresentative free inhibitor levels.
(ii) Differences in the procedures used to isolate the various 
tissues and to prepare sub-cellular fractions may result in 
variations in inhibitor or enzyme levels.
(iii) Differences in the procedures utilized to assay inhibitor 
and enzyme, together with differences in the definition of 
units in the early literature, make it difficult to compare 
results from different laboratories.
(iv) The assumption that the ratio of free to bound inhibitor 
can be calculated by expressing cytoplasmic ribonuclease 
activity as RNase A equivalents is subject to some criticism. 
Results presented in this thesis and from other laboratories 
(Button e_t al. , 1982; Davies ejfc al. , I960} Kumagai ejfc al. . 
1983), demonstrate that the cytoplasmic enzymes are distinct 
from their secretory counterparts on the basis of molecular 
weight and a number of other properties.
The results presented in Figure 20 are in agreement 
with those of Roth (1956) and Bartholeyns and Baudhin (l977) 
to the extent that free inhibitor was detected in rat liver 
and brain, and not in kidney. Whilst it is clear that further 
studies are required, it is hoped that immunoblotting from 
non-denaturing gels will provide a powerful technique for 
the analysis of the inhibitor/ribonuclease system. The 
use of immunoblots to study inhibitor/ribonuclease complexes 
did however produce some unexplained artifacts:-
(i) For unknown reasons immunoblots did not detect the 
ribonuclease inhibitor in rat pancreas, (Figure 20). 
Furthermore, pre-incubation of purified inhibitor with excess 
RNase A decreased the quantity of total bound and unbound 
inhibitor detected (Figure l6b). These two results indicated 
that the presence of high levels of secretory ribonuclease 
had some unknown effect on the electrophoretic mobility of 
inhibitor/ribonuclease complexes.
(ii) An unidentified band occurred near the origin of the 
gel in Figure 20. It is possible that this represented 
inhibitor associated with free mRNP particles, as described
by Gileadi ejt al. (1984). Confirmation of this awaits further 
analysis. Whether this signal represents inhibitor associated 
with enzyme or not is also of interest.
(iii) Possible differences in the ability of the antiserum
to recognize free or bound inhibitor, together with possible 
differences in the efficiency of transfer of free and bound
inhibitor, may lead to inaccuracies in any attempt to 
quantitate free to bound ratios.
4.4 Studies on the uterine cytoplasmic ribonucleases
McGregor ejfc al. (198I) and Munro and Knowler (1982) 
found that the loss of inhibitor activity in oestrogen-treated 
and developing uteri was accompanied by an increase in total 
cytoplasmic ribonuclease activity. However, because it was 
not possible to relate units of enzyme and inhibitor activity 
to molar ratios, the possibility that the increased enzyme 
activity could lead to the loss of inhibitor activity was 
not investigated.
In these studies, quantitative data on the level of 
inhibitor, together with studies on the level of free 
and bound enzyme, activities, provided evidence that the 
loss of inhibitor activity resulted from increased cytoplasmic 
ribonuclease (Table 3 (A)). ^
A number of studies have demonstrated that the ribo­
nuclease inhibitor activity in various tissues changes in 
response to certain physiological and pharmacological stimuli 
(Section 1.4.4). Although these studies have often demonstrated 
that such changes are accompanied by increased or decreased 
total cytoplasmic ribonuclease activity, many workers seem 
to have assumed that inhibitor activity is regulated by changes 
in the level of the inhibitor protein. Thus, Shortman (1961) 
proposed that the increase in inhibitor activity seen in 
regenerating rat liver results from increased concentration 
of the inhibitor protein. Liu et al. (1975) proposed that 
the increased inhibitor activity of lactating mammary glands 
was also due to increased levels of the inhibitor protein. 
However, in both of these cases a decrease in total cytoplasmic 
ribonuclease activity was also seen. It was therefore possible 
that the observed changes were in the enzyme rather than 
the inhibitor.
Careful analysis of the literature reveals that increased 
inhibitor activity is often accompanied by decreased total 
cytoplasmic ribonuclease activity, whilst decreased inhibitor 
activity is often accompanied by increased total cytoplasmic 
ribonuclease activity (von Tigerstrom, 1972; Chesters and 
Will, I97S; Poels, 1976; Quirin-Strieker et al. i960 and others).
This observation raises the possibility that regulation 
of the inhibitor;ribonuclease ratio may be attributable 
to changes in the level of the enzyme moiety rather than 
the inhibitor. Confirmation of this hypothesis will require 
a detailed quantitative analysis of the systems concerned, 
using methods similar to those applied to the oestrogen- 
treated uterus in this study.
In the previous section it was stated that the data 
presented in Table 3(a ) indicated that the ribonuclease activity 
bound to a given quantity of inhibitor increased in the 
oestrogen-treated or mature uterus relative to untreated 
immature rat uteri. Whilst some of this increase may be 
attributable to variability in the quantitative analysis, 
the overall implication was that there are differences in 
the properties of the ribonuclease present in control and 
oestrogen-stimulated uteri. This hypothesis was supported 
indirectly by the observation that there is heterogeneity 
amongst the ribonucleases present in uterine cytoplasm, and 
that the level of the different species is differentially 
affected by oestrogen-treatment.
Activity stain analysis of uterine cytoplasm (Figure 11) 
revealed the presence of at least two ribonuclease species 
differing on the basis of molecular weight. This method 
had previously been used to analyze the secretory type I 
ribonucleases, (Blank e_t , I982). The method was particularly 
suited to the detection of these enzymes due to their ability 
to regain activity after SDS-denaturation. The activity of
most enzymes is lost after SDS-denaturation, and activity 
stain methods using SDS-polyacrylamide gels have been 
developed for relatively few enzymes, e.g. proteases, 
amylases and dehydrogenases (Lacks and Springhorn, I98O) 
and DNA polymerases (Spanos ^t al., I98I). The method of 
Blank ejt al. (1982) was very sensitive, detecting as little 
as 10 pg of bovine RNase A. Ribonucleases from human serum 
were also readily detected. The result presented in Figure 11 
however represents the first demonstration that the non- 
secretory type I ribonucleases can also be detected by 
this method.
Some caution should however be exercised in the 
interpretation of the results. The reasons for this are 
as follows:-
(i) Because the samples were boiled in the presence of SDS 
prior to electrophoresis, enzymes existing as dimers or higher 
oligomers in vivo would become dissociated. Thus multiple 
subunit ribonucleases, if they exist, would be missed.
(ii) Because ^-mercaptoethanol was omitted from the sample 
buffer, it is possible that some of the disulphide bonds 
of the enzymes remained intact. This would affect their 
mobility in the gel and lead to anomalous molecular weights. 
Furthermore, it is not known what effect the RNA incorporated 
into the gel may have on the migration of the enzymes and 
molecular weight markers.
(iii) The slow migration of RNA during the period of electro­
phoresis meant that the top part of the gel was weakly stained. 
As a consequence it would have been difficult to detect species
with high molecular weights. This problem was less apparent 
when a stacking gel containing RNA was utilized. This 
however led to leakage of samples at the stacking gel/ 
resolving gel junction, resulting in cross contamination 
of the tracks.
(iv) Some enzyme species detected may not have renatured as 
efficiently as others, whilst some species may not have 
renatured at all. Therefore the apparent relative intensity 
of the bands may not have reflected the actual enzyme 
concentration in the original sample.
(v) The zymogram method would not resolve enzymes with the 
same molecular weight but different charges.
The ribonuclease species detected by activity staining 
were not detectable by immunoblot analysis using antiserum 
raised to bovine RNase A, (Figure 12). In retrospect this 
finding was not altogether unexpected: Firstly, the pancreatic
enzymes exhibit a relatively rapid rate of evolutionary 
change (Blackburn and Moore, I982). It would perhaps have 
been wiser to raise antisera to rat pancreatic RNase A, 
although this would have involved purifying the enzyme. 
Secondly, immunological studies on human ribonucleases 
(Weick-mann and Glitz, I982) demonstrated that antiserum 
raised to human RNase A cross-reacted with the enzymes of 
human serum and urine, but not with the intracellular enzymes 
of spleen and liver. Similar findings were reported for the 
ribonucleases of rat (Gordon, 1963).
Immunoblot analysis of uterine cytoplasm using anti- 
bovine RNase À did however reveal two bands (molecular weight
25.000 and 100,000), although as was previously stated the 
identity of these proteins was unknown. A preliminary 
activity stain experiment revealed a faint band with a 
molecular weight of approximately 100,000, that was present 
in immature uterine cytoplasm, but disappeared in response 
to oestrogen, (data not shown). This result was not however 
repeatable, possibly because the omission of stacking gels 
made it difficult to detect high molecular weight bands. It 
is therefore possible that the high molecular weight protein 
seen by immunoblot analysis represents a ribonuclease that 
is either repressed or relocalized in response to oestrogen.
This result probably warrants further investigation. The
25.000 molecular weight band detected by immunoblotting may 
represent a rat serum ribonuclease, as contamination from the 
serum fraction is likely to occur in the cytoplasmic preparations. 
There is however no direct evidence to support this contention.
The experiments presented in Sections 3*2.3 - 3*2.5 
represented an attempt to determine whether the induction of 
uterine cytoplasmic ribonucleases was due to increased 
transcription from the gene(s) coding for these enzymes.
The observation that the induced ribonucleases first appear 
in uterine cytoplasm 12-18 h after hormone treatment supported 
this hypothesis, as a marked stimulation of uterine RNA 
synthesis occurs 8-24 h after administration of oestrogen 
implants, (Waters and Knowler, I98I). Unfortunately, this
approach failed to detect a clear example of a RNase A like 
mRNA that was induced in response to oestrogen. This was 
most likely due to insufficient homology between the probe 
and the induced mRNA, although the possibility that the 
cytoplasmic ribonucleases were induced by a mechanism other 
than transcriptional activation cannot be ruled out. Further 
studies are clearly required in order to clarify this point.
As was described in Section 3.2.4, the plasmid pcXP6-105 
was not as originally described by MacDonald e_t al. (1982).
A Pst I site flanking the insert appeared to have been replaced 
by an EcoRI site. One possible explanation for this observation 
was that a small deletion occurred in the region containing 
the Pst I site, probably as a result of nicking of the 
homopolymeric dC/dG tails used in cloning the insert, thus 
bringing together sequences that formed an EcoRI site.
Because the plasmid was supplied in the form of naked DNA 
it was necessary to redone it in E. coli HBlOl cells. Thus, 
the events leading to the mutation of the plasmid may well 
have occurred during the transformation process. The plasmid 
utilized in subsequent analyses was derived from a single 
colony after transformation. In retrospect it would have 
been better to select a number of colonies, prepare plasmid 
DNA by a mini-prep method, and confirm that the insert could 
be removed by Pst I digestion.
The method of immunoblotting from non-denaturing gels 
was developed in order to confirm that the loss of inhibitor 
activity from immature rat uteri was due to saturation of 
the inhibitor by the induced ribonucleases, (Section 3*3*1)*
These experiments also provided further evidence of the 
heterogeneity of uterine cytoplasmic ribonucleases, and 
demonstrated that the enzymes differ on the basis of charge 
as well as molecular weight (Sections 3•3»2 and 3*3*3)*
Previously, van der Broeck ejfc al. (1974) demonstrated 
that ribonuclease inhibitor activity could be recovered 
from polyacrylamide gel slices after electrophoresis of 
crude cytoplasm on alkaline pH polyacrylamide tube gels, 
under non-denaturing conditions. Furthermore, it was found 
that free ribonuclease activity was present near the origin 
of the gel, whilst latent ribonuclease was present between 
the free ribonuclease and free inhibitor. Thus, the acidic 
inhibitor migrated most rapidly, the slightly acidic 
inhibitor/ribonuclease complexes were slightly retarded and 
the basic free ribonucleases migrated least rapidly. In 
this study the method of van der Broeck al. (1974) was 
extensively modified;-
(i) A discontinuous h i ^  pH slab gel system was utilized in 
order to improve the resolution of the method.
(ii) The inhibitor and inhibitor/ribonuclease complexes were 
detected by immunoblotting. The identity of the bands was 
however confirmed by assaying gel slices for free and latent 
ribonuclease activity (Figure 17). The failure to detect 
free ribonuclease activity in the gel slices was probably 
due to the inability of the enzymes to migrate beyond the 
stacking gel because of their low mobility at alkaline pH.
(iii) The precautions described in Section 3*3*1 were 
taken in order to ensure the maintenance of inhibitor 
activity prior to or during electrophoresis.
Analysis of uterine cytoplasmic protein resulted in 
the detection of 5-6 inhibitor/ribonuclease complexes.
These were designated B, B ’, C, C ’, D and E (Fig. 18).
Ferguson plot analysis of these bands (Section 3«3»2) 
indicated that the major difference in the complexes resided 
in charge heterogeneity of the enzyme moiety, although 
small differences in molecular weight were also observed.
Chromatography on DEAE cellulose of inhibitor/ribonuclease 
complexes from rat reticulocytes (Aoki j^b al. , 1981 )^ and 
human placenta (Blackburn ejb al. , personal communication, 1985), 
revealed the presence of 2-3 overlapping peaks of latent 
ribonuclease activity. These findings also implied that the 
inhibitor/ribonuclease complexes differ on the basis of 
charge, although it is unlikely that this technique could 
resolve some of the more closely related species seen by 
immunoblotting from non-denaturing gels.
It is difficult to determine the molecular weight of 
proteins with any degree of accuracy using the method of 
non-denaturing polyacrylamide gel electrophoresis. Hedrick 
and Smith (1968) demonstrated that the slope of the Ferguson 
plot for a given protein, (K^), is inversely proportional to 
the molecular weight of the protein. By determining the 
for a large number of proteins of known molecular weight, 
they succeeded in constructing a standard plot from which 
the molecular weight of unknown proteins could be estimated.
However, the large number of proteins required to construct 
a significant plot meant that this method was impractical 
for routine analyses. Whilst the derivation of values 
negates the effect of charge differences, the effect of the 
shape of individual proteins on their electrophoretic 
mobilities is not accounted for. For these reasons it was 
not possible to determine the molecular weight of the inhibitor/ 
ribonuclease complexes detected.
The molecular weight of the individual complexes relative 
to one another and to free inhibitor was however estimated, 
(Table 5)« This data indicated that the highest molecular 
weight complexes were C, C’ and B, B ’. The fact that C and 
C* intensify after treatment with oestrogen suggested that 
the enzymes giving rise to these complexes may correspond to 
the oestrogen-induced high molecular weight ribonuclease 
detected by activity staining (Figure 11). The low molecular 
weight band detected by activity staining also intensified 
after oestrogen-treatment, and it is possible that this 
species, when complexed to inhibitor gives rise to the complexes 
D and E detected by immunoblotting. These complexes had the 
lowest relative molecular weight and were induced by oestrogen- 
treatment. These interpretations are however speculative 
and could only be tested if the complexes were reconstituted 
using purified inhibitor and enzyme.
4. 5 Studies on the purified ribonucleases of rat liver
and uterine cytoplasm
The purification and characterization of cytoplasmic 
ribonucleases was described in Sections 3.4.1 - 3*4.9.
These studies were performed primarily to compare the 
properties of the different species present. In addition 
it was hoped that sufficient quantities could be obtained 
to use in the raising of antisera, that could in turn be 
used to quantitate the enzymes of uterine cytoplasm. 
Unfortunately the time available was not sufficient to carry 
out these studies.
The cytoplasmic ribonucleases of mammalian tissues are 
present in very small quantities. As an approximate guide, 
in rat liver they represent l/l30,000 part of the total 
cytoplasmic protein (Table 6).
Until recently, attempts to purify these enzymes from 
various sources have resulted in only partial purifications 
(Gordon, I963; Okazaki et aT., 1975; Bartholeyns and Baudhin, 
197?; Frank and Levy, 1976; Davies ejfc al. , 1900, and Button 
et al. 1982). Some of these studies were performed on crude 
tissue extracts and it was therefore unknown whether the 
enzymes purified represented those associated with the 
inhibitor Ln vivo. Furthermore, most of these studies utilized 
an acid extraction step in addition to salt fractionation, 
ion exchange chromatography and gel filtration. The exception 
to this was the purification of the cytoplasmic ribonucleases 
of porcine thyroid, (Button ejk aT. , I982), using salt 
fractionation and affinity chromatography. In a later study
by the same group (Rutherford e_t al. , I983), the same 
enzymes were purified by a procedure involving an acid 
extraction step. Comparison of this activity with the 
affinity purified enzymes indicated that acid extraction 
resulted in changes in the charge, molecular weight and 
other properties of the enzymes.
Kumagai ejfc aT. (1983) described a procedure whereby the 
cytoplasmic ribonuclease associated with the inhibitor vivo 
was purified to homogeneity from rat liver. The purification 
procedure was however extremely lengthy and resulted in 
relatively low yields, (approximately 8%). As a consequence, 
large quantities of tissue had to be processed.
None of the above procedures were considered suitable 
for the purposes of this study. Fortunately, at this point 
in these studies P. Blackburn was kind enough to send the 
unpublished details of a purification procedure utilized 
to purify the cytoplasmic enzymes of human placenta. This 
procedure was relatively simple and resulted in high yields 
of the enzymes. However, extensive characterization of the 
homogeneity of the purified enzymes was not available.
The purification of rat liver cytoplasmic ribonucleases 
using the aforementioned procedure was described in Section 
3.4.2. It was necessary to include an extra step, namely 
affinity chromatography on agarose - 2’(3')5* UDF in order 
to obtain homogeneous enzyme preparations. This affinity 
resin has been utilized in the purification of various type I 
ribonucleases, including those of porcine thyroid (Button 
ejt aT. , 1982), and rat liver (Kumagai _et aT. , 1983)*
The kinetic parameters, pH optimum and preference for
poly (c) of the main peak of liver activity (RLC I),
indicated that it was the same enzyme described by Kumagai
et al. (1983)* The molecular weight of RLC I was slightly
higher than bovine RNase A (Figure 23)* Whilst this finding
was in agreement with that of Kumagai’s group, the actual
molecular weights derived in this study appeared to be
aberrant for RLC I and bovine RNase A, (20,000 and 16,300
respectively). This observation may relate to the abnormal
behaviour displayed by some highly basic proteins in SDS-PAGE
although it is not clear why Kumagai*s group did not encounter
a similar problem. The only differences in the procedures
was that Kumagai aT. (1983) utilized a l4% acrylamide gel
(as opposed to 12.59^ this study), and a different set of
molecular weight standards. Purified RLC I had a specific
activity of 3 x 10^ units/mg protein (Table 6),whilst the
enzyme of Kumagai aT. had a specific activity of I.3 x 10
units/mg protein. This difference was probably due to the
different assays utilized; Kumtigai assayed ribonuclease
using 1 mg/ml RNA, which corresponds to the K^ of the enzyme
(i.e. 1/2 V ). RLC I was assayed in 5 mg/ml RNA, a ' ’ max' ' '
concentration at which the enzyme should hydrolyze RNA at 
its maximum velocity.
Activity stain analysis of RLC I (Figure 23) revealed 
the presence of two bands, one with a molecular weight 
slightly higher than bovine RNase A, and a weaker band with 
a similar molecular weight to RNase A. It seemed likely 
that the minor band corresponded to a minor species detected
at an early stage in the purification procedure of Kumagai ejfc al. 
(1983). This however was not investigated further. It was 
assumed that heparin-sepharose chromatography was not sufficient 
to resolve these species, although on one occasion overlapping 
peaks were seen using SP-sephadex chromatography (Figure 21b).
The major inhibitor/ribonuclease complexes detected in 
rat liver by immunoblotting were B and B ’, (Figure 20). It 
therefore seemed likely that these complexes arose through 
binding of the inhibitor to the RLC I species. A third 
complex, C’, was also detected in rat liver cytoplasm. This 
complex may have arisen through binding of the inhibitor to 
the minor RLC II peak detected by heparin-sepharose 
chromatography (Figure 22a). This contention was supported 
by the observation that RLC II was eluted from heparin-sepharose 
by high salt concentrations relative to RLC I, indicating 
that it was a more basic protein, and the complex C ’ was 
more basic than B and B', as indicated by its slower 
migration rate.
Heparin-sepharose chromatography of mature rat uterine 
cytoplasm revealed the presence of three major peaks of 
ribonuclease activity, RUC I, RUC II and RUC III (Figure 24). 
RUC I was eluted by a similar salt concentration to RLC I, 
and appeared to be similar when analysed by activity staining 
(Figure 23). It therefore seemed likely that this activity 
gives rise to the complexes B and B ’ seen in immature, 
oestrogen-treated, and mature rat uterine cytoplasm (Figure 20). 
This contention was supported by the observation that RUC I,
(and RLC l) were eluted from heparin-sepharose by lower 
salt concentrations than any of the other species observed, 
indicating that they were the most acidic enzymes present, 
and that B and B* were the most acidic complexes detected.
Using the same argument, it seemed likely that RUC II gave 
rise to the complexes C and C ’, and that RUC III gave rise 
to the complexes D and E. Further support for this contention 
comes from the observation that the molecular weight, as 
determined by activity staining was higher for RUC II than 
for RUC III (Figure 23), and that the apparent molecular 
weight of the complexes C and C  was higher than that of D 
and E (Table 3)* If the above contentions are correct, then 
RUC II and RUC III represent the enzymes induced by oestrogen, 
as the complexes C, C ’, D and E all intensify after oestrogen- 
treatment, (Figure 18).
When the cytoplasmic ribonucleases of human placenta 
were chromatographed on heparin-sepharose, (Blackburn et al., 
personal communication, I983), 3-6 overlapping peaks of 
activity were seen. The amino acid composition of the two 
major peaks (HP RNase II and HP RNase V, o 7) was
compared, and it was found that HP RNase V resembled human 
pancreatic RNase A, whilst HP RNase II resembled a ribonuclease 
purified from human liver (Frank and Levy, 1976). HP RNase II 
showed a preference for poly (u) compared with tRNA and poly (c), 
whilst HP RNase V showed a preference for poly (c) compared 
with tRNA and poly (u). It was suggested that the 3-4 
remaining species were related to one or other of the major 
species on the basis of their relative activities towards
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tRNA, poly (c) and poly (u). However, it was not known 
whether the minor species represented distinct enzymes or 
whether the different behaviour on heparin-sepharose was due 
to post-translational modification of one of the major species. 
Furthermore, Blackburn calculated that up to 2% of the total 
activity may be contributed by contaminating serum ribonucleases. 
It was therefore possible that one of the minor species was 
derived from the serum fraction. Similarly, it is not known 
whether the different properties of the ribonucleases 
described in this thesis arise through post-translational 
modification, or whether some or all of the enzymes are the 
products of distinct genes. The extent to which serum 
ribonucleases contributed to the activities purified from 
rat liver and uterus is likely to be similar to that calculated 
by Blackburn, although this requires further investigation.
In this study, immunoblot analysis of inhibitor/ribonuclease 
complexes (Figure 20), indicated that 3-6 ribonucleases 
were present in the uterine cytoplasm of oestrogen-treated 
or mature rats. Heparin-sepharose chromatography however 
revealed only three species. The failure to resolve all 
of the species present was probably due to the relatively 
small quantity of material processed, thus making it difficult 
to distinguish overlapping peaks. The relative activity of 
the uterine enzymes towards poly (c), poly (u) and yeast RNA 
revealed that RUC I and RUC II showed a preference for 
poly (c) over poly (u) whilst RUC III showed a preference for 
poly (u). The liver enzyme RLC I showed a preference for
poly (c) compared with poly (u) and yeast RNA. In general 
these findings resemble those of Blackburn, specifically 
in that enzymes showing a preference for poly (u) or poly (c) 
are both present. Any differences observed may be attributable 
to species variations or the fact that Blackburn used tRNA 
as a substrate as opposed to the yeast RNA used in this 
study.
The use of relative activities towards homopolymers to 
compare type I ribonucleases is subject to some criticism; 
Firstly, the rate of cleavage of homopolymers by bovine 
RNase A depends on the ionic strength of the medium, and 
is modified by polyamines (Ball, 1974). Secondly, a 
preference for poly (c) or poly (u) by a given enzyme does 
not necessarily reflect a similar preference for these 
residues in RNA (von Tigerstrom and Manchak, 1976). Finally, 
the observation that rat RNase A shows a preference for 
poly (u), (Beintema e_t ad., 1973), whilst bovine RNase A 
shows a preference for poly (c), (Blackburn and Moore, 1982), 
indicates that these studies can only be used to compare 
the enzymes within a given species.
In the introduction to this thesis it was stated that 
the definition of a type I ribonuclease is "a pyrimidine 
specific endoribonuclease, optimally active at neutral or 
alkaline pH, and acid-thermostable". The observation that 
none of the enzymes purified from liver or uterus showed 
any activity towards poly (a ) or poly (g ) provided indirect 
evidence that they are pyrimidine specific endoribonucleases. 
Further studies are however required to confirm this. The
thermostability of these enzymes was indicated by the fact 
that prior to activity staining, samples were boiled for 
2-3 min. However, as shown dn Figure 27, the pH optimum 
of all of the enzymes except RLC I was not restricted to 
neutral or alkaline pH. This finding was somewhat unexpected 
and it will be interesting to see whether a similar pattern 
is seen with cytoplasmic ribonucleases derived from other 
sources. Bartholeyns ejfc al. (1974) demonstrated that the 
physiological form of bovine RNase A exhibits a dual pH 
optimum at pH 4.5 and 7*5, hut that the purified enzyme is 
only active at pH 7»5* It was suggested that the use of 
acid extraction in such purifications may give rise to this 
phenomenon. It is therefore possible that the dual pH 
optimum seen with the rat cytoplasmic ribonucleases may be 
a general characteristic of type I ribonucleases, and that 
the acid extraction utilized in the purification of most of 
these enzymes has led to the idea that these enzymes are 
only active at neutral or alkaline pH.
It was difficult to draw any concrete conclusions from 
the kinetic data derived for the purified enzymes. The 
data presented in Table 3{a ) indicated that the specific 
activity of the oestrogen-induced ribonucleases was higher 
than that of the enzymes present in unstimulated uteri.
The similar values obtained for RUG I, II and III does 
not support this idea. It is however possible that the assay 
conditions used for the kinetic analysis were not optimal 
for one or more of the enzymes. Thus, variations in the pH
or ionic strength of the medium may reveal more notable 
differences.
Finally, it should be stated that the heterogeneity of 
the purified activities when they were analysed by activity 
staining (Figure 2 5 means that the interpretation of the 
data concerning the characterization of the enzymes is 
subject to some criticism.
4.6. Conclusions concerning the function of the inhibitor/ 
ribonuclease system
The precise function of the inhibitor/ribonuclease system 
is unknown at present. It was hoped that these studies 
would help to answer this question. In general, this aim 
has not been achieved, although certain observations have 
provided an indication of areas for future research.
The presence of excess ribonuclease inhibitor in the 
immature rat uterus, a tissue with low biosynthetic activity, 
and the appearance of free ribonuclease in oestrogen-treated 
uteri, a tissue with elevated levels of RNA and protein 
synthesis, appeared to contradict the hypothesis that 
elevated levels of inhibitor are present in tissues with 
high biosynthetic activity. It was stated in the introduction 
to this thesis that this observation may relate to the 
increased cell growth and differentiation of the oestrogen- 
treated uterus. It is however difficult to explain why a 
single injection of oestradiol-lT^, which induces the growth 
response, has no effect on the inhibitor/ribonuclease system. 
It is possible that these results do not reflect the situation
in vivo ;-
(i) The heterogeneity of cell types in the uterus make it 
difficult to a t t a c h  great significance to findings with 
whole tissue homogenates.
(ii) It is conceivable that homogenization disrupts some 
form of intracellular structure that would normally separate 
the components of the system, (RNA, inhibitor and ribonuclease).
In contrast to the findings in the rat uterus, the 
effect of oestrogen in rooster liver was to increase the 
activity of ribonuclease inhibitor (Djikstra ejfc aT., 1978). 
However, unlike the uterus, oestrogen effects in rooster liver 
include the induction of the major yolk protein vitellogenin.
As was discussed in Section 1.4.4, high inhibitor activity 
appears to correlate with the production of major abundant 
proteins in various tissues. Ambellan and Roth (1968) 
reported that corticoid treatment resulted in a large increase 
in the cytosolic ribonuclease activity in lymphoid tissues.
In a later study (Ambellan, 1978) it was demonstrated that 
glucocorticoid treatment of liver cytoplasm in vitro reduced 
the activity of the ribonuclease inhibitor by 3^ °^» Taken 
together, these results provided a further example of steroid 
hormones decreasing cytoplasmic inhibitor levels and an 
indication that such events can occur independently of nuclear 
binding of steroid/receptor complexes. However, the fact 
that the ribonuclease induced in lymphoid tissue was 
purportedly an acid ribonuclease, and the fact that gluco­
corticoid effects vivo were not examined in the latter 
study, indicate that further studies are required to determine 
the significance of these results.
There has been a recent interest in the effect of
ribonuclease on the physico-chemical properties of untransformed 
steroid hormone receptors. Tymoczkoand Phillips (1983) 
reported that the 8S glucocorticoid receptor is converted to 
a 4S form by RNase A treatment. The 4S form shoved increased 
affinity for DNA-cellulose. Essentially similar findings 
were reported for the oestrogen receptor of rat and rabbit 
uterine cytosol (Thomas and Kiang, 1985)» RNA is known to 
compete for DNA binding sites of androgen, oestrogen and 
glucocorticoid receptors (Liao ejt aT. , I98O; Feldman jet al. , 
1981). It is therefore possible that steroid receptors bind 
to RNA in the target cell cytoplasm. Whether this binding 
is specific, and plays a role in the function of the receptors 
remains to be determined. Furthermore, whether or not this 
phenomenon reflects a function for the endogenous cytoplasmic 
ribonucleases is conjectured.
The work presented in this thesis and by other workers 
indicates that the type I ribonucleases bound to the inhibitor 
in vivo are distinct from their secretory counterparts.
However, the precise function of these enzymes remains 
unclear. Some of the main points that require clarifying 
are the following;-
(i) If these enzymes are involved in eukaryotic RNA metabolism, 
under what circumstances are they liberated from the endogenous 
inhibitor?
(ii) Does the heterogeneity of these enzymes reflect different 
functions for the various species?
(iii) To vhat extent do serum ribonucleases or enzymes 
from sub-cellular fractions other than the cytoplasm 
contribute to the activity recovered from tissue homogenates?
4.7 Some considerations for future studies
One criticism of the aforementioned studies is that the 
attempts to relate the purified enzymes with the activity 
stain and non-denaturing immunoblot data is not supported 
by any direct evidence. A priority for futuire studies would 
therefore be to obtain sufficient quantities of the purified 
enzymes to carry out reconstitution studies with purified 
inhibitor, and subsequently analyse the reconstituted 
complexes by non-denaturing immunoblots.
4.7*1 Studies on the localization of the inhibitor protein 
Immunohistochemical studies on the rat uterus may help 
to achieve a better understanding of the changes in the 
inhibitor/ribonuclease system after oestrogen-treatment.
Such studies could be extended to a cell culture system in 
order to determine the localization of the inhibitor in 
intact cells. In addition the effect of varying the growth 
state of the cells could be investigated. Preliminary 
studies in our laboratory have shown that both free inhibitor 
and inhibitor/ribonuclease complexes can be detected in a 
number of rodent cell lines using the non-denaturing gel 
immunoblot method.
The observation that inhibitor/ribonuclease complexes 
are bound to free mRNP particles isolated from human placenta
(Gileadi e_t ad. , 1984) warrants further investigation. Such 
studies should be extended to investigate whether the 
inhibitor associates with polyribosomal mRNP’s. It will 
also be interesting to determine whether it is the enzyme 
or inhibitor that binds to the RNA or protein of mRNP’s.
The answer to this question may have some bearing on the 
question concerning the mode of inhibition of the enzymes, 
i.e. do enzyme : inhibitor; substrate complexes exist?
4.7*2 Further studies on the cytoplasmic ribonucleases
A number of properties of the purified enzymes described 
in this thesis were not investigated. These include the 
effect of monovalent and divalent ions and of polyamines on 
the activity of the enzymes, identification of the products 
of RNA hydrolysis, and studies on the stoichiometry of 
enzyme/inhibitor interaction. Determination of the sequences 
cleaved in an RNA molecule of known sequence may provide 
some information on the function of the different enzymes.
Such studies would be facilitated if larger quantities of the 
enzyme were available. In this respect, rat kidney appears to 
contain all of the enzymes detected in other tissues (Figure 
20), and may provide a good source for the purification. It 
may also be possible to resolve the individual species seen 
in each of the purified activities (Figure 25), using a 
technique such as HPLC.
The availability of larger quantities of the enzymes 
would also facilitate immunological studies. Thus, a mono- 
specific antiserum could be prepared and used to quantitate 
and compare the various enzymes. Antiserum could also be 
used to isolate cDNA clones encoding these enzymes. Similar
studies are already in progress in our laboratory, using 
the antiserum raised against rat inhibitor to screen a 
cDNA expression library. The availability of primary 
sequence data for the inhibitor and enzymes would provide 
an interesting system in which to study protein-protein 
interactions.
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